The effect of diet on the acute and chronic responses to exercise with a particular focus on adipose tissue by Chen, Yung-Chih
        
University of Bath
PHD
The effect of diet on the acute and chronic responses to exercise with a particular








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. May. 2019
1 
THE EFFECT OF DIET ON THE ACUTE AND 
CHRONIC RESPONSES TO EXERCISE WITH A 







A thesis submitted for the degree of Doctor of Philosophy 
 
University of Bath 






Attention is drawn to the fact that copyright of this thesis rests with the author. A copy of 
this thesis has been supplied on condition that anyone who consults it is understood to 
recognise that its copyright rests with the author and they must not copy it or use material 
from it except as permitted by law or with consent of the author. 
 
This thesis may be made available for consultation within the University Library and may 
be photocopied or lent to other libraries for the purposes of consultation with effect from 
31/10/2016. 
Signed on behalf of the Department for Health 





Long-term excessive positive energy balance results in overweight and obesity, which 
is caused by adipose tissue deposition. This increases the occurrence of cardiovascular 
diseases and type 2 diabetes. Adipose tissue plays an active role in the development of 
these diseases and so it is important to understand how this tissue responds to relevant 
stimuli such as feeding, fasting and physical activity.  
 
The study in Chapter 4 examined the impact of fasting and feeding, on adipose tissue 
responsiveness to prolonged moderate intensity exercise. Ten healthy overweight men 
aged 26 ± 5 years (mean ± SD) with a waist circumference of 105 ± 10 cm walked at 
60% of maximum oxygen uptake under either fasted (12 h overnight fasting) or fed 
(70% carbohydrate breakfast) conditions in a randomised, counterbalanced design. 
Feeding comprised 648 ± 115 kcal 2 h before exercise. The expression of several 
metabolism-related adipose tissue genes was acutely regulated whilst participants 
undertook fasted exercise, including up-regulation of lipolytic lipase and transporter 
(adipose triglyceride lipase, hormone sensitive lipase & fatty acid translocase/CD36), 
glycolytic inhibitor (pyruvate dehydrogenase 4), insulin singling molecules (glucose 
transporter type 4 & insulin receptor substrate 2) as well as adipose insulin receptor 
substrate 2 protein contents (all p ≤ 0.05), compared to exercise in the fed state. The 
results indicate that adipose tissue responsiveness to prolonged exercise is affected by 
the dietary conditions. The study in Chapter 5 examined whether adipose tissue would 
be influenced by more modest changes in accumulated physical activity. Eleven 
overweight participants (7 men and 4 post-menopausal women) aged 50 ± 5 years 
(means ± SD) completed two identical mixed meal (~1,700 ± 360 kcal in total) feeding 
trials (prolonged sitting versus breaking sitting) in a randomised, counterbalanced 
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design. The breaking sitting intervention comprised walking for 2 min every 20 min 
over 5 h. The results demonstrated that postprandial insulin and glucose concentrations 
were attenuated (all p ≤ 0.05) while participating in regular small bouts of walking but 
this did not affect adipose tissue metabolic- and insulin-associated pathways in adipose 
tissue. The study in Chapter 6 examined the responsiveness to aforementioned 
different forms of physical activity (a single bout of prolonged exercise versus 
accumulation of small bout of physical activity) on a challenge imposed by 50% 
overfeeding. Twenty-four lean, active and heathy men aged 21 ± 3 years were recruited. 
Participants were randomised to either an overfeeding with restricted physical activity 
(≤ 4,000 steps per day) group (OVER, n = 8), overfeeding with restricted physical 
activity (≤ 4,000 steps per day) plus daily 45 min endurance moderate intensity walking 
group (50% V̇O2max) (OVER + EN, n = 8) or overfeeding with restricted physical 
activity (≤ 4,000 steps per day) plus intermittent breaking sitting group (OVER + 
BREAKS, n = 8). All groups achieved the same overfeeding (50% of overfeeding based 
on their habitual diet). Notably, despite the impairment of insulin sensitivity as a result 
of the energy surplus, the accumulation of small bouts of physical activity blunted 
overfeeding induced up-regulation of adipose lipogenetic activity (i.e. the down-
regulation of sterol regulatory element binding protein 1c and fatty acid synthase) and 
circulating inflammation (i.e. no change of white blood cell count) compared to energy 
surplus with sedentary lifestyle and/or overfeeding plus a single bout of moderate 
intensity exercise. This could mean that the form of physical activity undertaken could 
play a key role in lipogenesis activation. 
 
Based on the results from this thesis, it appears that energy consumption and physical 
activity are both capable of acutely and chronically influencing adipose tissue metabolic 
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1 Chapter 1: Introduction 
 
1.1 Overview of physical activity 
The balance of energy expenditure and intake dictates whether people will gain or lose 
weight. Daily energy expenditure (DEE) consists of basal metabolic rate (BMR), diet-
induced thermogenesis (DIT) and physical activity-induced energy expenditure 
(PAEE). BMR accounts for approximately 60% of DEE and is influenced by body size, 
amount of skeletal muscle and health condition. DIT is typically approximately 10 % 
of DEE and is influenced by the kind of food ingested, as well as digestion and 
absorption processes. Relative to BMR and DIT, PAEE is the most unpredictable 
element of DEE that could range widely from inactive (i.e. a sedentary office worker) 
to very active (i.e. a professional athlete). Indeed, PAEE could vary by up to 2000 
kcal·day-1 (Levine, 2007).  
 
Physical activity includes any types of body movement produced by skeletal muscle, 
leading to energy expenditure above resting level (Caspersen et al., 1985), including 
structured (exercise) and unstructured physical activity (non-exercise activity 
thermogenesis, NEAT). Moreover, the intensity is an important component of physical 
activity and it consists of the concept of relative and absolute intensity. The percentage 
of maximal oxygen up take (% V̇O2max) is the concept of relative exercise intensity and, 
based on American College of Sports Medicine (ACSM) position, moderate intensity 
ranges from 46% to 63% V̇O2max and vigorous intensity ranges from 64% to 90% 
V̇O2max (Garber et al., 2011). In terms of absolute physical activity intensity, metabolic 
equivalents (METs) are frequently used, representing fixed units of energy expenditure 
to define the intensity of physical activity where the value ranges from below 3 METs, 
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indicating sedentary behaviour (e.g. sitting or lying) to above 9 METs meaning high 
intensity exercise (e.g. running) (Norton et al., 2010; Nimmo et al., 2013) (Figure 1.1). 
 
Figure 1.1 The definition of physical activity intensity 
  (Norton et al., 2010) 
 
 Prolonged exercise  
Physical activity induced thermogenesis can be further divided into two subcomponents 
including volitional exercise thermogenesis and non-exercise activity thermogenesis 
(NEAT). Exercise is a type of planed, structured physical activity resulting in skeletal 
muscle movement and aims to maintain or to promote physical fitness (Caspersen et al., 
1985). In the past few decades, participation in regular exercise has been confirmed as 
a useful strategy to maintain body weight and to prevent cardiovascular disease and 
type 2 diabetes. In general, the concept of ‘exercise’ is expressed in terms of frequency, 
intensity, type and time. The latest American College of Sports Medicine (ACSM) 
position stand published in 2011 stated that the aerobic exercise prescription for general 
individuals is to engage in moderate intensity activity (i.e. 46% to 63% V̇O2max) at least 
30 min per day for 5 days a week or vigorous intensity (i.e. 64% to 90% V̇O2max) at 
least 20 min a day on 3 days a week, or to combine the variation of moderate- and 
vigorous- intensity exercise to accumulate ≥ 500–1000 METs a week (Garber et al., 
2011). 
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It is well known that participating in structured prolonged exercise training can change 
adipose tissue masses (Campbell et al., 2013; Vissers et al., 2013). It has been suggested 
that changes in adipose masses might due to the reduction of adipocyte size and/or 
number after exercise training (Campbell et al., 2013). Adipose tissue is not just a 
storage tissue but plays an active role in health such as energy metabolism and 
inflammation-related adipokines regulation (Thompson et al., 2012). And, it has been 
shown that adipose gene expression is modified after acute prolonged exercise 
irrespective of changes in adipose masses (Frydelund-Larsen et al., 2007; Hojbjerre et 
al., 2007; Christiansen et al., 2013a). Most acute exercise studies are conducted after 
overnight fasting. Interestingly, diet impacts upon circulating substrate utilization (Wu 
et al., 2003; Cluberton et al., 2005; De Bock et al., 2005; Backhouse et al., 2007), and 
also alters skeletal muscle gene expression responses including energy metabolism, 
glucose and lipid transport as well as insulin signalling pathway (Civitarese et al., 2005; 
Cluberton et al., 2005; De Bock et al., 2005; Nieman et al., 2005; Treebak et al., 2014). 
The effect of diet on acute skeletal muscle responses has been proposed to influence 
physiological adaptations after long-term exercise training (De Bock et al., 2008; 
Stannard et al., 2010; Van Proeyen et al., 2010; Van Proeyen et al., 2011). Thus, it is 
also possible that diet interacts with exercise to change the adipose tissue responses to 
exercise (especially given that adipose is very active in the postprandial period 
(Enevoldsen et al., 2004) and also involved energy metabolism regulation during 
exercise (Horowitz, 2003)) But, surprisingly, adipose tissue responses to acute exercise 
under different dietary conditions has never been studied. So, it is important to 
determine how adipose tissue responds to acute exercise under fasted or fed conditions 
and this will be the first step of this PhD.  
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However, engaging in planed structured continuous exercise for at least 30 min is not 
feasible for everyone. This has led to the notion that exercise can be accumulated in 
shorter bouts 10 min. This has been proved as equally effective to reduce triglycerides 
(TG) concentrations as continuous exercise whether cycling at 60% maximum heart 
rate (HRmax) in obese males (Miyashita, 2008), jogging at 60% V̇O2max in a sedentary 
population (Altena et al., 2004), running at 70% V̇O2max in healthy males (Miyashita et 
al., 2006) or brisk walking at 40% V̇O2max in self-selected pace physical activity 
(Miyashita et al., 2008). Participating in regular exercise aims to maintain physical 
fitness and energy balance, and thus prevent the burden from obesity-related diseases. 
On the other hand, continuous or accumulated exercise takes up a small part of daily 
life – and there may be an alternative non-exercise way to enhance energy expenditure 
and/or improve health.  
 
 Non-exercise activity thermogenesis (NEAT) 
NEAT is similar to spontaneous physical activity (SPA) and contains any type of 
physical activities, which increases energy expenditure, but excluding volitional 
sporting-like exercise. NEAT is the most variable component of physical activity 
energy expenditure ranging from 15% to 50% of total energy expenditure (TEE) 
(Levine, 2003) and can vary by approximately 2,000 kcal·day-1 between active and 
inactive people of the same body size (Levine, 2007). Indeed, for sedentary individuals, 
the role of NEAT is a key determinant of energy expenditure and the major source of 
physical activity (Hamilton et al., 2007). As shown in Figure 1.2 (A), taking away 
exercise does not have a major impact on total energy expenditure. In contrast, for 
inactive people the manipulation of NEAT will have a major impact on their energy 
balance (Figure 1.2B). Therefore, enhancing NEAT could be another option for 
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maintaining body weight and preventing obesity-related disease, especially for those 
who are the most sedentary. 
 
 
Figure 1.2 The component of total energy expenditure 
(A) The proportion of energy expenditure in active people (B) The proportion of 
energy expenditure in inactive people (Hamilton et al., 2007) 
 
In addition to the manipulation of energy balance, NEAT-type behaviours could have 
a profound metabolic and physiological effect, over-and-above the impact on energy 
balance. Prolonged sitting or sedentary behaviour shows a positive correlation with 
metabolic-related diseases (Ford et al., 2005; Grontved & Hu, 2011; Dunstan et al., 
2012a) independent of physical activity (Biswas et al., 2015). Recent research shows 
that breaking prolonged sitting and sedentary time (i.e., increasing NEAT-type 
behaviours) appears to offer various health benefits, including muscle health, fat 
oxidation and postprandial glycemia and insulinemia (Dunstan et al., 2012b; Ando et 
al., 2013; Latouche et al., 2013; Peddie et al., 2013; Bailey & Locke, 2015; Henson et 
al., 2016). Even low intensity physical activity elicits powerful effects in adipose tissue 
(Thompson et al., 2012). However, it is unclear whether one of the mechanisms through 
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which breaking prolonged sedentary behaviour and increasing NEAT improves health 
is through changes in adipose tissue physiology and function. Therefore, the second 
project of this PhD will explore this question. 
 
 Sedentary life style and overfeeding 
Lack of physical activities and/or NEAT is part of cause resulting in energy imbalance 
which contributes overweight and obesity. Several studies have shown that increased 
sedentary behaviour is significantly associated with increased risk of abnormal glucose 
metabolism, metabolic syndrome, type 2 diabetes and cardiovascular disease (Ford et 
al., 2005; Wilmot et al., 2012). Apart from sedentary life style, overfeeding can also 
induce weight gain, glucose intolerance, insulin resistance, mitochondria dysfunction 
as well as adipose tissue remodelling after short-term overfeeding (Brons et al., 2009; 
Tam et al., 2010; Alligier et al., 2012; Walhin et al., 2013). However, high amount of 
NEAT (Levine et al., 1999) or a single bout of 45 min high intensity exercise (70% 
V̇O2max) (Walhin et al., 2013) can counteract such an overfeeding effect. But, studies 
have never compared the impact of these two different strategies (i.e. a single bout of 
exercise versus breaking sedentary behaviour) on the impact of overfeeding. Acutely 
participating in small bouts of walking throughout a day or single bout of continuous 
excise impacts skeletal muscle responses at a cellular level (Civitarese et al., 2005; 
Cluberton et al., 2005; De Bock et al., 2005; Latouche et al., 2013). However, it is 
unclear how adipose tissue responds to such different physical activity strategies. 
Therefore, the final project of this PhD will examine how adipose tissue responds to 
two different types of physical activity intervention in the context of overfeeding and a 
positive energy balance.
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2 Chapter 2: Literature review 
 
2.1 Overweight/obesity and adipose tissue  
 The definitions of overweight and obesity 
Obesity and being overweight are caused by energy consumption outweighing energy 
expenditure, so excess energy is stored as adipose tissue. The accumulation of excess 
adipose tissue is associated with insulin resistance, metabolic syndrome, cardiovascular 
disease and type 2 diabetes mellitus (T2DM). Generally, obesity can be estimated by 
body mass index (BMI) according to the calculation of height and weight of an 
individual. While a BMI ≥ 25 and ≥ 30 (kg·m-2) represents being overweight and obese 
respectively, this does not take into account the impact of variation in body 
composition. For example, high amounts of muscle mass can lead to an overweight 
classification using BMI but the person actually has a low fat proportion and a low risk 
of cardiovascular diseases (CVD)/T2DM. A 9-year follow-up study further 
demonstrated that abdominal obesity is a stronger predictor for coronary heart disease 
(CHD) compared to BMI (Canoy et al., 2007). In addition, a great number of studies 
have shown that the accumulation of adipose tissue in the upper body (i.e. abdominal 
adipose tissue) has a strong positive correlation with insulin resistance (Carey et al., 
1996; Goodpaster et al., 1997). Therefore, waist circumference could be a better way 
to examine metabolic risks. The World Health Organization (WHO) states that the risk 
of metabolic complications increases when waist circumference is greater than 94 cm 
for males and 80 cm for females (WHO, 2008).  
 
Chapter 2                                                     Literature Review  
24 
 Overview of adipose tissue  
In general, there are two major types of adipose tissue in humans – namely white and 
brown adipose tissue (Giralt & Villarroya, 2013). Traditionally, the function of white 
adipose tissue (WAT) is responsible for energy storage and utilization whereas brown 
adipose tissue (BAT) operates thermogenesis and the generation of body heat.  
 
Aside from different types, adipose tissue is stored in different depots and the 
distribution of adipose tissue is associated with metabolic function and health (Kissebah 
et al., 1982). The accumulation of human adipose tissue in the upper body is 
significantly positively related to CVD risk factors (Williams et al., 1997). On the other 
hand, depending on diverse depots, WAT can be further categorized into subcutaneous 
adipose tissues (SCAT) and visceral adipose tissues (VAT). SCAT is located 
underneath the skin and VAT surrounds the internal organs. Studies have shown that 
both VAT and abdominal SCAT have a substantial correlation with insulin resistance 
and that VAT is a stronger predictor when compared with abdominal SCAT (Preis et 
al., 2010). The potential mechanism could be that when lipid is mobilized from visceral 
adipose tissue, it is released directly into the portal circulation, which has been 
suggested as a contributing factor in cardiovascular disease (Smith et al., 2001). 
 
It has been well documented that adipose tissue serves not only for energy storage and 
mobilization but also plays an active role as an endocrine organ. Adipose-secreted 
molecules have been termed “adipokines” and include adiponectin, leptin, visfatin, 
resistin, interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), etc. These 
undertake various roles including serving as pro- and anti-inflammatory mediators, 
signals of energy metabolism and appetite and so on (Calabro & Yeh, 2007; Galic et 
al., 2010) by paracrine and autocrine regulations (Fain et al., 2004b; Karastergiou & 
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Mohamed-Ali, 2010). In adipose tissue, both adipocytes and non-adipocytes are able to 
produce adipokines (Fain et al., 2004b). In obese populations, the secretion of pro-
inflammatory adipokines such as IL-6, TNF-α and interleukin 8 (IL-8) are increased 
and the secretion of anti-inflammatory adiponectin is decreased (Karastergiou & 
Mohamed-Ali, 2010). 
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2.2 Impact of fasting on adipose tissue metabolism 
Lipid and glucose utilization and interaction are crucial in response to fasting and/or 
exercise. Energy metabolism and molecular responses in either adipose tissue (Palou et 
al., 2008; Palou et al., 2010; Nielsen et al., 2011) or skeletal muscle (Tunstall et al., 
2002; Pilegaard et al., 2003a; Spriet et al., 2004; Wijngaarden et al., 2014) is altered 
after overnight fasting prior to experimental manipulations and this further impacts 
circulating substrate utilization (Klein et al., 1993; Samra et al., 1996; Gjedsted et al., 
2007; Wijngaarden et al., 2014). This could potentially influence how scientists 
interpret the results related to the mechanisms and/or pathways involved during and 
after exercise. Therefore, it is important to understand how adipose tissue (the main 
energy storage organ) and skeletal muscle (the biggest energy utilization organ) 
responds to overnight fasting.  
 
 The general responses after fasting 
Fasting triggers physiological challenges that induce changes in substrate supply, 
mobilization and utilization (Klein et al., 1993). In general, overnight fasting decreases 
circulating glucose and insulin levels, and increases non-esterified fatty acids (NEFA) 
levels (Tunstall et al., 2002; Spriet et al., 2004). This is shown when triglyceride is 
hydrolysed as an energy resource in order to save glucose for other vital organs such as 
brain. The overall processes of adipose tissue lipolysis is shown in Figure 2.1 and the 
details are described as follows. Catecholamine represents the primary hormone to 
stimulate lipolysis in a fasted state via the cyclic adenosine monophosphate (cAMP) 
pathway (Duncan et al., 2007), following activation of protein kinase A (PKA) resulting 
in phosphorylation and activation of some pivotal lipases. Two receptors in the cell 
membrane, including β-adrenoceptors and α-adrenoceptors, can be activated by 
catecholamine via enhancing and inhibiting lipolytic processes respectively (Horowitz, 
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2003). Other hormones such as testosterone, cortisol, and growth hormone also affect 
the rate of lipolysis. In addition to these hormones, the reduction of circulating insulin 
level is another crucial factor that increases lipolysis (Klein et al., 1993; Wijngaarden 
et al., 2014).  
 
Prior to lipid oxidation, stored triglyceride is hydrolysed into NEFA and glycerol. 
Adipose triglyceride lipase (ATGL) and hormones-sensitive lipase (HSL) are two 
crucial lipases to regulate lipolysis (Carmen & Victor, 2006; Duncan et al., 2007), and 
are together responsible for up to 95% triglycerides hydrolysis in WAT (Schweiger et 
al., 2006). The initial step of lipolysis is catalysed by ATGL for hydrolysis of 
triglycerides into diglycerides (Zimmermann et al., 2004), followed by the next step 
from diglycerides to monoglycerides by functioning of HSL (Fredrikson et al., 1981). 
The last step of lipolysis is completed by monoglycerides lipase (MGL) (Tornqvist & 
Belfrage, 1981), which releases the final fatty acid and glycerol. However, during long-
term food deprivation of up to a few days, ATGL and HSL might not coordinate to 
regulate lipolysis (Bertile & Raclot, 2011). Of note, lipolysis is also much greater than 
fat oxidation after overnight fasting (Wolfe et al., 1990; Horowitz et al., 1997), which 
means that lipid resource is enough to supply fat utilization either during exercise, 
fasting or exercise under a fasted state. 
 
Figure 2.1 The process of adipose tissue lipolysis. 
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 Short-term fasting – adipose tissue mRNA expression 
Fat storage and mobilization are tightly controlled by a number of enzymatic steps 
involved with different molecular regulation (Frayn et al., 1995). In human studies, it 
has been suggested that adipose tissue triglycerides mobilization is increased after 18 
and 24 h of fasting (Klein et al., 1993) and serum NEFA levels is increased after 
overnight fasting owing to increased lipolysis (Tunstall et al., 2002; Wijngaarden et al., 
2014). When it comes to different populations, health status has been observed to 
influence adipose tissue gene expression (Costabile et al., 2011; Weiss et al., 2011). 
HSL mRNA regulation in adipose tissue was not different among lean normal weight, 
obese without T2DM and obese with T2DM groups after overnight fasting but 
lipoprotein lipase (LPL) messenger RNA (mRNA) in the lean normal weight group was 
higher than obese with T2DM patients (Costabile et al., 2011). However, the evidence 
of short-term fasting in human adipose genes is relatively limited, so adipose gene 
expression in rodents in response to short-term fasting (shorter than 24 h) is discussed 
in the following section.  
 
AMP-activated protein kinase (AMPK) is an energy homeostasis sensor and regulates 
lipid and glucose metabolism when the ratio of AMP/adenosine triphosphate (ATP) is 
low (Daval et al., 2006). Fasting-induced energy imbalance in adipose tissue can be 
seen by showing increased AMPK and the AMP/ATP ratio after 15 h of fasting (Kajita 
et al., 2008). The increase of adipose AMPK might potentially evoke the regulation of 
other adipose genes (Daval et al., 2006; Anthony et al., 2009). Unsurprisingly, 24 h of 
short-term fasting affects the expression of several key adipose tissue genes in rodents 
(Kim et al., 1998; Li et al., 2006; Palou et al., 2008; Palou et al., 2010), with depot-
specific and age-related differences (Bertile et al., 2003; Palou et al., 2010; Wronska et 
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al., 2015). The abdominal subcutaneous adipose tissue is usually sampled in human 
studies, and this is an important consideration when interpreting the findings. 
 
It has been found that the elevation NEFA levels was observed after 4 h of fasting and 
peaked at 8 h of fasting (Palou et al., 2008; Palou et al., 2010). In addition, the increases 
in  carnitine palmitoyl transferase 1 (CPT-1) mRNA expression, which transports 
NEFA in to the mitochondria, have been seen after both 4 and 8 h of fasting and went 
up remarkably after 24 h of fasting (Palou et al., 2008). The results of adipose lipolytic 
mRNA genes (ATGL & HSL) in animal models were inconsistent after short-term 
fasting (between 4-12 h of fasting) (Villena et al., 2004; Palou et al., 2008; Palou et al., 
2010), but one study found that ATGL mRNA was transiently increased after 12 h of 
fasting (Villena et al., 2004). In addition, results have consistently shown that 
lipogenesis-related genes were decreased after 8 h and 24 h of fasting, including sterol 
regulatory element binding protein 1c (SREBP1c), fatty acid synthase (FAS), acetyl-
coenzyme A carboxylase α (ACC1), glycerol-3-phosphate acyltransferase (GPAT) and 
peroxisome proliferator-activated receptor gamma (PPARγ) (Palou et al., 2008; Palou 
et al., 2010). In particular, PPARγ mRNA was shown to be more sensitive to fasting 
compared to other genes as it was reduced after just 4 h of fasting (Palou et al., 2008). 
Based on the above observations, it appears that lipid-related energy metabolism is 
regulated via the elevation of lipolysis and the reduction of lipogenesis after short-term 
fasting. The subsequent rise in circulating NEFA is transported for oxidation. However, 
in rodent studies, the results of expression in lipolytic mRNA genes are not consistent 
after short-term fasting, and thus it is important to directly test these pathways in 
humans.   
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Apart from HSL and ATGL, LPL, another form of lipase, hydrolyses circulating 
triglyceride in capillary into NEFA, especially targeting chylomicrons and very low-
density lipoproteins (VLDL). Fasting affects the expression of LPL in WAT. Short-
term fasting induces the reduction of LPL activity in animal adipose tissue, without a 
change in gene expression and protein levels (Doolittle et al., 1990; Bergo et al., 2002). 
Its activity shows a different response to gene expression, and varies according to 
different adipose depots (Palou et al., 2010). The down-regulation of adipose tissue 
LPL mRNA after fasting might be due to hydrolysis of circulating triglycerides into 
NEFA, and their reesterification for storage within adipocytes, so that the down-
regulation of LPL mRNA might prevent further lipogenic processes. 
 
Glucose-related pathways have also been shown to regulate energy metabolism in 
adipose tissue in response to fasting. The expression of glucose transporter type 4 
(GLUT4) mRNA was reduced after 8 and 24 h of fasting (Palou et al., 2008; Palou et 
al., 2010). Hexokinase II (HK II) mRNA expression and protein levels were found to 
be down-regulated after fasting (Gosmain et al., 2005). The expression of pyruvate 
dehydrogenase 4 (PDK4) mRNA, the enzyme which inhibits pyruvate dehydrogenase 
(PDH), was slightly increased after 24 h of fasting (Li et al., 2006). This evidence 
indicates that not only lipid-related genes but also glucose transportation (GLUT4) and 
glycolysis regulation (HK II and PDK4) genes are regulated whilst under a fasted state. 
In addition, Markan et al. (2010) propose in their review paper, that adipose glycogen 
might also influence adipose tissue metabolism under a fasted state.  Furthermore, 
transcription factors are regulated after short-term fasting including SREBP1c and 
PPARs (Vidal-Puig et al., 1996; Kim et al., 1998; Bertile et al., 2003; Kajita et al., 
2008; Palou et al., 2008; Palou et al., 2010).  
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Taken together, as shown in Figure 2.2, under a fasted state in rodents, it is possible 
that the elevation of lipolytic adipose gene expression, combined with the reduction of 
lipogenic genes for releasing NEFA into circulation. In addition to these changes in 
lipid-related pathways, a reduction in glycolysis in adipose tissue could also influence 
adipose metabolism. Moreover, transcription factors such as SREBP1c and PPARγ can 





Figure 2.2 Pathways influenced by short-term fasting.   
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2.3 Effect of acute exercise on adipose adipokines 
Over the past few decades, a number of researchers have investigated the impact of 
different types of exercise, including variation of intensity, duration and population, on 
circulating cytokines. During prolonged exercise, adipose triglycerides play a critical 
role of supplying energy substrates. There are different depots of adipose tissue 
involved including upper- and lower-body subcutaneous adipose tissue, intra-
abdominal adipose tissue, plasma and intramuscular triglycerides, which all contribute 
diverse proportions of energy during exercise (Horowitz, 2003). Although VAT 
exhibits a high lipolysis rate, it is cleared by the liver so that it is not the major substrate 
oxidised during exercise. SCAT is the primary adipose tissue depot which contributes 
energy towards the overall cost of exercise, especially upper body SCAT (Horowitz, 
2003). In addition to upper body SCAT, intramuscular triglycerides can be directly used 
and are a major fuel during exercise (Horowitz, 2003).  
 
Cytokines can be released from diverse organs - for example skeletal muscle, liver, 
brain or adipose tissue. Depending on the source, these can be referred to as cytokines, 
myokines or adipokines. To identify the source of cytokine secretion, direct observation 
within tissues can help, although there has been relatively little progress in 
measurements such as adipokine gene expression in adipose in response to exercise in 
humans until relatively recently. 
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 Impact of exercise on gene expression 
2.3.1.1 IL-6 mRNA expression in SCAT in acute exercise 
The adipokine which has received the most attention to date at the gene expression level 
is IL-6. At rest, adipose tissue is responsible for 15−35% of circulating IL-6 (Mohamed-
Ali et al., 1997b). A number of studies have investigated IL-6 mRNA in SCAT after 
acute prolonged exercise. During long duration exercise, circulating IL-6 is secreted 
primarily by contracting skeletal muscle. Subsequently, as shown in Figure 2.1, after 
the cessation of exercise, adipose tissue could be a major source of IL-6 if the increase 




Figure 2.3 IL-6 mRNA expression in skeletal muscle and abdominal adipose 
tissue after 3 h of 60% V̇O2max cycling. 
* means difference over time (Keller et al., 2003b) 
 
Lyngso et al. (2002) used the Fick technique (arterial-venous concentration differences) 
in order to identify IL-6 output from abdominal subcutaneous adipose tissue and found 
that IL-6 concentration did not change during and immediately after 1 h exercise at 60% 
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V̇O2max in young males, but started to secrete IL-6 30 min post-exercise for the 





Figure 2.4: Net IL-6 production from adipose tissue during exercise. 
Exercise was started at 30 min and ended at 90 min (exercise versus rest group).  
* significant difference compared to baseline (30 min) (Lyngso et al., 2002) 
 
A similar study investigated the impact of 1 h of cycling exercise at 55% V̇O2max on IL-
6 mRNA expression and found that IL-6 mRNA expression was enhanced in SCAT 
during exercise and reached a peak at 2.5 h post-exercise in both overweight and lean 
young males (Hojbjerre et al., 2007). This study confirmed that, after cessation of 
exercise, IL-6 mRNA expression in SCAT remained elevated for the following 2.5 h.  
 
One Study revealed that both overweight/obese and lean males substantially increased 
IL-6 mRNA in SCAT immediately after 2 h cycling at 55−60% HRmax (Christiansen et 
al., 2013a). These studies showed that IL-6 mRNA expression in SCAT increased 
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during prolonged exercise, but the time course of IL-6 mRNA expression in SCAT 
remains uncertain. 
 
Other studies also demonstrated that IL-6 mRNA expression in SCAT was elevated 
immediately post-exercise after 3 h prolonged moderate intensity exercise. Keller et al. 
(2003a) indicated that after 3 h of cycling at 60% V̇O2max, IL-6 mRNA in SCAT was 
approximately 6.5-fold higher at the end of exercise and reached a peak of 7.5-fold at 
1.5 h post-exercise – but was still raised at 3 h post-exercise in young males. Similar 
results can be found in other studies (Keller et al., 2003b; Holmes et al., 2004; 
Frydelund-Larsen et al., 2007). Even more profoundly, one study revealed that after 3 
h exercise, IL-6 mRNA in SCAT was increased at 3, 4.5, 6 and 9 h post-exercise while 
compared with pre-exercise (Frydelund-Larsen et al., 2007). According to the above 
studies, it seems that IL-6 mRNA expression in SCAT might be elevated during 
prolonged exercise (> 2 h) and reaches a peak value in the post-exercise period. The 
potential mechanism of the enhanced expression and secretion of IL-6 post-exercise 
may be associated with providing energy by lipolysis and fatty acid mobilization from 
SCAT via autocrine/paracrine mechanisms to maintain energy supply (Lyngso et al., 
2002). It can be confirmed that lipid mobilization from adipose tissue is substantially 
elevated for about 1 h post-exercise and remains increased for the following 2 h (Mulla 
et al., 2000). 
 
In addition, IL-6 mRNA expression in SCAT could also be affected by the last acute 
bout of exercise. Compared to rest, obese males with a high fasting triacylglycerol 
concentration showed a decrease in IL-6 mRNA expression in SCAT in a fasted state 
16 h after acute 60 min walking at 55% V̇O2max (Dekker et al., 2010). However, there 
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was no difference in IL-6 in the circulation between exercise and rest groups at this 
point.  
 
2.3.1.2 Adiponectin mRNA expression in SCAT 
One study has shown that, during 1 h of cycling exercise at 55% V̇O2max, subcutaneous 
abdominal adipose tissue interstitial adiponectin concentration increased but there was 
no corresponding change in plasma adiponectin in either overweight or lean men 
(Hojbjerre et al., 2007). Surprisingly, this study found that adiponectin mRNA in SCAT 
declined in overweight and lean male groups during and post-exercise (Hojbjerre et al., 
2007). In contrast, other studies have found that adiponectin mRNA in SCAT increased 
after 2 h cycling at 55−60% maximum heart rate (HRmax) in lean, overweight and obese 
men (Christiansen et al., 2013a). At present, the reason for the differences between 
these two studies is unclear.  
 
2.3.1.3 Leptin mRNA expression in SCAT in acute exercise 
After 3 h of cycling exercise at 60% V̇O2max, leptin mRNA in SCAT decreased over the 
following 5 h; although this was not statistically different to a resting control group 
(Keller et al., 2005). Another study also found that after 1 h of cycling exercise at 55% 
V̇O2max, leptin mRNA in SCAT declined during and after exercise for the following 2.5 
h in both overweight and lean men; even though the baseline leptin mRNA was higher 
in the overweight group compared to the lean group (Hojbjerre et al., 2007). This result 
indicates that participating in at least 1 h moderate intensity exercise can decrease leptin 
mRNA expression in SCAT and it lasts for a period after exercise.  
 
Chapter 2                                                     Literature Review  
37 
2.3.1.4 Other adipokines mRNA expression in SCAT in acute exercise 
Circulating interleukin 18 (IL-18) concentrations positively correlate with BMI, waist-
to-hip ratio and inversely with insulin sensitivity (Escobar-Morreale et al., 2004). In 
addition, IL-18 mRNA in adipose tissue and plasma concentrations are higher in obese 
and metabolic syndrome populations (Leick et al., 2007; Weiss et al., 2011). Obesity 
and metabolic syndrome all have a connection with low inflammatory processes and a 
link to insulin resistance. As a result, this could mean that IL-18 is an inflammatory 
marker, and plays a role to induce metabolic-related disorders. One study found that 
IL-18 mRNA in SCAT was not affected in either 2 h at 60% V̇O2max or 1.5 h exercise 
at 70% V̇O2max exercise in lean individuals (Leick et al., 2007). Thus, this means that 
IL-18 may not affect metabolic changes after acute exercise, but more research is still 
needed to confirm this. 
 
After 3 h of cycling at 60% V̇O2max, visfatin mRNA expression was raised 3-fold 
compared with pre-exercise and increased at 3, 4.5 and 6 h post-exercise (compared 
with resting control group), but plasma visfatin did not change after exercise 
(Frydelund-Larsen et al., 2007). In addition, another study showed that TNF-α mRNA 
increased in abdominal SCAT in overweight and lean men after acute 1 h exercise; 
although plasma TNF-α did not change after exercise in either the overweight or lean 
people (Hojbjerre et al., 2007). The same study revealed that resistin mRNA in SCAT 
was not changed in overweight or lean men after acute exercise (Hojbjerre et al., 2007). 
However, few studies have been done on the effect of acute exercise on adipokine gene 
expression.  
 
According to the afore-mentioned adipokine gene expression studies, it appears that IL-
6 mRNA in SCAT may be enhanced during prolonged exercise (at least 2 h), but it is 
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still unclear whether there is any change in IL-6 mRNA with shorter duration exercise 
(less than 1 h). IL-6 mRNA in SCAT remains increased after prolonged exercise (at 
least 1 h) and reaches a peak over the following hours. The increase in IL-6 mRNA in 
the post-exercise period might be associated with lipolytic processes. IL-6 mRNA 
might be decreased the next day after acute exercise in people with a high fasting TG 
concentration, but the potential mechanism still requires further research. The change 
of adiponectin mRNA in SCAT after acute exercise is still controversial. Leptin mRNA 
in SCAT decreases after acute exercise either in overweight or lean individuals and 
lasts for several hours. There have been only a few isolated studies that have examined 
other adipokines in adipose tissue. Thus, we need further research to build up a 
systematic understanding of these responses. 
 
 Impact of acute exercise on circulating adipokines 
2.3.2.1 Circulating IL-6 in response to acute exercise 
IL-6 can be released by various organs including skeletal muscle and adipose tissue and 
the concentration of IL-6 in overweight/obese individuals is higher than in lean ones 
(Christiansen et al., 2013a). Circulating IL-6 can be increased after acute exercise 
(Mitchell et al., 2011; Ostapiuk-Karolczuk et al., 2012; Christiansen et al., 2013a), and 
plays the role of both a pro- and anti-inflammatory adipokine (Pedersen, 2006). At a 
similar exercise intensity, IL-6 production is greater after resistance exercise compared 
to aerobic exercise because of greater skeletal muscle recruitment (Mitchell et al., 
2011). In addition, exercise intensity is another crucial determinant that affects IL-6 
concentrations (Mendham et al., 2011; Scott et al., 2011). When exercise intensity is 
lower than 30% V̇O2max, circulating IL-6 is not changed (Mendham et al., 2011). 
However, the responses of circulating IL-6 to exercise in overweight/obese and lean 
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individuals are different. Christiansen et al. (2013a) found that both overweight/obese 
and lean groups increased concentration of circulating IL-6 during 2 h ~55–60% of 
HRmax cycling, but that the concentration of IL-6 in the overweight/obese was higher 
during exercise probably due to additional body fat. 
 
2.3.2.2 Circulating adiponectin in response to acute exercise  
Adiponectin is a typical adipokine which is mainly produced by adipose tissue, and it 
acts as an anti-inflammatory adipokine. The level of adiponectin is normally 5–20 
μg·ml-1 in the body (Matsuzawa, 2005). In general, adiponectin concentration has a 
negative correlation with body weight, BMI and waist-hip ratio (Han et al., 2007). In 
addition, in patients with chronic diseases or obesity, adiponectin levels were lower, 
though regular exercise training may improve these levels (Bruun et al., 2006; Kondo 
et al., 2006). With regard to acute aerobic exercise, studies in healthy populations have 
reported that adiponectin is not influenced by various exercise intensities (from 50 % 
V̇O2max to very strenuous intensities) and durations (from 30 min to 2 h)(Kraemer et al., 
2003; Ferguson et al., 2004; Punyadeera et al., 2005; Hojbjerre et al., 2007). Despite 
this, one study found that adiponectin increased after 30 min strenuous running; 
however, adiponectin was not different after adjusting plasma volume (Kraemer et al., 
2003). However, the findings from studies that have investigated the effect of acute 
aerobic exercise on circulating adiponectin in overweight and obese individuals are 
inconsistent. For example, Saunders et al. (2012) found that the plasma adiponectin 
increased immediately and 30 min post-exercise after either high (75% of V̇O2peak) or 
moderate (50% V̇O2peak) intensity running exercise with the same energy expenditure 
(~400 kcal). In contrast, other studies found that adiponectin decreased or remained 
unchanged during 1 h cycling at 70% and 50% V̇O2peak, respectively (Numao et al., 
2011) or was unchanged after moderate intensity exercise (Jamurtas et al., 2006; 
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Hojbjerre et al., 2007; Bouassida et al., 2010b). Thus, at the present time, the response 
of circulating adiponectin concentrations to acute exercise is inconsistent across studies.  
 
2.3.2.3  Circulating leptin in response to acute exercise  
In a 1994 study of mutations in the mouse ‘ob’ gene, leptin, was shown to play the role 
of a signalling relay in the regulation of bodyweight and energy balance (Zhang et al., 
1994; Campfield et al., 1995; Pelleymounter et al., 1995). It has been well reviewed 
that when exercise duration exceeds 60 min or energy expenditures greater than 800 
kcal, the circulating concentration of leptin will decrease (Bouassida et al., 2010a).  
 
2.4 Impact of feeding on the acute responses to exercise  
It has been suggested that molecular changes occur either in adipose tissue or skeletal 
muscle after short-term fasting, indicating that the alternation of energy metabolism is 
induced. The influence of fasting on exercise is likely to be related to its duration, but 
the precise definition of fasting in this context is rather vague. Broadly, the impact of 
feeding on the response to exercise is associated with the dietary components 
(carbohydrate, fat and protein proportions) and size (energy) of meals, as well as the 
time interval between a pre-exercise meal and exercise. 
 
It has been widely confirmed that fasting prior to exercise increases fat utilization 
during exercise (Coyle et al., 1985; Dohm et al., 1986; Wu et al., 2003; Backhouse et 
al., 2007). Lipolysis during exercise in a fasting trial was greater than fat oxidation 
based on the calculation of glycerol appearance rate and there was no difference in 
lipolysis and fat oxidation in glucose and fructose-fed trials; however, both lipolysis 
and fat oxidation in the fasting trial were higher than other two trials (Horowitz et al., 
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1997). A feeding-induced increase in insulin before exercise is likely to play a major 
role in suppressing lipolysis during exercise (Horowitz et al., 1997).  
 
 Impact of feeding on exercise – in tissue level  
It has been demonstrated that feeding affects skeletal muscle molecular responses to 
acute exercise (De Glisezinski et al., 1998; Nieman et al., 2003; Civitarese et al., 2005; 
Cluberton et al., 2005; De Bock et al., 2005; Nieman et al., 2005; Harber et al., 2010; 
Treebak et al., 2014). 
 
Cluberton et al. (2005) found that glucose consumption before and during exercise 
altered skeletal muscle gene expression response to exercise (~75% V̇O2max for 1 h) in 
young healthy males. This study demonstrated that the expression of skeletal PDK4 and 
uncoupling-protein 3 (UCP3) mRNA were decreased in the feeding trial compared to 
an overnight fasting exercise trial. In addition, skeletal GLUT4 mRNA expression was 
higher (1 and 3 h after exercise) in the fasting trial compared with the feeding trial 
(although there was no statistical difference).  
 
De Bock et al. (2005) found that feeding (carbohydrate intake (~150 g) before and 
during (1 g (kg body weight)-1) exercise (~75% V̇O2max for 2 h) decreased total skeletal 
muscle UCP3 mRNA expression, α-AMPK phosphorylation and phosphorylation of 
acetyl-CoA carboxylase-β (ACC-β) in young healthy males immediately after exercise 
– but that there was no difference 4 h after exercise. However, energy was provided in 
both trials during 4 h recovery, so this study is not well placed to reflect the molecular 
responses during recovery.  
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Civitarese et al. (2005) extensively investigated how skeletal muscle glucose and lipid 
related metabolism genes respond to exercise (cycling at 50% V̇O2peak for 2 h) under 
either fed or fasted conditions in young healthy men. Muscle tissue was taken before 
and, 1 and 4 h after exercise. In terms of glucose metabolism genes, the expression of 
GLUT4 and PDK4 mRNA were all up-regulated after exercise in the fasting trial. In 
addition, the expression of PDK4 mRNA was further increased for the following 4 h in 
the fasting trial. In terms of lipid gene regulation, exercise in a fed state suppressed fatty 
acid translocase (FAT)/CD36, UCP3, CPT1 and AMPKα2 mRNA expressions 
throughout the trial. In line with other studies (Cluberton et al., 2005; De Bock et al., 
2005), this study demonstrated that substrate availability impacted upon glucose and 
lipid gene expression in skeletal muscle in response to submaximal exercise.   
 
Taken together, feeding state prior to exercise impacted upon skeletal muscle gene 
expression in energy regulation (↓ AMPK), glucose (↓ PDK4, GLUT4) and lipid 
metabolism (↓ FAT/CD36, CPT1 & UCP3). Adipose tissue is one of the organs that 
regulates energy metabolism in response to fasting and exercise. However, surprisingly, 
there are no studies investigating how adipose tissue responds to exercise under 
fasted/fed states.  
 
 Impact of feeding on exercise – circulating adipokines  
Only one study has investigated the impact of pre-exercise feeding only on circulating 
adipokines. Zoladz et al. (2005) found that there was no difference in circulating IL-6 
and leptin concentrations after a short bout of exercise in either a fed or fasted state. 
Interestingly, IL-6 was higher in fasted than fed (2 h after breakfast) prior to exercise 
and this was accompanied by a high plasma norepinephrine and low respiratory 
exchange ratio (RER) (Zoladz et al., 2005). The authors postulated that IL-6 might 
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serve to maintain energy supply such as modifying glucose concentrations and 
enhancing fat oxidation – even at rest. However, this study did not take blood samples 
before the meal and this could be a source of bias. In addition, the duration of exercise 
in this study only lasted 12 min, and this might be not long enough to understand if and 
how adipokines respond to exercise under different dietary conditions.  
 
 Impact of different feeding conditions on exercise responses at a whole 
body level  
The effect of different feeding states prior to exercise has drawn attention over the past 
few decades (Coyle et al., 1985; Diboll et al., 1999; Wu et al., 2003; Backhouse et al., 
2007; Gonzalez et al., 2013; de Lima et al., 2015). Exercise under a fasted state 
increases lipid oxidation owing to high lipolytic rate and increased levels of NEFA and 
low concentrations of circulating insulin and glucose, which is reflected by a low RER 
(Coyle et al., 1985; Wu et al., 2003; Backhouse et al., 2007). The impact of different 
types of feeding on whole body responses to exercise is shown in Table 2.1. The results 
are summarized in the following section. 
 
Glucose feeding from 25 to 312 grams between 45 min to 4 h prior to exercise reduces 
lipid oxidation during exercise when compared to exercise in a fasted state (Sherman et 
al., 1989; Sherman et al., 1991; Short et al., 1997; Jentjens et al., 2003). In addition, 
high glycemic index (GI), medium GI or low GI pre-exercise feeding has been observed 
to reduce lipid oxidation during exercise (Wu et al., 2003; Backhouse et al., 2007). The 
reasons are partly due to pre-exercise meals elevating blood glucose availability and 
muscle glycogen concentration (Coyle et al., 1985; Wee et al., 2005). Furthermore, 
fitness level and/or training status could affect substrate utilization during exercise 
(Stisen et al., 2006); however, one study showed that pre-exercise meal consumption 
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induced the elevation of carbohydrate oxidation in both trained and untrained 
individuals at intensities ranging from 22% to 59% V̇O2peak, but with exercise at a 
vigorous intensity (75% V̇O2peak), the ratio of carbohydrate and lipid oxidation was the 
same irrespective of training levels (Bergman & Brooks, 1999). 
 
The time interval between a pre-exercise feeding and exercise could critically affect 
substrate utilization and metabolism during exercise (Montain et al., 1991; Dumortier 
et al., 2005). Montain et al. (1991) compared the impact of different meal timing (2, 4, 
6, 8 and 12 h) in response to exercise (70% V̇O2max for 30 min) and found that exercise 
2 and 4 h after feeding promoted carbohydrate oxidation by approximately 15% 
compared to an interval of 8−12 h; and that the effect disappeared by 6 h. Dumortier et 
al. (2005) found that feeding 3 h prior to exercise showed a higher fat oxidation rate 
compared to 1 h pre-exercise meal. In terms of meal frequency, when compared to 
single and multiple doses and feeding with the same calories, single or multiple feedings 
did not alter substrate utilizations during exercise; however, lipolysis was inhibited with 
either single or multiple feedings compared to fasted trials (sugar-free orange juice) 
(Chryssanthopoulos et al., 2008).  
 
In addition to young and healthy populations, feeding also influences how people with 
T2DM respond to exercise (Poirier et al., 2000; Poirier et al., 2001; Gaudet-Savard et 
al., 2007; Ferland et al., 2009). Poirier et al. (2001) found that there were no differences 
in FFA and RER values while exercising under a fasted (overnight fasting) or fed state 
(meal consumed 2 h pre-exercise) in T2DM. This could mean that T2DM might 
demonstrate chronic adaptation of impaired lipolytic lipases which reduces lipid 
metabolism during exercise. Indeed, studies have indicated that, compared to lean 
humans, those with overweight and obesity show a decrease in catecholamine-induced 
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lipolysis and HSL expression (Langin et al., 2005) and the reduction of adipose ATGL 
and HSL in protein levels in insulin resistance humans (Jocken et al., 2007). On the 
contrary, Ferland et al. (2009) compared five distinct pre-exercise meals (HGI, LGI, 
high fat/low carbohydrate, low-calories and overnight fasting) consumed 2 h before a 
1 h 60% V̇O2max exercise in T2DM and found that exercise reduced circulating glucose 
levels between 36−51% among all meal trials compared to fasting (almost no change), 
but the proportion of carbohydrate and lipid oxidation is unclear due to unreported RER 
values. However, different levels of fasting circulating glucose (ranging from below 6 
to above 8 mmol·l-1) affects T2DM responses to exercise under different dietary states 
(Gaudet-Savard et al., 2007). With this in mind, it might be hard to directly compare 
the effect of pre-exercise feeding on the responses of people with T2DM. 
 
Based on the results from the aforementioned studies, most scenarios suggest that 
exercise under a fasted state increases lipolytic rate and lipid oxidation irrespective of 
the amount of energy intake, the difference of GI values, the level of fitness, time 
interval prior to feeding and the frequency of the meals provided. Pre-exercise feeding 
might affect how people with T2DM react to exercise but due to different levels of 
T2DM this is less clear at the present time.  
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Table 2.1 Impact of feeding on whole body responses to exercise 
Authors Participants  Protocol Meal Main findings (During exercise) 
(Allgrove et al., 2009) 16 young lean healthy (8 M & 
8 F) 
 
V̇O2max: M 51 ± 4 & F 40 ± 1 
ml·kg-1·min-1  
10−12 h of overnight fasting  
 
Meal  
2 h before 2 h 65% V̇O2peak cycling 
Fed (~530 kcal)  
Fasted (~15 kcal drink) 
RER (Fed > Fasted) 
 
(Backhouse et al., 
2007) 
6 young lean healthy F  
 
V̇O2max: 43 ± 2 ml·kg-1·min-1 
12 h of overnight fast  
 
Meal  
3 h before 1 h walk at 50% V̇O2max  
Fed (~650 kcal; MGI or HGI) 
Fasted  
NEFA & fat oxidation  
(all Fasted > Fed) 
(Bergman & Brooks, 
1999) 
7 untrained & trained young M  
 
V̇O2max: untrained 39 ± 2 & 
trained 58 ± 2 ml·kg-1·min-1 
12 h of overnight fasting 
 
Meal  
3 h before 2 h at 22% & 40%, 1.5 h at 
60%, 45 min at 80% V̇O2peak cycling 
for untrained and trained  
Fed (500 kcal; 53% CHO, 
31% fat & 16% protein) 
Fasted  
RER (Fed > Fasted) at 22, 40 & 59% 
V̇O2peak in trained and 40 & 59% 





8 young lean healthy M  
 
V̇O2max: 52 ± 1 ml·kg-1·min-1 
 
10 h of overnight fast  
 
Meal  
3 h before 1 h running at 70% V̇O2max  
 
Adipose tissue biopsy taken  
Fed (800 kcal; single or 
multiple meal)  
Fasted (22 kcal) 
RER, NEFA & glycerol  
(Fed > Fasted) 
 
 
(Coyle et al., 1985) 7 young lean healthy M  
 
V̇O2peak: 66 ± 1 ml·kg-1·min-1 
16 h of overnight fasting 
 
Meal  
4 h before 105 min 70% V̇O2peak 
cycling 
Fed (700 kcal; 85% CHO, 
15% protein) 
Fasted 
NEFA & glycerol (Fasted > Fed) 
RER (Fed > Fasted) 
 
(de Lima et al., 2015) 12 young lean healthy 
participants 
 
V̇O2max: 49 ± 7 ml·kg-1·min-1 
10 h of overnight fast  
 
Meal  
15 min before 36 min 65% V̇O2max on 
treadmill  
Fed (~349 kcal, 77% CHO, 
10% fat & 13% protein) 
Fasted 
Immediately after exercise  
Both TG ↑ (Fasted > Fed) 
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(Diboll et al., 1999) 
 
 
14 young lean healthy M  
 
V̇O2peak: 65 ± 9 ml·kg-1·min-1 
12 h of overnight fasting  
 
Meal  
15 min before 30 min 65% V̇O2peak on 
treadmill  
Fed (~500 kcal, 77% CHO, 
7% fat & 16% protein) 
Fasted 
RER (Fed = Fasted) 
(Dohm et al., 1986) 9 young lean healthy M  
 
V̇O2max: 61 ± 1 ml·kg-1·min-1 
23 h of overnight fasting 
 
Meal  
2-4 h before 90 min 70−75% V̇O2max 
on treadmill  
Fed (700 kcal; 85% CHO, 
15% protein) 
Fasted  
NEFA & glycerol (Fasted > Fed)  
RER (Fed > Fasted)  
(Febbraio & Stewart, 
1996) 
6 young lean healthy M  
 




45 min before 120 min 70% V̇O2peak 
cycling 
Fed (~280 kcal; HGI or LGI)  
Fasted (diet jelly) 
NEFA (Fasted > Fed) 
RER & CHO oxidation  
(Fed > Fasted) 
 
(Ferland et al., 2009)  10 T2DM patients  
 
V̇O2max: 30 ± 6 ml·kg-1·min-1 
 
Overnight fasting  
 
Meal  
2 h before 1 h 60% V̇O2peak cycling  
Fed (~450 kcal for HGI, LGI, 
high fat & low CHO; ~350 
kcal for low-calories)  
Fasted 
NEFA (Fasted > all Fed) 
 
 
(Horowitz et al., 1997) 6 young lean healthy M  
 
V̇O2peak: 53 ± 2 ml·kg-1·min-1 
12 h of overnight fasting 
 
Drink  
1 h before 60 min 45% V̇O2peak cycling  
Fed (~240 kcal; glucose, 
fructose or glucose + 20% TG 
infusion) 
Fasted 
Fat oxidation (Fasted > all Fed) 
 
(Jentjens et al., 2003) 9 young lean healthy M  
 
V̇O2max: 64 ± 2 ml·kg-1·min-1 
10-12 h of overnight fasting 
 
Drinks  
45 min before 20 min 65% V̇O2peak 
cycling followed by time-trial running   
Fed (25, 75 & 200 g CHO) 
Fasted 
RER (all Fed > Fasted) 
(Kirwan et al., 1998) 6 young lean healthy F 
 




45min before 60% V̇O2max cycling to 
exhaustion 
Fed (75 g CHO; high & Low 
fibre) 
Fasted 
RER (Fed > Fasted)  
NEFA (Fasted > Fed)  
 
(Kirwan et al., 2001a) 6 young lean healthy M  
 




45 min before 60% V̇O2peak cycling to 
exhaustion 
Fed (75 g CHO; HGI or MGI)  
Fasted 
Glycerol & RER (Fed = Fasted) 
NEFA (Fasted > all Fed) 
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(Kirwan et al., 2001b) 6 young lean healthy F  
 




45 min before 60% V̇O2peak cycling to 
exhaustion 
Fed (75 g oats; MGI) 
Fasted 
RER (Fed > Fasted)  
NEFA & glycerol (Fasted > Fed).  
(Koivisto et al., 1985) 8 young lean healthy M  
 
V̇O2peak: 57 ± 2 ml·kg-1·min-1 
10−12 h overnight fasting  
 
Drink  
45 min before 2 h 55% V̇O2peak cycling  
Fed (75 g; glucose or 
fructose)  
Fasted  
NEFA (Fasted > all Fed)  
(Montain et al., 1991) 9 untrained & trained young M  
 
V̇O2peak: untrained 48 ± 2 & 
trained 66 ± 2 ml·kg-1·min-1 
2, 4, 6, 8 & 12 h of fasting  
 
30 min at 70% V̇O2peak cycling 
~500−600 kcal CHO meal Combined untrained & trained 
CHO oxidation (2 & 4 h > 8 & 12 h 
fasting) 
(Sherman et al., 1989) 8 M & 2 F young lean healthy 
 
V̇O2max: ~4.2 ± 0.2 L·min-1  
10 h of overnight fasting  
 
Meal  
4 h before 70 min at 70% V̇O2peak 
combined with 20 min at 52% V̇O2peak 
cycling  
Fed (312 g CHO) 
Fasted  
RER (Fed > Fasted)  
Glycerol & NEFA (Fasted > Fed) 
(Sherman et al., 1991) 9 young lean healthy M 
 
V̇O2max: 4.1 ± 0.2 L·min-1 
10 h of overnight fasting 
 
Drink  
1 h before 90 min 70% V̇O2max 
followed by exercise performance test  
75, 150 g CHO & placebo Only compared exercise at first 90 
min  
RER (CHO meals > placebo) 
NEFA (placebo > CHO meals) 
(Wu et al., 2003) 9 young lean healthy M  
 
V̇O2max: 58 ± 2 ml·kg-1·min-1 
 
12 h of overnight fasting  
 
Meal  
3 h before a 60 min run at 65% V̇O2max 
on treadmill  
Fed (2 g/kg BM for a total 
141 g HGI, LGI)  
Fasted  
CHO oxidation (Fed > Fasted) 
NEFA & Fat oxidation (Fasted > 
Fed) 
Glycerol (Fasted > Fed) 
(Zoladz et al., 2005) 8 young lean healthy M  
 
V̇O2max: 3.7 ± 0.1 L·min-1 
 
overnight fasting  
 
Meal  
2 h before incremental cycling test for 
12 min from 30 W until 150 W  
Fed (870 kcal) 
Fasted  
RER(Fed > Fasted) 
Circulating IL-6 & leptin (Fed = 
Fasted)  
BM, body mass; M, Male; F, Female; Ex, exercise; CHO, carbohydrate; HGI, high glycemic index; MGI, medium glycemic index; LGI, low glycemic index; 
NEFA, non‐esterified fatty acids; RER, respiratory exchange ratio; V̇O2max, maximum oxygen uptake; V̇O2peak; peak oxygen uptake; TG, triglycerides  
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2.5 Breaking prolonged sitting physical activity  
There is no doubt about the health benefits of participating in either prolonged exercise 
or accumulated physical activity (Miyashita et al., 2006, 2008; Murphy et al., 2009; 
Miyashita et al., 2011, 2013). However, even though the reduction of cardiovascular-
related diseases after participating in regular physical activity has been confirmed, 
prolonged sedentary/sitting time is still another risk factor associated with 
cardiovascular-related diseases and that is independent of physical activity (Edwardson 
et al., 2012; Biswas et al., 2015). It could mean that preventing prolonged sitting is 
another crucial strategy to keep healthy. In the last few years, breaking prolonged sitting 
research has been extensively investigated (Dunstan et al., 2012b; Duvivier et al., 2013; 
Howard et al., 2013; van Dijk et al., 2013; Thorp et al., 2014; Henson et al., 2016). 
 
Table 2.2 summarises the breaking sitting research conducted in the past few years and 
the results are described in the following section. The first breaking prolonged sitting 
research was conducted by Dunstan et al. (2012b) and these authors found that whether 
2 min light (3.2 km·h-1) or moderate (5.8–6.4 km·h-1) intensity physical activity every 
20 min for a total 28 min walking, reduced postprandial glucose incremental area under 
the curve (iAUC) between 25–30% and insulin iAUC about 23% in obese middle-aged 
population when compared with prolonged unbroken sitting. The reduction of blood 
pressure was also observed during the postprandial period from the same research group 
(Larsen et al., 2014). Other studies also demonstrated the health benefits while breaking 
prolonged sitting was applied (Peddie et al., 2013; Bailey & Locke, 2015; Bailey et al., 
2016; Henson et al., 2016). 
 
Prolonged exercise and accumulated physical activity are both being suggested for 
exercise prescription guidelines. Small bouts of accumulated breaking sitting physical 
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activity has been directly compared to prolonged exercise, ranging from 1 m 40 sec to 
10 min (Miyashita et al., 2006; Miyashita, 2008; Miyashita et al., 2008, 2011; Duvivier 
et al., 2013; Peddie et al., 2013; Saunders et al., 2013; van Dijk et al., 2013; Kim et al., 
2014). Brisk walking throughout a 9 h postprandial period for only 1 min and 40 sec 
(totalling 30 min) was more effective at reducing glucose and insulin iAUC when 
compared to a single bout of 30 min walking (Peddie et al., 2013). Another study found 
that 4 days of breaking sitting physical activity intervention reduced fasting TG and 
postprandial insulin iAUC compared to prolonged sitting and prolonged sitting plus a 
daily bout of vigorous structured cycling (Duvivier et al., 2013). 
 
Only one study investigated the effect of breaking sitting at the tissue level, and showed 
that 75 skeletal muscle mRNA genes (10 genes directly involved in CHO metabolism 
regulation) were regulated after breaking sitting (Latouche et al., 2013). More precisely, 
Latouche et al. (2013) extensively examined postprandial skeletal muscle mRNA gene 
expression in 8 middle-aged obese/overweight sedentary population in response to 
acute breaking sitting physical activity, and demonstrated that merely 2 min walking 
every 20 min accumulated for 28 min walking is able to regulate metabolic pathways, 
and cellular development, growth and proliferation of skeletal muscle mRNA genes. 
This study provides information showing that brief breaks of accumulated walking 
elicits molecular changes and to provides physiological benefits. Whether the same is 
true in adipose tissue is uncertain at the present time. 
 
Collectively, breaking prolonged sedentary behaviour contributes to reduced 
postprandial insulin and glucose concentrations and also regulates skeletal muscle 
responses. But, studies have never looked into how adipose tissue responds to regular 
breaking sitting physical activity. 
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Table 2.2 The effect of breaking prolonged sitting on physiological responses 
Authors Participants Trials Meal Main findings 
*(Alkhajah et 
al., 2012) 
3 M & 29 W 
 
Age: SIT (40 ± 7); BREAKS 
(34 ± 9) years 
BMI: SIT (22 ± 3); 
BREAKS (23 ± 3) kg·m-2 
1 week and 3 months intervention 
 
SIT normal working group (n = 14) 
BREAKS sit-to-stand group (n = 18)  
 
N/A BREAKS (fasting HDL ↑ after 3 months)  
(Altenburg et 
al., 2013) 
5 M & 6 W 
 
Age: 18-24 years 
BMI: 23 (20–26) kg·m-2 
SIT: 420 min 
BREAKS: sitting (372 min) + hourly 8 min 
(48 min) cycling at 40-60% HRR 
1st meal (843 kcal; 92 g CHO, 
59 g fat & 16 g protein) 
+ 2nd meal (1,190 kcal; 77 g fat, 
117 g CHO & 28 g protein) 
 
TG & glucose iAUC ↔ between trials 
 
 




Age: 27 ± 3 years 
Fat mass (%): 24 ± 8 
SIT: 300 min 
L-BREAKS: sitting (272 min) + 2 min 
walking at 3.2 km/h every 20 min (28 min) 
M-BREAKS: sitting (272 min) + 2 min 
walking at 5.8-7.9 km/h every 20 min (28 
min) 
Drink (75 g CHO & 50 g Fat) M-BREAKS (glucose iAUC ↓) vs. SIT & 
L-BREAKS 
 
Insulin iAUC ↔ among trials 
(Bailey & 
Locke, 2015) 
7 M & 3 W  
 
Age: 24 ± 3 years 
BMI: 27 ± 4 kg·m-2 
SIT: 300 min 
STAND: sitting (272 min) + 2 min standing 
every 20 min (28 min)  
BREAKS: sitting (272 min) + 2 min walking 
at 3.2 km/h every 20 min (28 min) 
1st drink (273 kcal; 75 g CHO)   
+ 2nd drink (467 kcal; 4 g CHO, 
50 g fat & 7 g sodium)  
 
BREAKS (glucose iAUC ↓) vs. SIT & 
STAND  
 
TG iAUC ↔ among trials 
(Dunstan et al., 
2012b) 
11 M & 8 W 
 
Age: 54 ± 5 years 
BMI: 31 ± 4 kg·m-2 
 
SIT: 420 min 
L-BREAKS: sitting (392 min) + 2 min 
walking (3.2 km/h) every 20 min (28 min) 
M-BREAKS: sitting (392 min) + 2 min 
walking (5.8-6.4 km/h) every 20 min (28 min) 
Drink (75 g CHO & 50 g fat) 
 
 
L- & M-BREAKS (glucose & insulin 





3 M & 17 W 
 
Age: 21 ± 2 years 
BMI: 23 ± 3 kg·m-2 
 
4 days intervention  
 
SIT: sitting (14 h) + standing (1 h) + walking 
(1 h) 
BREAKS: sitting (8 h) + walking (5 h) + 
standing (3 h) 
EX: sitting (13 h) + standing (1 h) + walking 
(1 h) + vigorous cycling (1 h) 
OGTT after 16 h of last bout 
of cycling  
 
BREAKS (fasting TG & insulin iAUC ↓ 
vs EX & SIT) 
 
Fasting glucose, HDL, LDL, insulin, & 
glucose & glucose iAUC ↔ among trials 
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Age: 67 ± 5 years 
BMI: 33 ± 5 kg·m-2 
 
SIT: 450 min 
STAND: sitting (390 min) + 5 min standing 
every 30 min (60 min) 
BREAKS: sitting (390 min) + 5 min walking 
(~3 km·h-1) every 30 min (60 min)  
Breakfast: (26% CHO, 58% 
fat & 16% protein) and lunch 
(identical meal)  
 
 
STAND & BREAKS (glucose, insulin & 
NEFA iAUC ↓; TG iAUC ↔) vs SIT 
 
 
(Larsen et al., 
2014) 
11 M & 8 W 
 
Age: 54 ± 5 years 
BMI: 31 ± 4 kg·m-2 
Protocol see (Dunstan et al., 2012b) Protocol see (Dunstan et al., 
2012b) 




7 M & 1 W 
 
Age: 55 ± 6 years 
 
BMI: 31 ± 3 kg·m-2 




Muscle biopsy  
Protocol see (Dunstan et al., 
2012b) 
 
L- & M-BREAKS (insulin iAUC ↓) vs. 
SIT 
 
L- & M-BREAKS (75 mRNA genes were 
regulated) vs. SIT 
(Peddie et al., 
2013) 
38 M & 42 W 
 
Age: 26 ± 5 years 
BMI: 24 ± 4 kg·m-2 
SIT: 540 min 
BREAKS: sitting (510 min) + (1 min 40 sec * 
18 walk every 30 min (30 min) ~45% V̇O2max 
EX: Prolonged sitting (510 min) + 30 min 
exercise at ~ 60% V̇O2max 
3 drinks (1.12 g CHO, 0.46 g & 
fat 0.54 g protein g/kg BM)  
 
Drank at 60, 240 & 420 min 
during trial 
BREAKS (insulin, glucose iAUC ↓, mean 
resting RER ↑, TG iAUC ↔) vs. SIT & 
EX 
 
EX (TAG iAUC ↓) vs. BREAKS & SIT 
(Saunders et 
al., 2013) 
11 M & 8 W 
 
Age: M (13 ± 1) & W (11 ± 
1 ) years 
BMI: M (19 ± 5) & W (17 ± 
3) kg·m-2 
SIT: 480 min 
BREAKS: sitting (440 min) + 2 min exercise 
at 30% V̇O2peak every 20 min (40 min) 
EX: sitting (400 min) + 2 min exercise at 30% 
V̇O2peak every 20 min (40 min) + 20 min 
exercise at 60% V̇O2peak twice (40 min) 
Breakfast (20% daily needs; 
2,322 ± 410 kj) + lunch (40% 
daily needs; 3,669 ± 799 kJ)  
 
Consumed at 0 & 4 h during 
trial 
Insulin, glucose, HDL, LDL & TG iAUCs 
↔ among trials  
* Represents intervention study. M, men; W, women; BMI, body mass index; SIT, prolonged sitting; Ex, prolonged exercise; BREAKS, breaking sitting physical 
activity; STAND, standing. L-light intensity; M-moderate intensity; ↔ no difference between trials; ↓ decrease; ↑ increase; iAUC, postprandial incremental area under 
the curve; RER, respiratory exchange ratio; HDL, high-density lipoprotein; LDL; low-density lipoprotein; TG, triglycerides; CHO, carbohydrate; NEFA, non‐esterified 
fatty acids.
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2.6 Aim: 
This review has demonstrated that exercise under a fasted state alters several crucial 
adipokines at the mRNA level such as IL-6, adiponectin and leptin. In addition, feeding 
prior to prolonged exercise impacts upon physiological responses including circulating 
parameters, energy metabolism, insulin signalling as well as skeletal muscle mRNA 
gene expression. Adipose tissue plays an important role in the postprandial state, during 
fasting and exercise. Surprisingly, studies have never examined how adipose tissue 
responds to exercise under different dietary conditions. On the other hand, in terms of 
structured exercise, participating in short bouts of physical activity has been suggested 
to reduce postprandial glucose, insulin concentrations, blood pressure and regulate 
skeletal muscle molecules responses. In the postprandial state, adipose tissue is one of 
the vital organs to balance the energy homeostasis. However, we are still unclear of the 
impact of the accumulation of short bouts of physical activity on adipose tissue 
responses in the postprandial state. Moreover, obesity and being overweight are the 
result of an energy surplus, so excess energy is stored as adipose tissue. But, we still do 
not understand the effect of the above-mentioned two types of physical exercise on 
adipogenesis. Therefore, to investigate how different types of physical activity (a single 
bout of structured exercise versus regular small bouts of intermittent physical activity) 
influences general physiological reactions and adipose tissue this will be examined 
during an imposed energy surplus. 
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3 Chapter 3: General methodology 
 
3.1 Introduction 
Ethical approval was received from Bristol Research Ethics Committee for each 
individual study. All experimental procedures were conducted in the Applied 
Physiology and Metabolic Research Laboratories in the Department for Health at the 
University of Bath, apart from Western blot analysis, which was conducted in the 
Department of Biology and Biochemistry, all other biochemical analysis was carried 
out in the biochemistry laboratory in the Department for Health. This chapter outlines 
the general protocols used throughout all three studies in this thesis. Methods and 
protocols used only in specific projects are described in each relevant chapter.  
 
In all studies, participants provided verbal and written informed consent before taking 
part. In the first study (Chapter 4), participants were all overweight males aged between 
18–35 years. In the second study (Chapter 5), participants were overweight males and 
females (postmenopausal) aged between 35–64 years. In the third study (Chapter 6), 
participants were all active, normal weight males aged between 18–35 years. 
Participants were asked to complete Physical Activity Readiness Questionnaire (PAR-
Q) before any preliminary exercise testing. Smokers and participants diagnosed with 
any of medical conditions or taking medication that may influence metabolic or 
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3.2 Anthropometry 
Body weight, after voiding, was measured using digital mass scales to within 0.1 kg 
(Inner Scan; Body Composition Monitor, model BC-543, TANITA corp. Japan). 
Height was measured to within 0.1 cm on a fixed stadiometer (SECA, Germany). The 
body mass index (BMI) was calculated using the following the formula; BMI = body 
mass (kg)·height (m2)-1. 
 
The measurement of waist and hip circumference to the nearest 0.1 cm was undertaken 
according to World Health Organisation guidelines (WHO, 2008) using a non-stretch 
tape. Waist circumference was measured at midway point between the lowest rib and 
the iliac crest at end of normal breath expiration – and the tape was parallel to the floor 
when passed around the waist. Hip circumference was measured horizontally around 
the widest portion of the buttocks (WHO, 2008). All of the waist and hip circumferences 
measurements were taken 3 times in total and then the mean value determined. 
 
3.3 Body composition analysis 
Body composition was estimated using Dual energy X-ray absorptiometry (DEXA; 
Discovery, Hologic, Bedford, UK) in the morning between 08:00–09:00 am after 10–
12 h of fast in all three studies. The DEXA scan was performed by an individual who 
had completed training in ionising radiation (medical exposure) regulations (IR(ME)R). 
An hour prior to measurement, participants were asked to drink 1 pint of water to 
prevent dehydration. The results of the DEXA scan might be affected by body water 
(Lohman et al., 2000). Therefore, before the measurement, participants voided their 
bladder in order to minimize variations in hydration status. Individuals were only 
allowed to wear lightweight shorts during analysis. Participants were asked to lie on the 
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DEXA scanning table (Discovery, Hologic, Bedford, UK) and the body position of 
participants were adjusted to the scanning area and the whole scanning process was 
approximately 7 min. Following completion of the scan, whole body composition 
analysis was performed with regions sectioned as recommended in the QDR (DEXA 
provided software) for Windows manual (Hologic, Bedford, UK). Abdominal 
subcutaneous and visceral adipose tissue (central adipose tissue) was estimated from a 
central region between lumber vertebrae 1–4 (L1-L4) (Glickman et al., 2004). 
 
3.4 Physical activity assessment 
As part of the preliminary measurements, for one week, participants were fitted with a 
combined heart rate/accelerometer monitor (Actiheart, Cambridge Neurotechnology 
Ltd., Cambridge, UK; Figure 3.1) attached to the left of the sternum via 2 adhesive ECG 
pads, as illustrated in Figure 3.1, for 24 h per day except for when 
showering/bathing/swimming. Participants were asked to maintain their normal life 
style and physical activity during the monitored week. 
 
 
Figure 3.1 The range of locations of Actiheart monitor can be worn. 
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The manufacturer's software (Actiheart 2.0, Cambridge Neurotechnology LtD., 
Cambridge, UK) was used to estimate energy expenditure. Physical activity level (PAL) 
was calculated based on 24-h period total energy expenditure divided by basal 
metabolic rate (BMR).  
 
3.5 Dietary record 
In order to minimize the variations of physiological conditions between main trials, in 
the 2 days prior to the 1st main trial in Chapter 4 and 5, participants were asked to record 
their food and fluid consumption and replicated the same type intake patterns in the 2 
days prior to following main trial. In Chapter 6, participants were asked to complete a 
one week dietary record in order to prescribe their intervention diet. Further details 
concerning dietary intervention procedures are described in Chapter 6.  
 
3.6 Restrictions for participant pre-trial day 
In the 72 h prior to V̇O2max tests and main trials, participants were asked to refrain from 
any type of vigorous exercise. In Chapter 5 only, in the 48 h before main trial days, 
participants were asked to restrict their step counts under 4,000 steps in order to mimic 
a sedentary life style (Tudor-Locke & Bassett, 2004; Tudor-Locke et al., 2013). In 
Chapter 6 only, participants were asked to do one, 30 min bout of moderate intensity 
exercise before 2 pm on the day prior to the 1st main trials in order to standardise their 
physical activity. In the 48 h before main trials, participants were asked to avoid alcohol 
and caffeine intake. In the 3 h prior to V̇O2max measurement, participants were asked 
not to consume any type of foods or drinks (except for water). Prior to each main trial, 
participants were asked to arrive at the laboratory after 12 h of fasting and to consume 
1 pint of water upon waking on the day of main trials. 
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3.7 Gas collection and analysis for indirect calorimetry 
One hour prior to each trial, the gas analyser was calibrated using 100% Nitrogen and 
mixed gas of 15.9% Oxygen and 5.005% Carbon Dioxide, and checked against 
atmospheric values 20.9% Oxygen and 0.04% Carbon Dioxide. The fraction of expired 
O2 and CO2 was analysed using a gas analyser (Series 1400, Servomex Ltd, Sussex, 
UK). In order to avoid contamination of inspired gases, during gas collections and 
ambient atmospheric gas samplings were undertaken with as few individuals as possible 
in the room. 
 
During gas collections, participants were required to wear a nose clip and breathe into 
a mouthpiece with breathing valves to ensure all expired gas was collected into 
evacuated Douglas bags (Douglas Bags, Hans Rudolph, MO, USA). At least 30 seconds 
prior to gas sampling, participants were given the mouthpiece and nose clip. During 
each gas collection, ambient CO2 and O2 samples were measured to account for small 
changes observed throughout the day in an enclosed room, rather than assuming outside 
atmospheric values for inspired gas concentrations. The gas sampling tube was held 
within 1 meter of the participant for the final 2 min of each separate gas collection (read 
after 1 min 30 seconds of ambient sampling allowing sufficient time for values to 
stabilise). The stopwatch was started as soon as the stopcock was turned diverting 
expired gases into Douglas bag. 
 
After gas sample collection was finished, gases concentrations in the expired air within 
the Douglas bag was sampled for 2 min at a flow rate of 2 L·min-1 and were recorded 
after 1 min 30 seconds of sampling when values had stabilised. The Douglas bag was 
then completely evacuated using a dry gas meter (Harvard Apparatus, UK) and the total 
volume of expired air and its temperature (measured with a digital thermometer 
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(Checktemp 1, HANNA, UK) attached to the dry gas meter) were recorded. The 
ambient temperature of the laboratory was also measured and adjustments made as 
necessary to maintain it between 20–25 °C. 
 
3.8 Maximal oxygen uptake test 
Maximal oxygen uptake (V̇O2max) was measured in Chapter 4 and 6 only. V̇O2max was 
determined using an incremental continuous treadmill test until the point of volitional 
fatigue. One minute expired air samples were collected into Douglas bags (Hans 
Rudolph, MO, USA), ratings of perceived exertion (RPE) using a 6–20 scale (Borg, 
1973) and heart rates (HR) were measured in the final minute of each stage and also at 
the point of volitional exhaustion, defined as when the participant indicated that only 1 
min remained until fatigue. Samples were analysed for relative expired fractions of 
oxygen and carbon dioxide gas (Servomex, Crowborough, UK) and the total volume 
within the bag was measured using a dry gas meter (Harvard Apparatus, Kent, UK). 
This measure was used to determine the relationship between V̇O2max and submaximal 
V̇O2max in order to estimate the exercise intensity required in subsequent main trials. 
The protocol was slightly different due to diverse population in Chapter 4 and 6. 
 
In Chapter 4, for most participants, a treadmill speed of 4 km·h-1 and gradient of 8.5% 
was chosen. Participants exercised at this speed and gradient with the speed increased 
by 1 km·h-1 after every 3 min stage until volitional fatigue. 
 
In Chapter 6, for all participants, the testing speed was chosen between 9 to 12 km·h-1. 
The testing speed did not change until the end of test once the speed was selected. The 
initial gradient of treadmill was set to 2.5% and increased 2.5% every 3 min stage with 
fixed speed until volitional fatigue. 
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3.9 Determining resting metabolic rate 
Participants laid on the bed for 15 min prior to the resting metabolic rate (RMR) 
measurement. The RMR was estimated using a minimum of 2–4 separate consecutive 
collections each lasting 5 min (Compher et al., 2006; Betts et al., 2011) and the values 
were determined using substrate oxidation under resting conditions as described (Frayn, 
1983a). Participants were given the option to have a 2 min break in order to minimise 
any discomfort. 
 
3.10 Blood sampling and processing 
A 20-gauge 1.1 × 32 mm cannula (BD VenflonTM Pro, Becton Dickenson & Co., 
Sweden) was inserted into an antecubital forearm vein immediately following RMR 
assessment on main trial days. Blood samples were taken by using stopcock (BD 
connecta, Beckton Dickenson, Sweden) and syringe(s) at required time points during 
the all of main trials. Patency of the cannula was maintained by flushing with isotonic 
saline following blood sampling. Before collecting the each subsequent sample, 5 ml 
waste was taken from the cannula to remove the saline that would otherwise dilute the 
sample. 
 
Venous blood samples were collected using syringes and dispensed into blood 
collection tubes (Sarstedt Ltd., Leicester, UK) containing either serum separator beads 
for serum collection or potassium-ethylenediaminetera acetic acid (K3-EDTA) as an 
anticoagulant for plasma samples. Blood was dispensed into serum tubes first to avoid 
EDTA contamination which may affect some metabolite and enzyme measurements. 
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After gentle mixing by inversion, EDTA tubes were immediately spun at 5,000 rpm for 
10 min at 4 °C (Heraeus Biofuge Primo R, Kendro Laboratory Products Plc., Bishops 
Stortford, UK). Venous blood in serum tubes was gently mixed by inversion and left to 
clot at room temperature before being centrifuged. After centrifugation, plasma and 
serum samples were then transferred to 1.5 ml eppendorf tubes and frozen at –80 °C for 
later analysis. 
 
3.11 Blood analysis  
Blood glucose, triglycerides (TG), non-esterified fatty acids (NEFA), total cholesterol, 
HDL-cholesterol, and alanine transaminase (ALT) were measured using commercially 
available assay kits (Randox, Crumlin, UK) and analyser (Daytona Rx, Crumlin, UK). 
Serum insulin (Mercodia, Uppsala, Sweden), and both serum and adipose tissue culture 
secretions of IL-6, leptin, and adiponectin (R&D systems Inc, UK) were measured 
using commercially available Enzyme-linked immunosorbent assay (ELISA) in 
Chapters 4 and 5. A SPECTROstar®Nano plate reader (BMG LABTECH’s, Germany) 
was used to determine absorption at the wavelengths specified by the kit’s manufacturer. 
Coefficients of variation and lower limits of detection for each blood parameter are 
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Table 3.1 Coefficients of variation (CV) and sensitivity data for the assay used to 
measure blood parameters 




Glucose 0.335 mmol·l-1 < 5% < 6% 
NEFA 0.072 mmol·l-1 < 5% < 5% 
Triglycerides 0.134 mmol·l-1 < 4% < 4% 
Total-Cholesterol 0.865 mmol·l-1 < 4% < 2% 
HDL-Cholesterol 0.189 mmol·l-1 < 4% < 3% 
ALT 9.70 U·l-1 < 6% <5% 
IL-6 0.039 pg·ml-1 < 8% < 10% 
Leptin 7.8 pg·ml-1 < 4% < 6% 
Adiponectin 0.246 ng·ml-1 < 5% < 8% 
Insulin 1 mU·l-1 < 4% < 5% 
There were multiple quality controls utilised to analyse CV, the highest of these values 
is shown based on manufacturers values. 
 
3.12 Adipose tissue sampling 
In all three experimental chapters, adipose tissue was taken from the area around the 
waist, approximately 5 cm lateral to the umbilicus, using a well-established ‘needle 
aspiration’ technique (Walhin et al., 2013; Travers et al., 2015b). The area was 
thoroughly disinfected with videne, before injecting that anaesthetic (approximately 5 
ml lignocaine hydrochloride 1%) into a small fan shaped area beneath the skin using a 
27G 1¼ needle (PrecisionGlide, Beckton Dickinson, USA). Five minutes later, a larger 
14G needle (Kendall Monoject, Tyco Healthcare, USA) was inserted into the 
subcutaneous fat tissue around the waist, approximately 5 cm lateral to the umbilicus, 
in order to collect approximately 0.5–1 g of adipose tissue. Sterile swabs and pressure 
were then applied to the area once the sample was collected and before a dressing was 
applied. The whole process lasted about 30 min. 
 
Chapter 3                                                  General Methodology 
63 
Visible connective tissue and blood vessels then were removed from the adipose tissue 
with sterilised scissors before the remaining adipose tissue was cleaned with isotonic 
saline over single-use sterile gauze membrane to remove any further blood, clots and 
connective tissue. All re-usable equipment used for tissue handling was pre-sterilised 
by autoclaving. 
 
3.13 Whole adipose tissue culture 
After cleaning adipose tissue, tissue explants was minced into approximately 5–10 mg 
portions and directly transferred to sterile culture plates in quadruplicate in Chapter 4 
and duplicate in Chapter 5 (Nunclon surface, Nunc, Denmark) containing Endothelial 
cell Basal media (ECBM) (Promocell, Germany) supplemented with 0.1% fatty acid-
free bovine serum albumin 100 U·ml-1 penicillin and 0.1 mg·ml-1 streptomycin (Sigma-
Aldrich, Gillingham, UK). Adipose tissue explants were incubated at a final 
concentration of approximately 100 mg tissue per 1 ml (Fain et al., 2004b). Explants 
were then transferred to an incubator (MCO-18A1C CO2 incubator, SANYO) at 37 °C, 
5% CO2 and 95 ± 5% relative humidity. After 3 h of incubation, the media was removed 
and transferred into sterile Eppendorf’s and stored at –80 °C for further analysis. 
 
3.14 Adipose gene expression analysis 
 Adipose tissue collection 
In Chapter 4 and 5, the remaining adipose tissue (approximately 200 mg) was then 
homogenised in 5 ml TRIzol reagent (Invitrogen, Paisley, UK) in a 15 ml RNase/DNase 
free sterile centrifuge tube (Invitrogen, Paisley, UK) and frozen immediately on dry ice. 
After the trial was completed, tissues was stored in a freezer at −80 °C until further 
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analysis. Ethanol and distilled water were used to wash the homogenizer between 
samples. 
 
 Adipose tissue gene extraction  
An RNeasy Mini Kit (Qiagen, Crawley, UK) was used to extract RNA from adipose 
tissue following the following protocol; after thawing and vortexing, tissue samples 
were centrifuged at ~4,000 rpm at 4 °C for 5 min. After centrifuging, TRIzol was 
transferred to a new 15 ml RNase/DNase free sterile centrifuge tube (Invitrogen, 
Paisley, UK) using pipette and sterile filter tips without taking up any pellet/lipid. One 
ml of chloroform was then added into a new TRIzol tube (200 μl chloroform per ml 
TRIzol) and was vigorously shaken for 15 seconds by hand, followed by a 3 min 
incubation. After the 3 min incubation, samples were centrifuged again at ~4,000 rpm 
at 4 °C for another 15 min (aqueous phase and organic phenol-chloroform phase were 
separated after this process). The aqueous phase (about 3 ml) was then transferred to 
another new 15 ml RNase/DNase free sterile centrifuge tube, mixed well with 70% 
ethanol (about 3 ml) in a 1:1 ratio by pipetting up and down.  
 
 
Figure 3.2. Aqueous phase and organic phenol-chloroform phase 
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After mixing with 3 ml of 70% ethanol, the aqueous phase was transferred onto the 
RNeasy Mini spin column (simplified to spin column in following content), 
centrifuged in a microfuge tubes until reaching top speed (the step was repeated until 
all the aqueous phase passed through the column). 700 μl RW1 wash buffer was added 
to spin column and centrifuged for 10 seconds at top speed. 500 μl RPE buffer was then 
added to the spin column and centrifuged at top speed (repeated twice with 10 seconds 
for the 1st spin and 2 min for the 2nd spin). All liquid was discarded after every single 
centrifugation. 
 
After the 2nd spin, all ethanol was removed as many as possible. Spin columns were put 
onto a new Eppendorf and spun for 2 min at top speed to remove as much ethanol as 
possible (this processes was repeated twice). Afterwards, spin columns were transferred 
onto respective marked collection tubes (supplied by the kit) and left open to the air for 
approximately 5 min to dry. The final step of gene extraction was to add 50 μl RNase-
free water directly into the spin columns, which were then centrifuged at top speed for 
1 min to elute the RNA. The organic phenol-chloroform phase from the RNA extraction 
was kept for further protein analysis (Western blotting analysis details is described in 
study 1 only). All top speeds in this gene extraction protocol refers to 13,000 rpm. 
 
  Adipose tissue gene quantification 
In all three experimental chapters, mRNA samples were quantified using Qubit® RNA 
BR Assay kit (Life Technologies, Oregon, USA) after gene extraction. The protocol 
used as follows: 
 
Master mix reagent was made up by diluting Qubit® RNA BR Reagent in a 1:200 ratio 
in Qubit® RNA BR Buffer. For standards, 10 μl of standard 1 and 2 mixed up with 190 
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ul master mix separately, then mixed by vortexing. For samples, each individual 2 μl of 
mRNA sample was added to 198 μl master mix. The total volume of each individual 
standards and samples were 200 μl. Samples were then quantified by a Qubit® 2.0 
Fluorometer (Life Technologies, Paisley, UK). 
 
  Conversion adipose mRNA to cDNA 
RNA was reversed transcribed (1 μg) to cDNA using a High Capacity Reverse 
Transcription Kit (Applied Biosystems, Warrington, UK). The protocol is described as 
follows. The required amount of Diethylpyrocarbonate (DEPC)-treated Water (Fisher 
Scientific, USA) was added to each tube using a pipette filter tip, followed by adding 
the correct volume of RNA samples. Mixed RNA samples were vortex briefly, then 
centrifuged to top speed. Reverse transcription (RT) mix was made up with fixed 
volumes of 10x RT buffer 2 μl, dNTP 0.8 μl, random primers 2 μl, multiscribe (enzyme) 
1 μl and water 4.2 μl for per sample. An electronic multidispensing pipette was used to 
dispense 10 μl RT mix per sample, followed by centrifuging samples briefly to reach 
maximum speed to mix. RNA samples were vortex again, and then centrifuged to mix 
at top speed. Afterwards, RNA samples were placed in a heating block following the 
steps: 25 °C for 10 min (this step was completed after RT), 37 °C for 120 min and 85 
°C for 5 min. After heating cycles, samples were centrifuged to reach top speed to get 
all the contents to the bottom of the tube. All samples were then stored at –80 °C for 
further analysis. 
 
  RT-PCR analysis 
Real-time polymerase chain reaction (RT-PCR) was performed using a StepOne 
(Applied Biosystems). cDNA samples were vortex briefly and centrifuged at top speed 
to force all contents to the bottom of the tube. Assay mix was made up in a total volume 
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of 18 μl (10 μl mastermix 2x, 7 μl DEPC water and 1 μl gene specific assay mix) per 
cDNA sample. 2 μl cDNA sample was added to a 48 well MicroAmp@ Reaction Plate 
(Applied Biosystems, China) in duplicate. 18 μl assay mix (Applied Biosystems, USA) 
was then added to each well and the plate was spun to top speed (4,000 rpm) for 2 min 
(each cDNA sample and assay mix was well mixed after this process). The plate was 
covered with optical seal (Applied Biosystems, USA). The plate was placed on an RT-
PCR analyser, with the following cycles: 50 °C for 2 min, 95 °C for 10 min, 95 °C for 
15 seconds and 60 °C for 1 min. The whole process lasted approximately 2 h.  
 
  Adipose tissue gene expression calculations 
Peptidylpropyl isomerase A (PPIA) was used as an endogenous control (Neville et al., 
2011) for all three studies. The comparative threshold cycle (Ct) is defined as the PCR 
cycle at which the fluorescent signal of the reporter dye crosses an arbitrarily placed 
threshold. Throughout this thesis, Ct method was used to process data where ΔCt = Ct 
target gene − Ct PPIA. Ct target genes were normalised to an internal calibrator (lowest 
ΔCt for each target gene) and baseline. Samples outside the detectable limit (Ct > 35) 
were excluded from the analysis. 
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4 Chapter 4: Feeding influences adipose tissue 
responses to exercise in overweight men 
 
4.1 Introduction 
It has become clear in the last 10 years or so that adipose tissue plays an active role in 
many physiological processes and pathological states (Weisberg et al., 2003; Xu et al., 
2003) and dysfunction within this tissue is characterised by poor metabolic control (e.g., 
tissue-specific insulin resistance, local inflammation, fibrosis, and the abnormal 
secretion of adipokines) (Langin et al., 2009). Adipose tissue secretes dozens of 
mediators including the archetypal adipokines, adiponectin and leptin (Fain et al., 
2004a; Moro et al., 2007; Lehr et al., 2012). Adiponectin is exclusively derived from 
adipose tissue and circulates in high concentrations (10–20 mg·l-1). In other cases, the 
quantitative amounts secreted by adipose can be substantial, for example, subcutaneous 
adipose contributes up to a third of circulating interleukin-6 (IL-6) (Mohamed-Ali et 
al., 1997a). 
 
Feeding has a pronounced effect on the whole-body metabolic responses to exercise 
and reduces the contribution of fat towards metabolism (Coyle et al., 1985; Wu et al., 
2003; Backhouse et al., 2007; Gonzalez et al., 2013). In addition, feeding influences 
the skeletal muscle responses to various forms of exercise (Civitarese et al., 2005; 
Cluberton et al., 2005; De Bock et al., 2005; Cheng et al., 2009; Harber et al., 2010; 
Dalbo et al., 2013). For example, PDK4 is significantly up-regulated in muscle with 
exercise in fasted but not fed conditions (Cluberton et al., 2005). Other feeding-related 
changes in gene expression in muscle after exercise have been reported including 
altered expression of GLUT4, PDK4, FAT/CD36, CPT-1, UCP3 and AMPK 
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(Civitarese et al., 2005). Collectively, therefore, there is strong evidence that feeding 
affects the responses to exercise in skeletal muscle. Adipose tissue and skeletal muscle 
both play a crucial role to regulate energy metabolism during exercise (Frayn, 2010) . 
This led us to speculate that pre-exercise feeding may also affect the adipose tissue 
responses to acute exercise. 
 
During exercise, adipose tissue plays an important role in contributing energy for 
working skeletal muscle (Horowitz, 2003). Exercise also initiates a number of other 
responses in adipose tissue such as increased blood flow and altered expression of 
various adipokines within abdominal subcutaneous adipose tissue (Thompson et al., 
2012). It is possible that these acute exercise-induced changes could be part of the 
mechanism through which exercise improves health (Thompson et al., 2012). However, 
all prior studies of adipose tissue responses to exercise in humans have been conducted 
in the fasted state (Keller et al., 2003a; Keller et al., 2003b; Holmes et al., 2004; Keller 
et al., 2005; Frydelund-Larsen et al., 2007; Hojbjerre et al., 2007; Leick et al., 2007; 
Christiansen et al., 2013b). The effect of feeding status on the response of human 
adipose tissue to exercise has never been studied. This is despite the fact that feeding 
has a profound effect on adipose tissue (Alligier et al., 2012; Johannsen et al., 2014) 
and that we spend the vast majority (~70%) of a 24-h period in a fed state (Ruge et al., 
2009). With this in mind, it is important to understand whether feeding alters the 
response of adipose tissue to physical activity. The aim of this study was therefore to 
investigate whether feeding influences the adipose tissue responses to exercise. 
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4.2 Methods 
 Experimental design  
Ten men aged 18 to 35 years with increased central adiposity were recruited via local 
advertisement. Participants attended the laboratory on three occasions for initial 
assessment of maximum oxygen uptake (V̇O2max) and two subsequent main trials. The 
trial days involved walking for 60 min at 60% V̇O2max under either FASTED or FED 
conditions in a randomised, counterbalanced design separated by a 3–4 week wash-out 
period. Blood and adipose tissue were sampled at baseline and after exercise to examine 
the impact of prior feeding. The protocol was approved by Bristol Research Ethics 
Committee (REC reference number: 13/SW/0020). This trial is registered at 
ClinicalTrials.gov (ID: NCT02870075), and all participants provided verbal and written 
informed consent before taking part.  
 
4.2.1.1 Inclusion and exclusion criteria 
To be eligible to take part, participants were required to be overweight with a waist 
circumference of 94–128 cm (WHO, 2008). Participants were also required to be weight 
stable (no change in mass ± 3%) (Stevens et al., 2006) for at least 3 months. Participants 
completed a health questionnaire (Appendix 1) to exclude any existing cardiovascular 
and metabolic diseases and a Physical Activity Readiness Questionnaire (PAR-Q) 
(Appendix 2) to make sure that participants were able to exercise safely. Individuals 
taking any medications known to influence lipid/carbohydrate metabolism or immune 
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4.2.1.2 Participants’ physical characteristics 
A summary of participants’ physical characteristics is shown in Table 4.1. 
 
Table 4.1 Participant physical characteristics (n = 10) 
Characteristics Mean ± SD  
Age (years) 26 ± 5 
Body mass (kg) 102.4 ± 10.6  
Waist circumference (cm) 105 ± 10  
Hip circumference (cm) 115 ± 6  
Body mass index (kg·m-2) 30.2 ± 3.7  
Fat in L1-L4 region (kg) 3.4 ± 1.5  
V̇O2max (ml·kg-1·min-1) 42.4 ± 6.4  
Systolic blood pressure (mmHg) 132 ± 21  
Diastolic blood pressure (mmHg) 73 ± 12  
 
 
 Pre-trial assessments  
4.2.2.1 V̇O2max measurement  
An incremental continuous treadmill test until the point of volitional fatigue was used 
to determine V̇O2max. For most participants, a treadmill speed of 4 km·h-1 and gradient 
of 8.5% was appropriate. Participants were tested at this speed and gradient with the 
speed increased by 1 km·h-1 after every 3 min stage. One minute expired air samples 
were collected into Douglas bags (Hans Rudolph, MO, USA) and rate of perceived 
exertion (RPE) and heart rate were measured in the final minute of each stage and also 
at the point of volitional fatigue, defined as when the participant indicated that only 1 
min remained until fatigue. Samples were analysed for relative expired fractions of 
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oxygen and carbon dioxide gas (Servomex, Crowborough, UK) and the total volume 
within the bag was measured using a dry gas meter (Harvard Apparatus, Kent, UK). 
 
4.2.2.2 Physical activity assessment  
As part of the pre-trial assessments, participants wore a combined heart 
rate/accelerometer monitor for one week to assess their habitual physical activity 
energy expenditure (Actiheart, Cambridge Neurotechnology Ltd., Cambridge, UK). 
This was attached to the chest via 2 adhesive ECG pads for 24 h per day except for 
during showering/bathing/swimming (Thompson et al., 2006). 
 
4.2.2.3 Body composition analysis 
Body mass was measured using digital scales following an overnight fast and post-void 
(TANITA corp., Tokyo, Japan). Waist and hip circumference was assessed according 
to World Health Organisation guidelines (WHO, 2008). Body composition was 
determined using Dual Energy X-ray Absorptiometry (DEXA; Discovery, Hologic, 
Bedford, UK). Abdominal subcutaneous and visceral adipose tissue mass was estimated 
from a central region between L1-L4 (Glickman et al., 2004).  
 
 Trial days 
In the 72 h prior to each main trial, participants were asked to refrain from performing 
any strenuous physical activity and from consuming alcohol/caffeine for 48 h prior to 
the main trials. A dietary record was completed 48 h before the first main trial and 
participants replicated this diet prior to their second main trial. 
 
On main trial days, participants arrived at the laboratory between 08:00–09:00 am 
following a 12 h fast. After anthropometric measurements, participants rested on a bed 
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for 15 min, followed by four 5-min expired gas sample collections to determine resting 
metabolic rate (RMR) (Compher et al., 2006; Betts et al., 2011) using substrate 
oxidation under resting conditions (Frayn, 1983b) and during exercise (Jeukendrup & 
Wallis, 2005) (Figure 4.1). 
 
After RMR assessment, a cannula was inserted into an antecubital forearm vein and a 
baseline venous blood sample was taken and allocated into tubes with either EDTA or 
serum separation beads (Sarstedt Ltd, Leicester, UK). Plasma samples were centrifuged 
immediately at 5,000 rpm at 4 °C for 10 min. Serum samples were left for 45 min to 
clot before centrifugation. Subcutaneous adipose tissue samples (~1 g) were taken 
under local anaesthetic (1% lidocaine) from the area around the waist approximately 5 
cm lateral to the umbilicus with a 14 G needle using an aspiration technique (Walhin et 
al., 2013) followed by adipose tissue cleaning and processing as described previously 
(Travers et al., 2015a). 
 
The study protocol is shown in Figure 4.1 and the protocol details are described as 
follows. Participants then either consumed a meal (FED) or remained fasting 
(FASTED) and cannula blood samples were taken every 15 min for the following 60 
min. A further blood sample was collected at 120 min immediately before the walking 
protocol. In both the FASTED and FED treatments, participants walked on the treadmill 
at 60% V̇O2max for 60 min and one minute of expired air samples, RPE and heart rate 
were collected at 5, 20, 40 and 60 min. After finishing exercise, another blood sample 
was immediately collected and participants then rested for a further 60 min. At this 
point, a second adipose tissue and final blood sample were taken.  
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Figure 4.1 Experimental protocol    
 




The meal in the FED trial was provided as previously described by Chowdhury et al. 
(2015). The total energy provided was 648 ± 115 kcal (CHO 120.1 ± 21.3 g, fat 12.7 ± 
2.3 g and protein 20.9 ± 3.7 g) (mean ± SD). The meal included white bread (Brace’s 
thick white), cornflakes (Kellogg’s cornflakes), semi-skimmed milk (Sainsbury; British 
semi skimmed milk), orange juice (Sainsbury; 100% pure squeezed smooth orange 
juice), spread (Unilever; I can’t believe its not butter), jam (Sainsbury; strawberry jam) 
and sugar (Sainsbury; British white granulated sugar). Participants were asked to 
consume the meal within 15 min. In the FASTED trial, participants sat quietly for a 15-
min period. 
 
 Experimental analysis 
4.2.4.1 Adipose tissue culture and gene expression  
After cleaning the adipose tissue biopsy, tissue was minced to approximately 5–10 mg 
and 400 mg was directly placed in sterile culture plates in quadruplicate (Nunc, 
Roskilde, Denmark) with endothelial cell basal media (ECBM) (Promocell, Germany) 
containing 0.1% fatty acid-free bovine serum albumin 100 U·ml-1 penicillin and 0.1 
mg·ml-1 streptomycin (Sigma-Aldrich, Gillingham, UK). Adipose tissue was incubated 
with a final ratio of 100 mg tissue per 1 ml ECBM media for 3 h (Travers et al., 2015b) 
at 37 °C in a 5% CO2 and 95 ± 5% relative humidity incubator (MCO-18A1C CO2 
incubator; Sanyo, Osaka, Japan). After the 3-h incubation, media was transferred to 
sterile tubes and stored at −80 °C. Adipokine secretion from adipose explants was 
normalised to L1-L4 fat mass as described (Travers et al., 2015a). The remaining 
adipose tissue (approximately 200 mg) was homogenised in 5 ml Trizol (Invitrogen, 
Chapter 4                                                             Study 1 
76 
Paisley, UK) in an RNase/DNase-free sterile tube (Invitrogen, Paisley, UK) and stored 
at −80 °C before gene expression and protein analysis. 
 
4.2.4.2 Real-time PCR 
An RNeasy Mini Kit (Qiagen, Crawley, UK) was used to extract RNA from adipose 
tissue as described (Walhin et al., 2013). Tissue samples were further quantified using 
a Qubit 2.0 fluorimeter (Life Technologies, Paisley, UK). RNA was reversed 
transcribed (1 μg) to cDNA using a High Capacity Reverse Transcription Kit (Applied 
Biosystems, Warrington, UK). Organic phenol-chloroform phase from the RNA 
extraction was kept for further protein analysis. Real-time PCR was performed using a 
StepOne (Applied Biosystems). Predesigned primers and probes were obtained from 
Applied Biosystems for the measurement of expression of interleukin 6 (IL-6) 
(Hs00985639_m1), adiponectin (Hs00605917_m1), leptin (Hs00174877_m1), 
interleukin 18 (IL-18) (Hs00155517_m1), tumour necrosis factor alpha (TNF-α) 
(Hs99999043_m1), monocyte chemoattractant protein-1 (MCP-1) (Hs00234140_m1), 
5’ AMP-activated protein kinase (AMPK) (Hs01562315_m1 and Hs00178903_m1 
combined), glucose transporter type 4 (GLUT4) (Hs00168966_m1), hormone-sensitive 
lipase (HSL) (Hs00193510_m1), insulin receptor substrate 1 (IRS1) (Hs00178563_m1), 
insulin receptor substrate 2 (IRS2) (Hs00275843_s1), sterol regulatory element binding 
protein 1c (SREBP-1c) (Hs01088691_m1), pyruvate dehydrogenase kinase isozyme 
(PDK4) (Hs00176875_m1), peroxisome proliferator-activated receptor γ (PPARγ) 
(Hs01115513_m1), peroxisome proliferator-activated receptor-gamma coactivator 1 
alpha (PGC-1α) (Hs01016719_m1), RAC-alpha serine/threonine-protein kinase 
(AKT1) (Hs00178289_m1), adipose triglyceride lipase (ATGL) (Hs00386101_m1), 
fatty acid translocase (FAT)/CD36 (Hs00169627_m1), forkhead box protein O1 
(FOXO1) (Hs01054576_m1), hexokinase 2 (HK2) (Hs00606086_m1), PI3K-85α 
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(PIK3R1) (Hs00933163_m1), carnitine palmitoyltransferase 1B (CPT1B) 
(Hs03046298_s1), The G0/G1 switch gene 2 (G0S2) (Hs00605971_m1), 
peptidylpropyl isomerase A (PPIA) was used as an endogenous control (Neville et al., 
2011). The comparative cycle threshold (Ct) method was used to process data where 
ΔCt = Ct target gene − Ct PPIA. Ct target genes were normalised to an internal 
calibrator (lowest ΔCt for each target gene) and baseline. The Ct values for IL-6 (31 
out of 40 samples), TNF-α (16 out of 40 samples), and IL-18 (37 out of 40 samples) 
were frequently over 35 and thus these results are not included. 
 
4.2.4.3 Western blotting 
The adipose tissue protein fraction was isolated from the TRIzol phenol-chloroform 
phase following the manufacturer’s protocol (TRIzol Reagent, Life Technologies). 
Briefly, 1 ml of organic phase was mixed with 1.5 ml isopropanol. After mixing, the 
samples were incubated for 10 min at room temperature, followed by 10 min 
centrifugation at 12,000 g at 4 °C to pellet the protein. One millilitre of protein pellet 
was washed using 2 ml of 0.3 M guanidine hydrochloride in 95% ethanol for 20 min 
incubation followed by centrifugation at 7,500 g for 5 min at 4 °C. This process was 
repeated 3 times. After finishing the washing procedure, 2 ml of 100% ethanol was 
added to the protein pellet for a further 20 min incubation at room temperature before 
being centrifugation. The pellet was then left to air dry for 5−10 min. Then, 200 μl of 
1% SDS was added to resuspended the pellet. The protein content of the samples was 
determined using a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, 
Waltham, USA). Proteins (25 μg·lane-1) were separated by SDS-PAGE and transferred 
using a semidry electro-transfer method to a nitrocellulose membrane. Western blotting 
analysis was performed with the following antibodies: Akt2/PKBβ (Millipore), AMPK 
(Cell Signalling Technology, USA), GLUT4 (Holman et al., 1990), IRS1 (Millipore), 
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IRS2 (Millipore), PDK4 (ABGENT, San Diego, USA), HSL (Cell Signalling 
Technology, USA) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
(Proteintech, USA). The images were acquired in an EPI Chemi II darkroom (UVP) 
and bands quantified using VisionWorks LS analysis software (UVP). 
 
4.2.4.4 Biochemical analysis  
Plasma glucose and non-esterified fatty acids (NEFA) were measured using 
commercially available assay kits and analyser (Daytona Rx; Randox, Crumlin, UK). 
Serum insulin (Mercodia, Uppsala, Sweden) and both serum and adipose secretion of 
IL-6, leptin and adiponectin (R&D systems) were measured using Enzyme-linked 
immunosorbent assay (ELISA). 
 
 Statistics 
Descriptive data are presented as means ± standard deviation (SD). All other data are 
presented as means ± standard error of the mean (SEM). Incremental area under curve 
(iAUC) was calculated using the trapezoid method (Wolever & Jenkins, 1986). All data 
were checked for normality using visual checking of histograms, confirmed statistically 
by Shapiro-Wilk test. Non-normally distributed and ordinal data (e.g. RPE) were 
analysed using the equivalent non-parametric tests. The differences between trials in 
iAUC, gene expression and Western blotting outcomes were analysed using paired t-
tests. Glucose, insulin, NEFA, circulating adipokines and adipose cell culture outcomes 
were analysed using a two-way ANOVA with repeated measures using SPSS version 
22 (IBM, Armonk, NY, USA). Where significant interactions (trial × time) were found, 
post hoc t-tests with the Holm–Bonferroni correction were used (Atkinson, 2002). 
Statistical significance was set at p ≤ 0.05. 
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4.3 Results 
 Energy expenditure and substrate oxidation during FASTED and FED 
trials 
There were modest feeding-induced differences between trials for relative exercise 
intensity (% V̇O2max), RPE, energy expenditure and substrate oxidation (Table 4 2). Pre-
fed RMR was not different (2,103 ± 418 versus 2,058 ± 365 kcal·d-1 in FASTED and 
FED trials, respectively). 
 
Table 4.2 Physiological responses during 60 min exercise 
 FASTED FED 
Treadmill speed (km·h-1) 5.7 ± 0.2 5.7 ± 0.2 
V̇O2max (%) * 59 ± 1  60 ± 1  
Heart Rate (beat·min-1) 155 ± 4 155 ± 4 
RPE (6–20)  12 ± 1 12 ± 1 
Energy expenditure (kcal·h-1) * 746 ± 41  771 ± 43  
RER (V̇CO2:V̇O2) * 0.93 ± 0.01 0.97 ± 0.01 
Carbohydrate oxidation (g·h-1) * 147 ± 13 167 ± 12 
Fat oxidation (g·h-1) * 16 ± 3 9 ± 2 
Values are means ± SEM. * denotes significantly different between FASTED versus 
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 Plasma glucose, NEFA and serum insulin concentrations 
Trial × Time interaction effects were found for blood glucose, insulin and NEFA 
between FASTED and FED trials (p = 0.026, p = 0.003 and p = 0.001, respectively). 
As expected, iAUCs for glucose and insulin were elevated for all parameters in the FED 
trial (p = 0.02 and p = 0.03, respectively) (Figure 4.2b & d). Peak glucose and insulin 
concentrations in the FED trial were reached 15 min post-meal (7.1 ± 0.3 mmol·l-1 and 
370 ± 95 pmol·l-1, p = 0.001, Figure 4.2a; p = 0.03; Figure 4.2c, respectively). NEFA 




















Figure 4.2 Plasma glucose, NEFA and serum insulin concentrations. 
Glucose (a), insulin (c) and NEFA (e) concentrations in FASTED and FED trials and iAUC for 
glucose (b), insulin (d) and NEFA (f). In both FASTED and FED trials (n = 9), due to difficulty 
in cannulating one participant. Values are means ± SEM. # denotes significant interaction effect 
under both FED and FED trials. * denotes significantly different between FASTED versus FED 
(p ≤ 0.05). The shaded box in (a), (c) and (e) denotes meal time. 
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 Adipose tissue mRNA expression 
There was a difference in adipose tissue mRNA levels of PDK4, ATGL, HSL, 
FAT/CD36, GLUT4 and IRS2 (all p ≤ 0.05) when exercising under FASTED vs FED 
conditions (Figure 4.3). Expression of PDK4 (1.68-fold), ATGL (1.19-fold), HSL 
(2.09-fold) and FAT/CD36 (1.19-fold) were up-regulated under FASTED conditions 
and expression of PDK4 (0.77-fold) and IRS2 (0.81-fold) were down-regulated under 
FED conditions. The expression of the remaining genes was not significantly different 
between trials.





Figure 4.3 Fold changes in relative adipose tissue gene expression (mRNA levels) under FASTED and FED trial 
Fold changes in relative gene expression (mRNA levels) of metabolism, insulin signaling, glucose transport and inflammatory genes in 
adipose tissue under FASTED and FED trials (all n = 10, except for HSL and G0S2 n = 9 owing to Ct > 35 for one participant).The dashed line 
indicates baseline. Data normalised to PPIA, internal calibrator and baseline. Samples that exceeded the detectable limit (Ct > 35) were excluded 
from the analysis. Values are means ± SEM. # p ≤ 0.05 between FASTED and FED trials.
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 Adipose tissue protein expression  
There was a difference in IRS2 protein expression between trials (p ≤ 0.05), showing 
approximately a 2-fold increase in FASTED conditions, and no change in FED 
conditions. The change in the expression of the remaining proteins was not statistically 
different between FASTED and FED conditions (Figure 4.4). 
 
 
Figure 4.4 Fold changes in relative proteins levels in adipose tissue under FASTED 
and FED trials. The dashed line indicates baseline. Data were normalised to GAPDH. 
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The representative image of Western blotting is shown on Figure 4.5 (IRS1/2, AKT2 
and AMPK represents participant number 2 and 8. GLUT4, PDK4 and HSL represents 
participant number 3 and 4) 
 
           
Figure 4.5 Representative images of Western blotting results in adipose tissue 
under FASTED and FED trials using a density scan method. 
 
 Serum adipokine concentrations and adipose tissue secretion ex vivo  
Serum IL-6 increased (Figure 4.6 a) and serum leptin decreased (Figure 4.6 c) in both 
trials (p < 0.05). Time effects were also identified for adiponectin (Figure 4.6 e) (p < 
0.05). No interaction effects were identified for IL-6, leptin and adiponectin. 
Furthermore, no time or time × trial interactions were identified for ex vivo adipose 
explant secretion of IL-6, leptin and adiponectin in response to exercise under FASTED 
and FED trials (Figure 4.6) 
Participant No. 2 & 8 
Participant No. 3 & 4 





Figure 4.6 Serum adipokine concentrations and adipose tissue secretion ex vivo. 
Circulating serum IL-6 (a) leptin (c) and adiponectin (e) concentrations in FASTED 
and FED trials (n = 9). Ex-vivo adipose tissue explant protein secretion of IL-6 (b), 
leptin (d) and adiponectin (f) at baseline and 1 h post-exercise expressed relative to L1-
L4 fat mass (n = 10). Values are means ± SEM. The shaded box in (a), (c) and (e) 
denotes meal time. # p ≤ 0.05 denotes time effect.  
 




This study presents the first evidence that feeding status alters the human adipose tissue 
response to exercise. Exercise in the fasted-state altered the expression of genes 
involved in lipid metabolism, insulin signaling and glucose transport, whereas exercise 
in the fed-state did not. The divergent responses to exercise performed under different 
feeding status may have implications for adaptation to regular exercise.  
 
In the present study, our feeding protocol successfully manipulated systemic 
concentrations of glucose and insulin. In the two hours prior to exercise, there was a 
168-fold and 26-fold difference in insulin and glucose iAUC, respectively. As 
anticipated with this study design, prior feeding increased relative carbohydrate 
utilisation and decreased fat oxidation during exercise (Coyle et al., 1985; Wu et al., 
2003; Backhouse et al., 2007; Gonzalez et al., 2013). Thus, exercise in FED and 
FASTED trials was performed in a very different physiological state. 
 
At the gene expression level, we found that adipose tissue responds differently to 
moderate-intensity exercise under FASTED and FED conditions, with altered 
expression of PDK4, ATGL, HSL, FAT/CD36, GLUT4 and IRS2. These results 
indicate that exercise when fasting leads to changes in adipose tissue gene expression, 
whereas exercise in the fed state does not elicit such changes. Over time, acute 
differences in skeletal muscle gene expression with exercise conducted in the fasted 
versus the fed state have been proposed to contribute to diverse physiological 
adaptations (De Bock et al., 2008; Stannard et al., 2010; Van Proeyen et al., 2010; Van 
Proeyen et al., 2011). Our data demonstrate that feeding status also alters adipose tissue 
responses to an acute bout of exercise and thus it is also possible that feeding status 
could affect the adipose tissue response to long-term exercise training.  
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We found a difference in adipose IRS2 protein content although the other measured 
proteins were not affected. This could be partly explained by the fact that our post-
exercise biopsy was taken one hour after exercise had finished. Depending on the 
kinetics of each response, this sample timing framework will be appropriate for some 
outcomes and inappropriate for others. We should also highlight that our protein 
measurements represent only total protein content. Repeated small changes in adipose 
protein synthesis are likely lead to accumulated differences and functional changes in 
adipose phenotype over time (Booth & Neufer, 2005; Perry et al., 2010). Clearly, the 
only way to know if the acute changes observed in the current study translate into long 
term differences is to examine whether chronic training conducted in the fasted versus 
postprandial state leads to divergent adaptations.  
 
 Carbohydrate and lipid metabolism in adipose tissue 
A primary function of PDK4 is to regulate glucose metabolism by inhibiting pyruvate 
dehydrogenase complex activity. Fasting and exercise increase PDK4 mRNA 
expression in skeletal muscle (Pilegaard et al., 2000; Pilegaard et al., 2003a) and insulin 
suppresses PDK4 mRNA and protein content in skeletal muscle (Majer et al., 1998; 
Lee et al., 2004). It is possible that insulin could be responsible for the lower adipose 
PDK4 mRNA response in the FED trial, although higher NEFA in the FASTED trial 
could also have increased PDK4 expression (Arkinstall et al., 2004; Kiilerich et al., 
2010). Other feeding-related studies have shown that muscle PDK4 mRNA expression 
remained unchanged 1–4 h after exercise in the fed state (with lower NEFA 
concentrations), when compared with exercise in the fasted state (Civitarese et al., 2005; 
Cluberton et al., 2005). Thus, exercise in the fasted state appears to increase PDK4 
expression in both muscle and adipose, whereas exercise in the fed state does not.  
 
Chapter 4                                                             Study 1 
  
89 
ATGL and HSL mobilise stored fat and release it into the blood (Zimmermann et al., 
2004; Holloway et al., 2008; Lafontan & Langin, 2009). In the current study, gene 
expression of ATGL, HSL and FAT/CD36 in adipose were all increased in FASTED 
but not FED conditions. These differences were associated with higher fat oxidation 
during FASTED exercise (9 ± 6 versus 16 ± 8 g·h-1 in FED and FASTED trials, 
respectively). Other studies have also shown similar responses in fasted exercise with 
higher fat oxidation and increased skeletal muscle FAT/CD36 gene expression 
(Civitarese et al., 2005). Moreover, these findings are consistent with the previously 
observed increase in adipose HSL activity reported during cycling exercise, which is 
blunted with nicotinic acid ingestion (Watt et al., 2004). Our results indicate that 
exercise in the fed state does not lead to a change in gene expression for lipid 
mobilisation and transport pathways in adipose tissue and, at a conceptual level, feeding 
seems to blunt the exercise-induced stimulus on adipose tissue. 
 
We found higher GLUT4 mRNA and higher IRS2 mRNA and protein in adipose in the 
FASTED trial, compared to the FED trial. There are several explanations for this 
finding. One potential explanation is that glucose is required as precursor for 
oxaloacetic acid for lipid oxidation (Rui, 2014). Glucose is also essential for triglyceride 
synthesis (Nye et al., 2008) and, because samples were taken one hour after exercise, it 
is possible that our sampling framework captures the start of this process in adipose 
tissue after exercise. Interestingly, our findings in adipose mirror those reported in 
skeletal muscle, where an increase in GLUT4 mRNA in fasted but not fed conditions 
has been reported after exercise (Civitarese et al., 2005; Cluberton et al., 2005).  
 
PGC-1α mRNA is a transcriptional coactivator involved in mitochondrial biogenesis 
(Wu et al., 1999; Scarpulla et al., 2012). Acute exercise increases PGC-1α mRNA 
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expression in human skeletal muscle (Pilegaard et al., 2003b; Psilander et al., 2013; 
Norheim et al., 2014; Gidlund et al., 2015) and in rodent white adipose tissue 
(Sutherland et al., 2009). However, the impact of feeding status and/or carbohydrate 
variability prior to exercise on skeletal muscle PGC-1α mRNA is controversial. Some 
studies indicate that PGC-1α mRNA expression is up-regulated whether acute exercise 
was in fed or fasted conditions (Cluberton et al., 2005; Mathai et al., 2008) but other 
studies show that higher carbohydrate availability prior to exercise blunts PGC1-α 
mRNA expression in skeletal muscle both at rest and post-exercise (Bartlett et al., 2013; 
Psilander et al., 2013). In the present study, the increase in adipose PGC-1α mRNA 
expression was unaffected by feeding status. Chronic training studies indicate that 
adipose PGC1-α mRNA is increased in humans (Ruschke et al., 2010) and rodents 
(Sutherland et al., 2009; Trevellin et al., 2014) and this has also been reported to 
increase PGC1-α protein content and mitochondrial biogenesis in rodents (Trevellin et 
al., 2014). Whether the present results indicate an exercise-induced increase in 
mitochondrial biogenesis in human adipose tissue is unclear at the present time. 
 
 Adipokines response to exercise and impact of feeding status 
Previous studies have shown that circulating adipokine concentrations are affected by 
acute exercise (Fischer, 2006; Christiansen et al., 2013a) and energy consumption 
during exercise alters these systemic responses (Starkie et al., 2001; Lancaster et al., 
2005; Robson-Ansley et al., 2009). However, evidence from studies that have 
manipulated feeding status prior to exercise is scarce. Zoladz et al. (2005) found no 
difference in circulating IL-6 and leptin after a single bout of exercise, in a fed or fasted 
state; however, the duration of exercise lasted only 12 min and this might be insufficient 
to examine the notion that feeding status influences circulating adpokines. However, 
our exercise was 60 min long, and we too found no evidence that pre-exercise feeding 
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affects circulating IL-6, leptin and adiponectin. This may be due to the fact that 
moderate intensity exercise has only a modest effect on many of these parameters and 
thus there is little potential for feeding to interact with exercise and exert an effect 
(Markovitch et al., 2008). Serum IL-6 was increased over time in both fasted and fed 
trials in the present study, which could be partly due to the effect of exercise (Petersen 
& Pedersen, 2005), but it is also possible that this is a product of prolonged cannulation 
(Dixon et al., 2009).  
 
 Temporal and population-specific considerations 
This study is the first to examine the impact of feeding on adipose tissue responses to 
exercise. In this study, we recruited overweight participants and this focus is a strength 
given that ~62% of the UK population are overweight (Health and Social Care 
Information Centre, 2012). Increased adiposity has a profound effect on adipose tissue 
function (e.g., a down regulation of GLUT 4 mRNA (Travers et al., 2015a) and 
reduction in postprandial adipose tissue blood flow (McQuaid et al., 2011) and this is 
an important consideration when interpreting these findings. We should also highlight 
that in the current study we were limited to only two adipose tissue biopsies due to 
potential interference from repeated sampling (Dordevic et al., 2015) and so we do not 
have a full and complete time course. In the absence of an adipose biopsy immediately 
prior to exercise, it is hard to establish whether some effects in the FASTED trial are 
due to the modestly extended fasting period or due to exercise (or the interaction 
between fasting and exercise). What is apparent, however, is that exercise in FED 
conditions does not lead to the same changes as exercise in FASTED conditions.   
 




This study provides the first evidence that the feeding status in which exercise is 
performed alters the response of adipose tissue in overweight humans. Feeding prior to 
exercise suppresses the expression of genes involved in lipid metabolism, insulin 
signaling and glucose transport in subcutaneous abdominal adipose tissue. Given the 
potential role for adipose tissue in health, regular acute changes in adipose tissue gene 
expression with exercise in a fasted state could potentially impact upon the accumulated 
long-term responses to an exercise programme. 
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5 Chapter 5: The effect of breaking prolonged sitting 
on metabolism and adipose tissue in middle-age 
overweight men and women 
 
5.1 Introduction 
In the past few decades, traditional exercise guidance has focused on the prescription 
of structured physical activities such as performance of prolonged moderate intensity 
exercise lasting longer than 30 min. This form of physical activity has been shown to 
improve physical fitness and decrease cardiovascular risk factors, along with increased 
insulin sensitivity, glucose tolerance, adiponectin concentrations (etc) (Stallknecht et 
al., 2000; Akbarpour, 2013; Sakurai et al., 2013). Unfortunately, many people struggle 
to undertake such structured exercise and alternative complimentary strategies are 
required.  
 
In modern society, people spend much of their time using a computer, watching TV and 
so on causing sedentary behaviour or prolonged sitting to become increasingly 
common. Sedentary behaviour has been defined as step counts lower than 5,000 steps 
a day (Tudor-Locke & Bassett, 2004; Tudor-Locke et al., 2013) or only undertaking 
activities where energy expenditure is less than 1.5 metabolic equivalents (METs) (Pate 
et al., 2008; Owen et al., 2010). In addition to causing a positive energy balance and 
weight gain, several studies have shown that increased sedentary behaviour is 
significantly associated with increased risk of abnormal glucose metabolism, metabolic 
syndrome, type 2 diabetes and cardiovascular disease (Ford et al., 2005; Healy et al., 
2007; Wilmot et al., 2012). Targeting this sedentary behaviour may be just as important 
for health as the use of exercise for health. 
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In support of this suggestion, some researchers have shown that short bouts of 
accumulated physical activity lasting just a few minutes spread over the course of a day 
has the same effect as a single bout of exercise (Miyashita, 2008; Miyashita et al., 2008, 
2011). Indeed, breaking prolonged sitting and sedentary time appears to offer distinct 
benefits to various health outcomes, including fat oxidation and postprandial glycemia 
and insulinemia (Dunstan et al., 2012b; Ando et al., 2013; Latouche et al., 2013; Peddie 
et al., 2013; Bailey & Locke, 2015; Henson et al., 2016). Breaking prolonged sitting 
also influences skeletal muscle pathways involved in carbohydrate metabolism 
(Latouche et al., 2013). Thus, targeting sedentary behaviour could be a very effective 
strategy for health.  
 
We are learning more and more about the role of adipose tissue in health. Adipose tissue 
is not only an energy store, it is a complex endocrine organ that releases a number of 
hormones (called adipokines). These adipokines have different physiological functions 
and play an important role in the pathophysiology of chronic diseases such as type 2 
diabetes. Acute exercise elicits various changes in adipose tissue (Horowitz, 2003; 
Enevoldsen et al., 2004; Thompson et al., 2012) but it is not clear whether breaking 
prolonged sedentary time also affects adipose tissue. If this strategy is effective, it 
would have major implications for guidance towards means of combatting the disorders 
associated with dysfunctional adipose tissue. Therefore, the purpose of this study is to 
examine the effect of breaking prolonged sitting on systemic and adipose tissue 
responses to feeding. 
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5.2 Methods 
 Experimental design  
Eleven sedentary participants (7 men and 4 post-menopausal women) aged between 35 
to 64 years with increased central adiposity were recruited via local advertisement. An 
initial screening meeting was followed by two subsequent main trials (prolonged sitting 
and breaking sitting). Trials were conducted in a randomised, counterbalanced design 
separated by a 3–4 week wash-out period. Two identical meals based on participant’s 
total body mass were provided on the main trial days (morning and lunchtime). Blood 
was taken regularly during the course of each trial and adipose tissue biopsies were 
taken at baseline and at the end of each trial. The protocol was approved by Bristol 
Research Ethics Committee (REC reference number: 13/SW/0321). This trial is 
registered at ClinicalTrials.gov (ID: NCT02870088), and all participants provided 
verbal and written informed consent before taking part. 
 
5.2.1.1 Inclusion and exclusion criteria 
Participants were required to be overweight with a waist circumference of 94–128 cm 
(WHO, 2008) and weight stable (no change in weight ± 3%) (Stevens et al., 2006) for 
at least 3 months prior to taking part in this study. Participants completed a health 
questionnaire (Appendix 1) to exclude any existing cardiovascular and metabolic 
diseases and a Physical Activity Readiness Questionnaire (PAR-Q) (Appendix 2) to 
make sure that participants were able to walk on the treadmill safely. Smokers, pre-
menopausal women and volunteers who used any medications which could influence 
metabolic and inflammatory responses were excluded.  
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5.2.1.2 A summary of participants’ physical characteristics  
A summary of participants’ physical characteristics is shown in Table 5.1. 
 
Table 5.1 Participants physical characteristics (n = 11) 
Characteristics Means ± SD 
Age (years) 50 ± 5 
Body mass (kg) 97.6 ± 20.8 
Waist circumference (cm) 108.8 ± 14.0 
Hip circumference (cm) 112.0 ± 12.1  
Body mass index (kg·m-2) 32.5 ± 6.7  
 Fat mass (%) 34.8 ± 6.3 
Fat in L1-L4 region (kg) 4.7 ± 1.9 
Systolic blood pressure (mmHg) 137 ± 12  
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 Pre-trial assessments   
5.2.2.1 Physical activity assessment 
As part of the pre-trial assessments, participants wore a combined heart 
rate/accelerometer monitor for 7 days to assess habitual physical activity energy 
expenditure (Actiheart, Cambridge Neurotechnology Ltd., Cambridge, UK). This was 
attached to the left chest via 2 adhesive ECG pads for 24 h per day except for during 
showering/bathing/swimming (Thompson et al., 2006). 
 
5.2.2.2 Body composition analysis 
Body mass was assessed using digital scales post-void (TANITA corp., Tokyo, Japan). 
Waist and hip circumference was assessed based on World Health Organisation 
guidelines (WHO, 2008). Body composition was determined by using Dual energy X-
ray absorptiometry (Discovery, Hologic, Bedford, UK). Abdominal subcutaneous and 
visceral adipose tissue mass was estimated from a central region between L1-L4 
(Glickman et al., 2004).  
 
 Trial days 
In the 72 h prior to each main trial, participants were asked to refrain from performing 
any strenuous physical activity. In the 48 h prior to each main trial, consuming 
alcohol/caffeine was not allowed and a weighed food and fluid record was completed. 
Participants were asked to replicate this diet prior to their second main trial. In addition, 
in the 48 h prior to each main trial, participants were asked to restrict their step counts 
to under 4,000 steps per day in order to mimic a sedentary lifestyle (Tudor-Locke & 
Bassett, 2004; Tudor-Locke et al., 2013) and eliminate any acute effects from recent 
physical activity.  
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A 12 h fast was performed before arriving at the laboratory on main trial days between 
08:00–09:00 am. After anthropometric measurements, participants rested on a bed for 
15 min, followed by two 5 min expired gas samples collections to determine resting 
metabolic rate (RMR) (Compher et al., 2006; Betts et al., 2011) using stoichiometric 
equations as described by (Frayn, 1983b). 
 
After RMR assessment, a 20-gauge 1.1 × 32 mm cannula (BD, VenflonTM Pro) was 
inserted into an antecubital forearm vein and a 10 ml baseline venous blood sample was 
taken and allocated into tubes with either EDTA or serum separation beads (Sarstedt 
Ltd, Leicester, UK). Plasma samples were centrifuged immediately at 5,000 rpm and 4 
°C for 10 min. Serum samples were left for 45 min to clot before centrifugation. 
Subcutaneous adipose tissue samples (~1 g) were taken under local anaesthetic (1% 
lidocaine) from the area around the waist approximately 5 cm lateral to the umbilicus 
with a 14 G needle using an aspiration technique (Walhin et al., 2013) followed by 
adipose tissue cleaning and processing as previously described by Travers et al. (2014).  
 
The study protocol and details are shown in Figure 5.1 and details on main trial days 
are described as follows. Two trials were performed including one prolonged sitting 
and one breaking sitting trial. In the breaking trial, after consuming the 1st meal, 
participants walked for 2 min on a treadmill at 6.4 km·h-1 (Dunstan et al., 2012b) every 
20 min for the following 180 min. For the remainder of the time participants sat on the 
chair. The 2nd meal was provided after 180 min. After finishing the 2nd meal, 
participants continued the 2 min walks to break up prolonged periods of sitting at the 
same speed every 20 min for the following 120 min. Thus, in total, participants 
performed 15, 2 min bouts of physical activity throughout the trial (i.e., 30 min of 
physical activity over 300 min). In the prolonged sitting trial, participants sat on a chair 
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for the whole period. Second adipose tissue and final blood sample were taken at the 
end of trial. 
 
Expired air, ratings of perceived exertion (RPE) and heart rate were collected during 
two of the 2 min bouts of walking to determine exercise intensity, energy expenditure 
and energy substrate utilization as described by Jeukendrup and Wallis (2005). In 
addition, for both breaking sitting and prolonged sitting trials, during two 5 min periods 
of sitting, expired air and heart rate were taken to calculate total energy expenditure 
under sitting conditions as described by Frayn (1983b). While sitting, participants were 
only allowed to read, use a laptop or watch television but were otherwise asked to keep 
as still as possible throughout. In the first trial, participants were allowed to consume 
water ad libitum and the volume ingested was replicated for the 2nd trial. Expired air 
samples were collected into Douglas bags (Hans Rudolph, MO, USA). Samples were 
analysed for relative expired fractions of oxygen and carbon dioxide gas for 2 min 
(Servomex, Crowborough, UK) and the total volume within the bag was measured 
using a dry gas meter (Harvard Apparatus, Kent, UK). 
 
In each main trial, baseline blood samples was collected before the 1st meal and hourly 
for the following 5 h. Additional blood samples were collected every 15 min after the 
first and second meal. A total of 14 blood samples were collected for each trial. 
 




Figure 5.1 Experimental protocol 
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5.2.3.1 Meal  
Two identical meals (breakfast and lunch) were provided and consumed within a 15 min 
period during each main trial. The meal was prescribed according to total body mass 
and provided 0.35 g fat, 1.17 g carbohydrate, 0.29 g protein and 37 kJ of total energy 
per kilogram body mass (Miyashita, 2008). The percentage of energy from 
macronutrients was 35% fat, 52% carbohydrate and 13% protein. The meal comprised 
white bread (Hovis; soft white bread, medium sliced), sliced cheese (Sainsbury; cheese 
slices, basic), butter (Unilever; I can’t believe its not butter), mayonnaise (Hellmann; 
light mayonnaise), lettuce (Sainsbury; Iceberg lettuce), tomato (Sainsbury; tomatoes, 
basics), ham (Sainsbury; British honey roast), whole milk (Sainsbury; British), cocoa 
powder (Nesquick; cocoa powder), and yoghurt (Müller; fruit corner strawberry).  
 
 Experimental analysis  
5.2.4.1 Adipose tissue culture and gene expression  
After cleaning the adipose tissue biopsy, the tissue was minced to approximately 5–10 
mg segments and 200 mg was directly placed in sterile culture plates in duplicate (Nunc, 
Roskilde, Denmark) with endothelial cell basal media (ECBM) (Promocell, Germany) 
containing 0.1% fatty acid-free bovine serum albumin 100 U·ml-1 penicillin and 0.1 
mg·ml-1 streptomycin (Sigma-Aldrich, Gillingham, UK). Adipose tissue was incubated 
at a final ratio of 100 mg tissue per 1 ml ECBM media for 3 h (Travers et al., 2014). A 
37 °C, 5% CO2 and 95 ± 5% relative humidity incubator was used to incubate adipose 
tissue explants ex vivo (MCO-18A1C CO2 incubator; Sanyo, Osaka, Japan). After the 
3-h incubation, media was transferred to sterile Eppendorfs and stored at −80 °C. 
Adipokine secretion from adipose explants was normalised to L1-L4 fat mass as 
described (Travers et al., 2015b). The remaining adipose tissue (approximately 200 mg) 
was homogenised in 5 ml TRIzol (Invitrogen, Paisley, UK) in an RNase/DNase-free 
Chapter 5                                                             Study 2 
102 
sterile tube (Invitrogen, Paisley, UK) and stored at −80 °C before mRNA expression 
analysis. 
 
5.2.4.2 Real-time PCR 
An RNeasy Mini Kit (Qiagen, Crawley, UK) was used to extract RNA from TRIzol-
digested adipose tissue as described in Walhin et al. (2013). Tissue samples were 
further quantified using a Qubit 2.0 fluorimeter (Life Technologies, Paisley, UK). RNA 
was reversed transcribed (1 μg) to cDNA using a High Capacity Reverse Transcription 
Kit (Applied Biosystems, Warrington, UK). The organic phenol-chloroform phase from 
the RNA extraction was kept for future protein analysis. Real-time PCR was performed 
using a StepOne (Applied Biosystems, Warrington, UK). Predesigned primers and 
probes were obtained from Applied Biosystems for the measurement of expression of 
interleukin 6 (IL-6) (Hs00985639_m1), adiponectin (Hs00605917_m1), leptin 
(Hs00174877_m1), interleukin 18 (IL-18) (Hs00155517_m1), tumour necrosis factor 
alpha  (TNF-α) (Hs99999043_m1), monocyte chemoattractant protein-1 (MCP-1) 
(Hs00234140_m1), 5’ AMP-activated protein kinase (AMPK) (Hs01562315_m1 and 
Hs00178903_m1 combined), glucose transporter type 4 (GLUT4) (Hs00168966_m1), 
hormone-sensitive lipase (HSL) (Hs00193510_m1), insulin receptor substrate 1 (IRS1) 
(Hs00178563_m1), insulin receptor substrate 2 (IRS2) (Hs00275843_s1), sterol 
regulatory element binding protein 1c (SREBP-1c) (Hs01088691_m1), pyruvate 
dehydrogenase kinase isozyme (PDK4) (Hs00176875_m1), peroxisome proliferator-
activated receptor γ (PPARγ) (Hs01115513_m1), peroxisome proliferator-activated 
receptor-gamma coactivator 1 alpha (PGC-1α) (Hs01016719_m1), RAC-alpha 
serine/threonine-protein kinase (AKT1) (Hs00178289_m1), adipose triglyceride lipase 
(ATGL) (Hs00386101_m1), fatty acid translocase (FAT)/CD36 (Hs00169627_m1), 
forkhead box protein O1 (FOXO1) (Hs01054576_m1), hexokinase 2 (HK2) 
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(Hs00606086_m1), phosphoinositide 3-kinase 85α (PI3K-85α) (Hs00933163_m1), 
fatty acid synthase (FAS) (Hs00188012_m1), peptidylpropyl isomerase A (PPIA) was 
used as an endogenous control (Neville et al., 2011). The comparative Ct method was 
used to process data where ΔCt = Ct target gene − Ct PPIA. Ct target genes were 
normalised to an internal calibrator (lowest ΔCt for each target gene) and baseline. 
 
5.2.4.3 Biochemical analysis  
Blood glucose, triglycerides and non-esterified fatty acids were analysed using 
commercially available assay kits and analyser (Daytona Rx; Randox, Crumlin, UK). 
Serum insulin (Mercodia, Uppsala, Sweden), and both serum and adipose secretion of 
IL-6, leptin, and adiponectin (R&D systems) were measured using Enzyme-linked 
immunosorbent assay (ELISA).  
 
 Statistics 
Descriptive data are presented as means ± standard deviation (SD). All other data are 
presented as means ± standard error of the mean (SEM). Incremental area under curve 
(iAUC) was calculated using the trapezoid method (Wolever & Jenkins, 1986). All data 
were checked for normality using visual checking of histograms, confirmed statistically 
by the Shapiro-Wilk test. Differences in summative scores between trials for iAUC and 
mRNA expression outcomes were analysed using paired t-tests. Non-normally 
distributed data were analysed using the equivalent non-parametric tests. Serial glucose, 
insulin, NEFA, triglycerides, blood adipokines and adipose cell culture outcomes were 
determined using a two-way ANOVA with repeated measures using SPSS version 22 
(IBM, Armonk, NY, USA). Where significant interactions (trial × time) were found, a 
post hoc analysis was applied using t-tests with a Holm–Bonferroni correction 
(Atkinson, 2002). Statistical significance was set at p ≤ 0.05.  
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5.3 Results  
The average of two days of step counts prior to prolonged and breaking sitting trials 
was not different (3,868 ± 393 versus 3,669 ± 329 steps·day-1, respectively) and there 
was no difference in pre-fed RMR on the trial day between trials (1,882 ± 91 versus 
1,833 ± 102 kcal·day-1, respectively).  
 
 Physiological response during walking in breaking sitting 
During the 15 bouts of 2 min walking, the average heart rate was 135 ± 4 beats· min-1 
with an RPE (6–20 scale) of 10.5 ± 0.6. The difference in energy expenditure between 
trials was 211 kcal (Table 5.2).  
 
Table 5.2 Energy expenditure and substrate oxidation during each 330 min trial 
 Prolonged sitting Breaking sitting 
Energy expenditure (kcal)  552 ± 27 *  763 ± 48 
Carbohydrate oxidation (g)  112 ± 14 * 168 ± 15 
Fat oxidation (g)  17 ± 4 18 ± 3 
Values are means ± SEM. * denotes significantly different between prolonged sitting 
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 Blood glucose, insulin, triglyceride and NEFA in prolonged and breaking 
sitting trials 
Interaction effects were found in plasma glucose concentrations between prolonged and 
breaking sitting trials (p ≤ 0.05; Figure 5.2a). The glucose iAUC was attenuated 
significantly by breaking sitting compared to prolonged sitting trial (359 ± 117 versus 
697 ± 218 mmol·330 min·l-1, p = 0.001; Figure 5.2b).  
 
Figure 5.2 Plasma glucose concentrations (a) and glucose iAUC (b) in prolonged 
and breaking sitting trials. The sample size is n = 10 due to difficulty in cannulating 
one participant. Values are means ± SEM. # denotes significant interaction effect 
between prolonged and breaking sitting trials (p ≤ 0.05). * denotes significantly 
different between prolonged versus breaking sitting trials (p ≤ 0.05). The shaded box 
denotes meal time. 
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Interaction effects were also found in serum insulin concentrations between prolonged 
and breaking sitting trials (p ≤ 0.05; Figure 5.3a) The insulin iAUC were attenuated 
significantly by breaking sitting compared to prolonged sitting trial (2,024 ± 714 versus 





Figure 5.3 Serum insulin concentrations (a) and insulin iAUC (b) in prolonged and 
breaking sitting trials. The sample size is n = 10 due to difficulty in cannulating one 
participant. Values are means ± SEM. # denotes significant interaction effect between 
prolonged and breaking sitting trials (p ≤ 0.05). * denotes significantly different 
between prolonged versus breaking sitting trials (p ≤ 0.05). The shaded box denotes 
meal time. 
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There was no interaction in blood triglyceride and NEFA in prolonged and breaking 
sitting trials (Figure 5.4a and c). Triglyceride iAUC was significantly higher in the 
breaking sitting compared to the prolonged sitting trial (283 ± 36 versus 232 ± 32 
mmol·330 min·l-1, p = 0.002, respectively, Figure 5.4b). 
 
 
Figure 5.4 Blood triglyceride (a) and NEFA (c) concentrations in prolonged and 
breaking sitting trials. iAUC for triglyceride (b). The sample size is n = 10 due to 
difficulty in cannulating one participant. Values are means ± SEM. * denotes 
significantly different between prolonged versus breaking sitting trials (p ≤ 0.05). The 
shaded box denotes meal time.  
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Even after removing one participant who had a high glucose and insulin response 
compared to the other participants, a reduction in glucose and insulin iAUCs was still 
found in the breaking sitting trial compared to prolonged sitting trial (252 ± 48 versus 
491 ± 77 mmol·330 min·l-1 and 1,345 ± 230 versus 1,977 ± 322 nmol·330 min·l-1, p ≤ 
0.01; respectively, Figure 5.5a and b)   
 
Figure 5.5 Glucose and insulin iAUC in the prolonged and breaking sitting trials.  
* denotes difference between prolonged sitting versus breaking sitting trials (p ≤ 0.05) 
(One participant excluded, n = 9). 
 
 
 Adipose Tissue Gene Expression 
There was no difference in adipose tissue gene expression between breaking and 
prolonged sitting trials for any of the energy metabolic, insulin signalling and 
(anti)inflammatory genes analysed (Figure 5.6).
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Figure 5.6 Fold changes in relative adipose tissue gene expression (mRNA levels) under prolonged sitting and breaking sitting trials. 
Fold changes in relative gene expression (mRNA levels) of metabolism, insulin signaling, glucose transport and inflammatory genes in 
adipose tissue under prolonged sitting and breaking sitting trials (all n = 9) due to lack of tissue samples for two participants. The dashed line 
indicates baseline. Data normalised to PPIA, internal calibrator and baseline sample. Samples that exceeded the detectable limit (Ct > 35) were 
excluded from the analysis. Values are means ± SEM.
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 Serum Adipokine levels and Adipose Tissue Adipokine Secretion ex vivo  
There was no difference between prolonged and breaking sitting in serum IL-6, leptin 
and adiponectin, or the secretion, ex vivo, of IL-6, leptin and adiponectin (Figure 5.7) 
 
 
    
Figure 5.7 Serum adipokine levels and adipose tissue adipokine secretion ex vivo. 
Circulating serum IL-6 (a) leptin (c) and adiponectin (e) concentrations in prolonged 
and breaking sitting trials. Protein secretion of IL-6 (b), leptin (d) and adiponectin (f) 
at baseline (AM) and at the end of trial (PM). # denotes significant time effect (p ≤ 
0.05).Values are means ± SEM. The shaded box denotes meal time. 
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5.4 Discussion 
The present study investigated whether regular short bouts of walking influence 
circulating biomarkers, adipose gene expression and protein secretions from adipose 
tissue ex vivo. We found that regularly participating in short bouts of walking reduced 
postprandial glucose and insulin iAUC by 48% and 42%, respectively. However, in 
spite of the profound difference in postprandial insulin and glucose, subcutaneous 
adipose gene expression was similar in both trials. There was also no difference in 
adipose tissue secretions of IL-6, adiponectin or leptin. 
 
 The effect of breaking sitting on postprandial glycaemia and insulinaemia  
The extent of changes in postprandial glucose and insulin have been associated with 
cardiovascular disease (Bonora & Muggeo, 2001; Cavalot et al., 2006; Watanabe et al., 
2013) and overweight/obese populations typically show higher postprandial glucose 
and insulin (Perala et al., 2011). Therefore, strategies to attenuate postprandial glucose 
and insulin would be extremely useful. Breaking prolonged sitting has been proven to 
reduce postprandial glucose and insulin levels in most (Dunstan et al., 2012b; Peddie 
et al., 2013; van Dijk et al., 2013; Bailey & Locke, 2015; Henson et al., 2016) but not 
all studies (Altenburg et al., 2013; Saunders et al., 2013). We also showed that 
participating in regular short bouts of walking which break up prolonged sitting 
attenuates postprandial glucose and insulin concentrations in sedentary middle aged 
overweight men and women (the glucose and insulin iAUC were attenuated by 48% 
and 42%, respectively). The additional energy cost of walking during the breaking 
sitting trial was fuelled by carbohydrate oxidation and thus we propose that the 
oxidation of exogenous glucose explains the relatively lower glucose concentrations 
observed in this trial. Thus, breaking prolonged sitting is very effective at reducing 
postprandial glycaemia and insulinaemia.  
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 Adipose tissue responses to breaking prolonged sitting 
In skeletal muscle, breaking sitting with either light or moderate intensity walking 
increased the expression of genes involved in glucose metabolism, including PDK4 
(Latouche et al., 2013). In the present study, we did not find any differences between 
breaking sitting and prolonged sitting trials in adipose glucose metabolism gene 
expression including PDK4 mRNA expression even though our walking speed, 
frequency and duration was similar to this previous study that have shown effects in 
skeletal muscle (Latouche et al., 2013). This might reflect tissue-specificity with a 
greater effect in working skeletal muscle than adipose tissue. Skeletal muscle plays a 
major role in rapidly removing glucose from blood whereas adipose plays a very minor 
role (Im et al., 2007). An alternative explanation is that the effects of the meal are so 
pronounced in adipose tissue, that they ‘swamp’ any effects from brief episodes of 
physical activity.  
 
In the postprandial period, significant uptake of NEFA and triglyceride into adipose 
tissue is usually shown (Saleh et al., 1998; Bickerton et al., 2007; Koutsari et al., 2008). 
We provided two mixed meals with a total ~1,725 ± 369 (means ± SD) (8.83 kcal·kg-
1) kcal calories which is more than 2-fold the absolute energy intake of that consumed 
in the single meal (~763 kcal) given in the study by Latouche et al. (2013). Given the 
extended timescale of the present study, ~1,700 kcal is not an unreasonable amount of 
energy but it is possible that the physiological pressure of processing external energy 
might outweigh the impact of short bouts of physical activity in adipose tissue. Thus, 
unlike in working skeletal muscle, breaking prolonged sitting does not seem to affect 
adipose tissue in spite of a pronounced effect on postprandial systemic insulin and 
glucose concentrations. 
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 The regulation of adipose tissue gene expression after meal consumption  
IRS1/2-PI3K-Akt represents one insulin signalling pathways (Cheng et al., 2010).  
The expression of adipose IRS1/2-PI3K-Akt insulin signalling might be regulated due 
to different insulin concentrations, which would further regulate other downstream 
transcriptional molecules such as FOXO1, PGC1-α, and SREBP1c. However, in the 
present study, adipose IRS1/2-PI3K-Akt mRNA signalling was not different between 
trials, even though postprandial insulin concentrations were powerfully attenuated 
throughout the breaking sitting trial. This suggests that adipose IRS1/2-PI3K-Akt 
insulin signalling is not acutely influenced by changes in circulating insulin – or that 
both insulin (Dandona et al., 2004) and glucose (Esposito et al., 2002) influence 
inflammatory pathways in adipose and we speculated that differences in glycaemia and 
insulinaemia would translate into different inflammatory responses. However, we also 
saw no difference in (anti)inflammatory gene changes including IL-6, MCP-1, TNF-α, 
IL-18, adiponectin and leptin.  
 
Even though we did not observe any differences in adipose tissue gene expression 
between breaking and prolonged sitting trials, there appear to be temporal changes in 
both trials that could be a response to the meal. IRS1 and IRS2 mRNA expression were 
consistently up-regulated and down-regulated, respectively, at the end of both trials. 
IRS-1 plays a central role of insulin signalling receptor (Thirone et al., 2006) and IRS-
2 was down-regulated in lean, overweight and first class obese populations 6 h after 
meal consumption (Travers et al., 2015b). In addition, studies have shown that adipose 
IL-6 and MCP-1 mRNA expression was up-regulated in either lean, overweight or 
obese (Travers et al., 2015b), metabolic syndrome (Meneses et al., 2011), T2DM 
(Pietraszek et al., 2011) and heathy lean populations (Dordevic et al., 2015) after meal 
consumption. In the present study, we observed similar trends in adipose IL-6 and 
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MCP-1 mRNA expression. This might potentially support the notion that meal 
consumption enhances adipose inflammatory responses; however, based on the present 
results alone we cannot discount the possibility that these reflect a circadian rhythm. 
 
5.5 Conclusions 
Breaking prolonged periods of sitting acutely reduces postprandial glucose and insulin 
concentrations in overweight/obese populations, probably by increasing glucose 
oxidation. However, in spite of these differences, adipose tissue metabolic, insulin 
signalling and (anti)inflammatory gene expression was not affected by breaking 
prolonged periods of sitting, including the IRS1/2-PI3K-Akt insulin signalling 
pathway. Thus, whilst breaking prolonged sitting is an effective strategy for managing 
postprandial glycaemia and insulinaemia, this does not appear to elicit a corresponding 
change in adipose tissue, therefore, other strategies (e.g. longer breaking sitting walking 
intervention, continuous endurance exercise) might be required to elicit these 
responses, specifically.  
Chapter 6                                                             Study 3 
115 
6 Chapter 6: The effect of different physical activity 
strategies on short-term overfeeding in young 
healthy men 
 
6.1 Introduction  
A chronic positive energy imbalance leads to the excess deposition of adipose tissue 
that characterises obesity, and is implicated in adipose tissue hypertrophic expansion 
and chronic systemic low grade inflammation and ultimately results in cardiovascular 
diseases and type 2 diabetes. A combination of excessive energy intake and physical 
inactivity are the two main factors that contribute to a positive energy imbalance. 
Studies have consistently shown that overfeeding impairs insulin sensitivity (Wang et 
al., 2001; Brons et al., 2009; Walhin et al., 2013), and alters adipose tissue energy 
metabolism and inflammatory gene expression (Brons et al., 2009; Shea et al., 2009; 
Alligier et al., 2012; Johannsen et al., 2014; Gillberg et al., 2016). 
 
Studies have shown that prolonged endurance exercise alleviates impaired metabolic 
responses induced by short-term overfeeding (Hagobian & Braun, 2006; Walhin et al., 
2013). Hagobian and Braun (2006) demonstrated that a single, 60 min bout of cycling 
at 60% maximum oxygen uptake (V̇O2peak) decreased insulin responsiveness to a 
glucose challenge after 3 days of overfeeding. Furthermore, Walhin et al. (2013) 
indicated that maintaining a 50% energy surplus over 7 days induced weight gain, 
impaired glucose and insulin responses to feeding but, notably, a single, daily 45 min 
bout of vigorous intensity exercise (70% V̇O2max) reversed impaired metabolic changes 
brought about by the energy surplus, even after prescribing more energy intake to offset 
the impact of daily exercise (i.e., to match the energy surplus). This study showed that 
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the expression of fatty acid and lipid synthesis genes, including sterol regulatory 
element-binding transcription factor 1 (SREBP-1c) and fatty acid synthesis (FAS) were 
blunted in the exercise group (45 min of vigorous intensity exercise alongside 
overfeeding and reduced physical activity (Walhin et al., 2013). However, participating 
in structured vigorous intensity endurance exercise might not be practical for all 
populations. Small bouts of non-structured physical activity have been suggested to be 
an effective physical activity strategy (Miyashita et al., 2013), but we do not know if 
these forms of exercise are equally effective to counteract overfeeding induced 
impaired metabolic adaptation.   
 
Other studies have indicated that even small amounts of non-structured physical activity 
can have a profound impact on metabolic health outcomes. Small bouts of regular 
walking (from 1 min 40 seconds to under 10 min) to break prolonged periods of sitting 
attenuate postprandial insulin and glucose concentrations (Miyashita, 2008; Dunstan et 
al., 2012b; Miyashita et al., 2013; Peddie et al., 2013; Kim et al., 2014), and reduces 
resting blood pressure (Miyashita et al., 2011; Larsen et al., 2014). At the molecular 
level, both slow (3.2 km·h-1) and brisk (6.4 km·h-1) spells of walking to break up periods 
of prolonged sitting have been shown to alter carbohydrate-metabolism gene expression, 
including pyruvate dehydrogenase kinase 4 (PDK4), in skeletal muscle (Latouche et al., 
2013). One study also observed that the level of non-exercise activity thermogenesis 
(NEAT) could be a decisive element in determining the degree of adipose deposition 
after 8 weeks of 1,000 kcal·day-1 overfeeding (Levine et al., 1999).  
 
To compare prolonged exercise versus intermittent physical activity, Duvivier et al. 
(2013) compared the effect of maintaining a normal diet with prolonged sitting for 4 
days to prolonged sitting with regular breaks to prolonged sitting plus a daily, 1 h bout 
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of vigorous cycling. These authors found that 16 h post-intervention, insulin 
incremental area under curve (iAUC) during an oral glucose tolerance test (OGTT) was 
lower in the group taking regular breaks during prolonged sitting compared to 
prolonged sitting with added vigorous cycling. However, this study did not compensate 
for the extra energy expended (~450 kcal) during the 1 h vigorous cycle, or examine 
the physiological adaptations to the intervention in adipose tissue. Thus, the present 
investigation aimed to examine the impact of two different physical activity 
interventions (prolonged endurance versus intermittent physical activity) on the 
metabolic and adipose tissue responses to overfeeding and reduced activity.  
 
6.2 Methods 
 Experimental design  
Twenty-four lean, active and heathy men aged between 18 to 35 years were recruited 
via local advertisement. Participants were randomised to either an overfeeding with 
restricted physical activity (≤ 4,000 steps·day-1) group (OVER), overfeeding with 
restricted physical activity (≤ 4,000 steps·day-1) plus daily 45 min endurance moderate 
intensity walking group (50% V̇O2max) (OVER + EN) or overfeeding with restricted 
physical activity (≤ 4,000 steps·day-1) plus intermittent breaking sitting group (OVER 
+ BREAKS). All groups were achieved the same overfeeding (50% of overfeeding 
based on their habitual diet). Participants reported to the lab on three occasions 
including fitness tests and two subsequent main trials (Day 1 and Day 8). The one week 
intervention was implemented after the 1st main trial and participants returned on the 
8th day for the follow-up the 2nd main trial with identical procedures. Main trial days 
involved anthropometric assessments, a dual-energy x-ray absorptiometry (DEXA) 
scan and resting metabolic rate (RMR) measurements across 20 min, followed by a 
subcutaneous, abdominal adipose tissue biopsy and a 2 h oral glucose tolerance test 
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(OGTT). The blood pressure was measured in triplicate at the end of OGTT. The 
protocol was approved by the Bristol NHS Research Ethics Committee (REC reference 
number: 15/SW/0014). This trial is registered at ISRCTNregistry (registration number: 
ISRCTN18311163), and all participants provided verbal and written informed consent 
before taking part. 
 
This project is being conducted in partnership with a postdoctoral researcher who is 
focusing on different experimental outcomes (arm cranking exercise). This other work 
is not included in this thesis.   
 
6.2.1.1 Inclusion and exclusion criteria 
Participants had to be weight stable (body mass) for at least 3 months (± 3%) to be 
eligible for this study (Stevens et al., 2006). A health questionnaire was completed to 
exclude those with existing cardiovascular and metabolic diseases and a Physical 
Activity Readiness Questionnaire (PAR-Q) (Appendix 2) was completed to make sure 
that participants were able to exercise safely. Individuals taking any medications known 
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6.2.1.2 Participant baseline physical characteristics 
A summary of participants’ baseline physical characteristics is outlined in Table 6.1. 
 
Table 6.1 Participant baseline physical characteristics 
 OVER 
(n = 8) 
OVER + EN 
(n = 8) 
OVER + BREAKS 
(n = 8) 
Age (years) 22 ± 3  21 ± 2  22 ± 3  
BMI (kg·m-2) 23.8 ± 1.8 23.2 ± 1.2  23.5 ± 2.3 
Body mass (kg) 73.4 ± 9.6 72.9 ± 6.8 71.5 ± 8.8 
Physical activity level (PAL) 1.81 ± 0.19  1.89 ± 0.21  1.77 ± 0.13  
Total energy expenditure 
(kcal·day-1) 
3,319 ± 597 3,397 ± 395 3,178 ± 460 
V̇O2max (ml·kg-1·min-1) 50.1 ± 3.4  50.7 ± 6.4  52.1 ± 6.5 
Values are means ± SD.  
 
 Preliminary assessments  
6.2.2.1 Diet and physical activity assessments  
Over a period of 7 consecutive days, participants were required to record their habitual 
food using the weighed inventory method. Dietary records were analysed using the 
Nutrition Analysis Software version 1.8 (Nutritics, UK), which is based on food 
database in the UK. Energy intake was estimated using this software and 10% of diet 
induced thermogenesis (DIT) was estimated (Westerterp, 2004). During this period, a 
combined heart rate/accelerometer monitor (Actiheart, Cambridge Neurotechnology 
Ltd., Cambridge, UK) was attached at the base of the left Pectoralis Major via 2 
adhesive ECG pads 24 h per day except when showering/bathing/swimming 
(Thompson et al., 2006) to assess the participant’s habitual physical activity energy 
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expenditure, and a pedometer (Yamax, Japan) was worn to record habitual daily step 
count. 
 
6.2.2.2 Pre-trial fitness tests  
V̇O2max tests were performed by all participants at least one week prior to the 1st main 
trial. This was performed on a treadmill (Woodway, ELG70, Weiss, Germany), 
maintained at 9 to 12 km·h-1 with an initial gradient of 2.5%. The gradient was increased 
2.5% every 3 min in a stepwise manner until volitional exhaustion to determine V̇O2max. 
Samples were collected and analysed as described in Chapter 3.8. 
 
6.2.2.2.1 Gradient walking test 
A gradient walking test was performed by the OVER + EN and OVER + BREAKS 
groups to determine their 50% V̇O2max walking speed. The gradient walking test was 
undertaken on a treadmill (Woodway, ELG70, Weiss, Germany) maintained at 6 to 7 
km·h-1 with an initial 2.5% gradient and gradient was increased by 2.5% every 5 min 
until gradient reached 10%. To determine energy expenditure, expired air samples were 
collected for 1 min at the end of each 5 min stage using the method described in Chapter 
3.8. 
 
6.2.2.2.2 Self-selected speed test and target steps calculation 
In the OVER + BREAKS group, a 15 min a walking test at a self-selected speed was 
performed  to estimate energy expenditure during a 45 min walking test at 50% 
V̇O2max. Participants were allowed 1 min to choose their “normal walking speed” 
blinded from the treadmill speedometer. Once the speed was selected, participants 
walked at the chosen speed for the remaining ~14 mins, and expired air was collected 
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for 1 min at 5 min intervals to determine energy expenditure (Jeukendrup & Wallis, 
2005). Participants were then assigned a specific amount of steps to complete each day 
of the intervention period to match the energy expended during the 45 min walking test. 
To monitor this, pedometers were worn each day during the intervention period to 
record total step count to match the energy expended during the walking test.  
 
 Main trials  
To standardised physical activity in the 24 h leading up to the 1st main trial, all 
participants conducted a bout of 30 min physical activity before 2 pm. On the morning 
of the 1st day main trial, participants reported to the Resting Metabolic Laboratory 
between 07:00–08:00 am following a 10–12 h overnight fast. Body mass was assessed 
to the nearest 0.1kg using digital scales (TANITA corp., Tokyo, Japan) and waist and 
hip circumference was measured using non-stretch tape to the nearest 0.1 cm, based on 
World Health Organisation guidelines (WHO, 2008), following body composition 
assessed using by Dual energy X-ray absorptiometry (DEXA) (Discovery, Hologic, 
Bedford, UK) to determine muscle mass and fat mass and percentages. Participants then 
rested in bed for 10 min, after which, a mouthpiece connected to a Douglas bag was 
inserted and four consecutive, 5 min expired gas samples were collected with the mean 
of at least three bags within 100 kcal was used to determine resting metabolic rate 
(RMR) (Compher et al., 2006; Betts et al., 2011) applying substrate oxidation under 
resting conditions as described by Frayn (1983b). Following RMR assessments, a 20 G 
1.1 × 32 mm cannula (BD, VenflonTM Pro, Becton Dickenson & Co., Sweden) was 
inserted into an antecubital vein from which baseline 20 ml of blood was drawn through 
2, 10 ml syringes and placed into serum separation beads and EDTA-containing tubes 
(Sarstedt Ltd, Leicester, UK). Plasma samples were centrifuged immediately at 5,000 
rpm at 4 °C for 10 min. Serum samples were left to clot before centrifugation. An 
Chapter 6                                                             Study 3 
122 
adipose tissue biopsy was then performed. Adipose tissue samples (~0.5 g) were taken 
under local anaesthetic (1% lidocaine) from the area around the waist approximately 5 
cm lateral to the umbilicus using a 14 G needle using an aspiration technique (Walhin 
et al., 2013). Adipose tissue cleaning and processing was performed as described 
previously (Travers et al., 2014). Following the adipose tissue biopsy, a two hour oral 
glucose tolerance test (OGTT) was performed following the ingestion of a commercial 
glucose beverage (Polycal, Nutricia, UK) with blood samples taken at 15 min intervals. 
The blood pressure was measured in triplicate at the end of OGTT. This protocol was 
replicated at the follow-up trial on day 8. 
 
 One week intervention description 
In the OVER group, participants restricted daily physical activity to ≤ 4,000 steps per 
day and were required to consume 50% more of recorded habitual diets. In the OVER 
+ EN group, participants also restricted their daily physical activity to ≤ 4,000 steps per 
day and were required to consume prescribed energy intake, plus a daily single 45 min 
bout of treadmill walking at 50% V̇O2max. In the OVER + BREAKS group, participants 
were only allowed to walk throughout the day to reach their individual target steps and 
were required to consume prescribed energy intake. In accordance to a similar 
overfeeding with restricted physical activity study, approximately 4,000 steps per day 
were completed in their sedentary and sedentary + daily exercise groups during the one 
week intervention (Walhin et al., 2013); therefore, the OVER + BREAKS group were 
required to achieve their target steps plus an additional 4,000 steps. The accumulation 
of the designated daily step count for this group was requested to be performed “little 
and often” throughout the day (i.e., approximately every 30–40 min), each lasting ~5 
min (approximately 500–600 steps). In addition, participants were asked to limit longer 
walks of greater than 1,500 steps to only once per day, and were asked to try and keep 
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this under 2,000 steps as a maximum in one go. Participants were also instructed not to 
sit for longer than 1 h at a time. The details of breaking sitting instructions are shown 
on Appendix 3.   
 
The estimated energy expenditure during the 45 min at 50% V̇O2max walking test in the 
OVER + EN and OVER + BREAKS groups was 427 ± 54 kcal and 416 ± 89 kcal, 
respectively. In the OVER + EN group, treadmill speed was, on average, 6.4 ± 0.3 km·h-
1 with an average gradient of 6.5 ± 2.3%. In the OVER + BREAKS group, the target 
step count was 13,771 ± 1,778 steps per day (9,771 ± 1,778 target steps + additional 
4,000 steps for each individual). During the intervention, jogging, running and 
weightlifting related exercise were not permitted. 
 
Both exercise groups (OVER + EN and OVER + BREAKS) were required to consume 
additional energy each day to compensate for the extra energy expended during exercise 
interventions with an additional 5% of exercise energy expenditure to account for the 
excess post-exercise oxygen consumption (EPOC), respectively (Gore & Withers, 
1990). DIT associated with the extra energy intake prescribed to the OVER + EN and 
OVER + BREAKS was also factored into calculations as an additional 10% of the 
energy expenditure during physical activity (including EPOC) (Westerterp, 2004). 
Also, RMR towards total energy expenditure during exercise was subtracted from the 
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An example of habitual energy intake (3,000 kcal·day-1) among three groups during 
overfeeding intervention is shown as Table 6.2. 
 
Table 6.2 An example of overfeeding calculation 
 OVER OVER + EN OVER + BREAKS 
Energy intake (kcal·day-1) 3,000  3,000  3,000  
50% overfeeding  + 1,500 + 1,500 + 1,500  
Exercise energy expenditure  - + 500 + 500 
EPOC - + 25 + 25 
DIT (additional overfeeding) - + 53 + 53 
RMR (during exercise) - - 54 - 54 
Total energy intake prescribed  4,500 kcal 5,024 kcal 5,024 kcal 
    
Energy surplus 1,500 kcal 1,500 kcal 1,500 kcal 
 
 
 Post intervention energy surplus calculation  
The daily energy surplus was calculated by prescribed energy intake subtracted 
estimated energy expenditure (RMR + DIT + physical activity energy expenditure). 
RMR was estimated according to the average of baseline and follow-up data on the 
main trial days. DIT was calculated to be 10% of prescribed energy intake (Westerterp, 
2004). Unstructured physical activity energy expenditure was estimated based on 
recorded average daily step counts (Walhin et al., 2013), which was assumed stride 
length of 0.825 meters (Auvinet et al., 2002) with consumed oxygen cost of 0.125 
ml·meter-1·kg-1. In OVER + BREAKS groups, unstructured physical activity energy 
expenditure was calculated based on prescribed additional 4,000 steps as previous 
section described.  
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 Experimental analysis  
6.2.6.1 Adipose tissue gene expression  
After cleaning the adipose tissue biopsy, approximately 200 mg of adipose tissue was 
immediately homogenised in 5 ml TRIzol (Invitrogen, Paisley, UK) in an 
RNase/DNase-free sterile tube (Invitrogen, Paisley, UK) and stored at −80 °C until later 
gene expression analysis. The details of adipose tissue gene expression analysis was 
described in Chapter 3.14. 
 
6.2.6.2 Real-time PCR 
An RNeasy Mini Kit (Qiagen, Crawley, UK) was used to extract RNA from TRIzol-
digested adipose tissue as described in Walhin et al. (2013). RNA was reversed 
transcribed (1 μg) to cDNA using a High Capacity Reverse Transcription Kit (Applied 
Biosystems, Warrington, UK). The organic phenol-chloroform phase from the RNA 
extraction was kept for future protein analysis. Real-time PCR was performed using a 
StepOne (Applied Biosystems, Warrington, UK). Predesigned primers and probes were 
obtained from Applied Biosystems for the measurement of expression of interleukin 6 
(IL-6) (Hs00985639_m1), adiponectin (Hs00605917_m1), leptin (Hs00174877_m1), 
tumour necrosis factor alpha (TNF-α) (Hs99999043_m1), monocyte chemoattractant 
protein-1 (MCP-1) (Hs00234140_m1), 5’ AMP-activated protein kinase (AMPK) 
(Hs01562315_m1 and Hs00178903_m1 combined), glucose transporter type 4 
(GLUT4) (Hs00168966_m1), hormone-sensitive lipase (HSL) (Hs00193510_m1), 
insulin receptor substrate 2 (IRS2) (Hs00275843_s1), sterol regulatory element binding 
protein 1c (SREBP-1c) (Hs01088691_m1), pyruvate dehydrogenase kinase isozyme 
(PDK4) (Hs00176875_m1), peroxisome proliferator-activated receptor γ (PPARγ) 
(Hs01115513_m1), adipose triglyceride lipase (ATGL) (Hs00386101_m1), fatty acid 
synthase (FAS) (Hs00188012_m1) and peptidylpropyl isomerase A (PPIA) was used 
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as an endogenous control (Neville et al., 2011). The comparative Ct method was used 
to process data where ΔCt = Ct target gene − Ct PPIA. Ct target genes were normalised 
to an internal calibrator (lowest ΔCt for each target gene) and baseline. The Ct values 
for IL-6 (20 out of 36 samples) was frequently over 35 thus these results are not 
included. 
 
6.2.6.3 Biochemical analysis  
Blood glucose, triglycerides (TG), non-esterified fatty acids (NEFA), total cholesterol, 
high-density lipoprotein (HDL) cholesterol and alanine transaminase (ALT) were 
measured using commercially available assay kits and analyser (Daytona Rx; Randox, 
Crumlin, UK). Low-density lipoprotein (LDL) cholesterol was calculated based on the 
formula: LDL = total cholesterol − HDL − (TG/2.2) (Friedewald et al., 1972).  The 
homeostatic model assessment for insulin resistance (HOMA-IR) was calculated based 
on the formula: fasting glucose (mmol·l-1) × fasting insulin (mU·l-1)/22.5 (Turner et al., 
1979). Homeostasis model assessment for β-cell function (HOMA-β) was calculated 
based on the formula: fasting insulin (mU·l-1) × 20/fasting glucose (mmol·l-1) – 3.5 
(Matthews et al., 1985). Serum insulin concentrations (mU·l-1) were measured using a 




All data are presented as mean ± standard deviation (SD). Gene expression data are 
presented as mean ± standard error of the mean (SEM). Insulin and glucose iAUCs was 
calculated using the trapezoid method (Wolever & Jenkins, 1986). All data were 
checked for normality using visual checking of histograms, confirmed statistically by 
Shapiro-Wilk test. Where not normally distributed, data were analysed using equivalent 
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non-parametric tests. Gene expression data were analysed using a one-way ANOVA, 
pre- and post-intervention. The precise time-course of responses within and between 
trials were analysed using factorial 2- and 3-way mixed-model analysis of variance 
(group × day & group × day × time, respectively), Greenhouse-Geisser corrections were 
utilized to intra-individual contrasts where ε < 0.75; for less severe asphericity the 
Huynh-Feldt correction was chosen (Atkinson, 2002). Where the mixed-model 
interaction was found, multiple t tests were used to check the location of variance both 
between groups at level time points and within each group between each time points 
relative to baseline, with both method to a Holm-Bonferroni correction (Atkinson, 
2002). A main effect of the day denotes an effect of energy surplus (# denotes Day 1 
versus Day 8 three groups), whereas a day × group and day × group × time interaction 
means there was a mediating effect of exercise (∗ in figures and tables). A one–way 
ANOVA was also applied for habitual data (energy intake, steps and dietary 
composition). All data analysis was undertaken on SPSS version 22 software (IBM, 
Armonk, NY, USA). Statistical significance was set at p ≤ 0.05. 
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6.3 Results 
 Induced energy surplus and energy expenditure during the intervention 
The total energy intake and estimated energy expenditure in OVER, OVER + EN and 
OVER + BREAKS is presented in Table 6.3. There were no difference in energy surplus 
among three groups. 
 
Table 6.3 Daily energy intake and expenditure 
 OVER 
(n = 8) 
OVER + EN 
(n = 8)  
OVER + BREAKS 
  (n = 8) 
Caloric intake (kcal·day-1) 4,677 ± 1,001   5,569 ± 788 4,992 ± 978   
    
RMR (kcal·day-1) 1,892 ± 266 1,874 ± 213 1,839 ± 203 
DIT (kcal·day-1) 468 ± 100 557 ± 79 499 ± 98 
Estimated physical activity 
energy expenditure (kcal·day-1) 
111 ± 35 121 ± 28 149 ± 19 
Additional exercise energy 
expenditure (kcal·day-1) 
- 427 ± 54  416 ± 89 
    
Energy surplus (kcal·day-1) 2,206 ± 716 2,591 ± 786 2,089 ± 589 
Final energy surplus (%·day-1) 46 ± 6 46 ± 7 41 ± 4 
Values are means ± SD.  
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 Energy intake during habitual and the intervention 
The percentage of macronutrients was not different among the three groups, and was 
approximately 56% carbohydrate, 17% fat and 25% protein, during habitual and 
intervention weeks (Table 6.4).  
 
Table 6.4 The percentage of macronutrient intake in habitual and the intervention  
 OVER 
(n = 8) 
OVER + EN 
(n = 8) 
OVER + BREAKS 
(n = 8) 
Carbohydrate intake (%) 56 ± 5 58 ± 8 58 ± 7 
Fat intake (%)  17 ± 5 17 ± 3 18 ± 4 
Protein intake (%)  26 ± 4 24 ± 9 24 ± 8 
Alcohol intake (%) 0 ± 0 0 ± 0 0 ± 0 
Values are means ± SD. 
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There was no difference in total energy intake during the habitual week among the three 
groups (Table 6.5).  
 
Table 6.5 Habitual dietary composition  
 OVER 
(n = 8) 
OVER + EN 
(n = 8) 
OVER + BREAKS 
(n = 8) 
Caloric intake (kcal·day-1) 3,118 ± 667 3,415 ± 510 3,038 ± 584 
Carbohydrate intake (g·day-1) 366 ± 95 417 ± 87 365 ± 108  
Fat intake (g·day-1)  112 ± 36  123 ± 31 107 ± 25  
Protein intake (g·day-1)  167 ± 37  174 ± 66 144 ± 43  
Alcohol intake (g·day-1) 3 ± 5 1 ± 2 1 ± 3 
Values are means ± SD.  
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The total energy intake, dietary composition and overfeeding during the intervention is 
shown below (Table 6.6). Due to additional daily physical activity prescribed in OVER 
+ EN and OVER + BREAKS groups, the overfeeding is different when compared to 
OVER group in order to achieve the same energy surplus. 
 
Table 6.6 Dietary composition during the overfeeding intervention  
 OVER 
(n = 8) 
OVER + EN 
(n = 8) 
OVER + BREAKS 
(n = 8) 
Caloric intake (kcal·day-1) 4,677 ± 1,001   5,569 ± 788 4,992 ± 978   
Carbohydrate intake (g·day-1) 549 ± 143  680 ± 139   601 ± 181  
Fat intake (g·day-1)  251 ± 55  284 ± 113  237 ± 71  
Protein intake (g·day-1)  169 ± 54 200 ± 48  176 ± 41  
Alcohol intake (g·day-1) 5 ± 8 2 ± 4 2 ± 5 
Overfeeding (%) 50 ± 0 63 ± 3 64 ± 2 
Values are means ± SD. 
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 Energy expenditure during habitual and the intervention 
Habitual daily step counts were not different among three groups, nor was average 
energy expenditure from extra daily physical activity between OVER + EN and OVER 
+ BREAKS (427 ± 54 versus 416 ± 89 kcal·day-1). 
 
The average habitual daily steps was decreased from 11,390 ± 3,655 to 2,847 ± 821 
steps in OVER, from 10,176 ± 2,008 to 3,142 ± 585 steps in OVER + EN and from 
10,388 ± 4,752 to prescribed 4,000 steps (13,768 ± 1,850 steps subtracted from the 
estimated target of 9,768 ± 1,850 steps) in the OVER + BREAKS group (Figure 6.1).  
 
 
Figure 6.1 The change in average daily step counts at baseline (Habitual) and 
follow-up (intervention) in OVER, OVER + EN and OVER + BREAKS groups. 
All n = 8; these show the data outside the intervention (i.e., not including the steps taken 
during moderate intensity exercise or activity breaks in OVER + EN and OVER + 
BREAKS, respectively). Values are means ± SEM. ¥ The difference between habitual 
versus intervention (p ≤ 0.05).  
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 Physical characteristics measures after the intervention 
There was no interaction for all physical characteristics among three groups after 
intervention, except for lean mass which approached significance (p = 0.06) (Table 6.7). 
A day effect (Day 1 versus Day 8, the average of three groups; p ≤ 0.05) was, however, 
apparent for several parameters after overfeeding (Table 6.7), including resting 
metabolic rate (RMR) and respiratory exchange ratio (RER) for most of participants as 




Figure 6.2 Resting metabolic rate (a) and respiratory exchange ratio (b) at baseline 
(Day 1) and follow-up (Day 8) in OVER, OVER + EN and OVER + BREAKS 
groups (all n = 8). Values are means ± SEM. # Day effect (Day 1 versus Day 8, the 
average of three groups; p ≤ 0.05).






Table 6.7 Participant physical characteristics at baseline (Day 1) and after the intervention (Day 8) 
 OVER (n = 8) OVER + EN (n = 8) OVER + BREAKS (n = 8) 
 Day 1 Day 8 ∆ (95% CI) Day 1 Day 8 ∆ (95% CI) Day 1 Day 8 ∆ (95% CI) 
Body mass (kg; scale) # 74.3 ± 9.8 76.1 ± 9.9  1.8 (1.1–2.6) 72.8 ± 6.9   75.4 ± 7.8  2.7 (1.7–3.7) 71.5 ± 8.8  73.2 ± 9.4  1.7 (1.0–2.3)   
Body mass (kg) # 73.8 ± 9.7  75.6 ± 9.8  1.9 (1.1–2.6) 72.3 ± 6.8  74.9 ± 7.8  2.6 (1.4–3.8) 71.1 ± 8.8  72.7 ± 9.3  1.6 (1.0–2.2)  
Lean mass (kg) # 59.4 ± 8.3  60.4 ± 8.4  1.0 (0.5–1.6) 58.8 ± 7.4  61.2 ± 8.6  2.4 (1.2–3.6) 57.8 ± 7.2  58.8 ± 7.4  1.0 (0.2–1.8)  
Fat mass (kg) # 11.5 ± 4.5  12.4 ± 4.3  0.8 (0.2–1.5) 10.6 ± 4.4   10.8 ± 4.0  0.2 (-0.3 to 0.7) 10.3 ± 3.9  11.0 ± 4.3   0.6 (0.1–1.1)  
Fat mass (%) 15.5 ± 5.3  16.2 ± 5.0  0.8 (-0.1 to 1.6) 14.7 ± 6.3  14.5 ± 5.9  -0.1 (-0.8 to 0.5) 14.4 ± 4.4  14.9 ± 4.7  0.5 (-0.1 to 1.1) 
WC (cm) # 83.4 ± 7.1  85.0 ± 6.5  1.6 (0.7–1.0) 81.7 ± 5.2  83.9 ± 5.1  2.2 (1.0–3.3) 81.7 ± 7.6  82.6 ± 6.9  1.0 (-0.1 to 2.0)  
HC (cm) # 95.7 ± 6.0  96.9 ± 5.9  1.3 (0.8–1.7) 93.7 ± 3.3  94.8 ± 3.9  1.1 (0.2–2.1) 92.9 ± 4.2  93.4 ± 4.8  0.5 (-0.3 to 1.3)  
RMR (Kcal·d-1) # 1,841 ± 294  1,942 ± 268  101 (-29 to 230) 1,716 ± 181  2,033 ± 292   337 (181–492) 1,776 ± 188  1,901 ± 236  122 (33–210)  
RER (V̇CO2:V̇O2) # 0.80 ± 0.04  0.94 ± 0.09  0.15 (0.08–0.22) 0.82 ± 0.08  0.94 ± 0.12  0.16 (0.06–0.26) 0.86 ± 0.05  0.95 ± 0.05  0.09 (0.05–0.14)  
SBP (mmHg) # 122 ± 8  125 ± 8  3 (-0.8 to 7.2) 118 ± 7  127 ± 7  8 (3–14) 123 ± 8  123 ± 8  1 (-4 to 5) 
DBP (mmHg) # 71 ± 5   73 ± 6  3 (-2 to 7) 69 ± 7  76 ± 4  7 (2–12) 71 ± 9  70 ± 7  1 (-5 to 4)  
 
SBP, systolic blood pressure; DBP, diastolic blood pressure; RMR, resting metabolic rate; RER, resting metabolic rate; WC, waist circumference; HC, hip 
circumference. Values are means ± SD, with fold changes (Day 8 / Day 1) after intervention. Change scores with 95% confidence interval (CI) for each group. # Day 
effect (Day 1 versus Day 8, the average of three groups; p ≤ 0.05).
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 Blood parameters measures after the intervention 
A significant group × day × time interaction was found in serum insulin responses to 
the 2 h OGTT (p ≤ 0.05). This might be due to the OVER group showing higher serum 
insulin concentrations from 75 min to the end of OGTT test (Figure 6.4). There was no 
interaction for plasma glucose, serum insulin iAUCs (Figure 6.5), plasma glucose 
responses to the 2 h OGTT test (Figure 6.3) and other blood parameters (Table 6.8) 
among three groups. However, a day effect (Day 1 versus Day 8, the average of three 
groups; p ≤ 0.05) was found with a 1.5-fold increase in OVER, 1.8-fold increase in 
OVER + EN and 1.7-fold increase in OVER + BREAKS group in insulin iAUC as a 
result of the intervention (Figure 6.5 b). 
 
In addition, a group × day interaction was found in white blood cell (WBC) counts (p 
≤ 0.05) among three groups and when comparing baseline (Day 1) to follow-up (Day 
8) trials, WBC counts were increased in OVER (from 5.3 ± 1.3 to 7.3 ± 3.0; p = 0.06) 
and OVER + EN (from 5.3 ± 1.3 to 5.9 ± 1.1; p ≤ 0.05) but not in OVER + BREAKS 









Figure 6.3 Plasma glucose responses to a 2 h OGTT at baseline (Day 1) and follow-
up (Day 8) in OVER (a), OVER + EN (b) and OVER + BREAKS (c) groups (all n 
= 8). Values are means ± SEM. 





Figure 6.4 Serum insulin responses to a 2 h OGTT at baseline (Day 1) and follow-
up (Day 8) in OVER (a), OVER + EN (b) and OVER + BREAKS (c) groups (all n 
= 8). Values are means ± SEM. * indicates interaction effect (group × day × time; p ≤ 
0.05). # indicates time effect (day × time, Day 1 versus Day 8, the average of three 








Figure 6.5 Plasma glucose (a) and serum insulin (b) iAUCs in response to a 2 h 
OGTT at baseline (Day 1) and follow-up (Day 8) in OVER, OVER + EN, and 
OVER + BREAKS groups (all n = 8). Values are means ± SEM. # Day effect (Day 1 
versus Day 8, the average of three groups; p ≤ 0.05). 
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Table 6.8 HOMA-IR, HOMA-β and blood measures at baseline (Day 1) and after intervention (Day 8) 
 OVER (n = 8) OVER + EN (n = 8) OVER + BREAKS (n = 8) 
 Day 1 Day 8 Fold 
changes 
∆ (95% CI) Day 1 Day 8 Fold 
changes 
∆ (95% CI) Day 1 Day 8 Fold 
changes 
∆ (95% CI) 
Fasting glucose 
(mmol·l-1) 
5.1 ± 0.3 5.2 ± 0.3 1.0 ± 0.1 0.1 (-0.2 to 0.2) 5.0 ± 0.2 5.2 ± 0.3 1.0 ± 0.1 0.2 (0.0 to 0.3) 5.2 ± 0.3 5.1 ± 0.4 1.0 ± 0.1 -0.1 (-0.3 to 0.0) 
Fasting insulin 
(pmol·l-1) # 
27.9 ± 8.6 40.4 ± 16.2 1.5 ± 0.4  13 (5–20) 22.0 ± 3.9 35.5 ± 12.7 1.7 ± 0.7 14 (4–23) 37.1 ± 21.9 42.4 ± 17.2 1.3 ± 0.6 5 (-11 to 22)  
HOMA-IR # 1.06 ± 0.34 1.56 ± 0.69 1.5 ± 0.4 0.5 (0.1–0.8) 0.81 ± 0.14 1.37 ± 0.51 1.7 ± 0.8 0.6 (0.2–0.9) 1.41 ± 0.83 1.59 ± 0.73 1.3 ± 0.6 0.2 (-0.5 to 0.8)  
HOMA-β (%) # 60 ± 27 81 ± 29 1.4 ± 0.4 21 (8–35)  49 ± 12 72 ± 29 1.5 ± 0.6 23 (4–41) 78 ± 47 95 ± 41 1.4 ± 0.6 17 (-17 to 52)  
TG (mmol·l-1) # 0.7 ± 0.2 1.3 ± 0.7 1.8 ± 0.2  0.6 (0.2–1.0) 0.6 ± 0.2 0.9 ± 0.3 1.6 ± 0.7 0.3 (0.1–0.5) 0.8 ± 0.2 1.0 ± 0.4 1.3 ± 0.4 0.3 (0.0–0.5)  
NEFAs (mmol·l-1) #  0.5 ± 0.3 0.2 ± 0.1 0.6 ± 0.5 -0.3 (-0.6 to -0.1) 0.4 ± 0.2 0.1 ± 0.1 0.3 ± 0.2 -0.3 (-0.4 to -0.1) 0.8 ± 0.7 0.2 ± 0.1 0.3 ± 0.2 -0.6 (-1.1 to 1.02)  
Total cholesterol 
(mmol·l-1) 
3.9 ± 0.7 4.0 ± 0.7 1.0 ± 0.1 0.1 (-0.2 to 0.3) 3.7 ± 0.6 3.8 ± 0.3 1.0 ± 0.1 0.1 (-0.2 to 0.4) 4.0 ± 0.6 4.1 ± 0.5 1.0 ± 0.1 0.1 (-0.2 to 0.4) 
HDL cholesterol 
(mmol·l-1) 
1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.1 0.1 (-0.1 to 0.1) 1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.1 0.1 (-0.1 to 0.1) 1.3 ± 0.2 1.3 ± 0.2 1.0 ± 0.1 0.1 (-0.1 to 0.1) 
LDL cholesterol 
(mmol·l-1) 
2.5 ± 0.5 2.2 ± 0.4 0.9 ± 0.1 -0.2 (-0.4 to -0.1) 2.4 ± 0.5 2.3 ± 0.3 1.0 ± 0.2 -0.1 (-0.3 to 0.1) 2.3 ± 0.4 2.3 ± 0.3 1.0 ± 0.2 -0.1 (-0.3 to 0.3) 
ALT (U·l-1)  # 23 ± 7 29 ± 13 1.2 ± 0.5 6 (-1 to 13) 23 ± 11 36 ± 11 1.8 ± 0.7 13 (5–20) 24 ± 7 32 ± 12 1.4 ± 0.6 8 (0 to16)  
Whole blood WBC 
(×109·l-1) * 
5.3 ± 1.3 7.3 ± 3.0 1.4 ± 0.5 2.0 (0.3–3.8) 5.3 ± 1.3 5.9 ± 1.1 1.1 ± 0.1 0.6 (0.3–1.0) ¥ 5.7 ± 1.9 5.6 ± 1.5 1.0 ± 0.1 -0.1 (-0.7 to 0.5)  
 
HOMA-IR, homeostatic model assessment for insulin resistance; HOMA- β, homeostatic model assessment for β-cell function; ALT, alanine transaminase; TG, triglycerides; 
NEFA, non-esterified fatty acids; HDL, high-density lipoprotein; LDL, low-density lipoprotein; WBC, while blood cell. Values are means ± SD, with fold changes (Day 8 / 
Day 1) after intervention. Change scores with 95% confidence interval (CI) for each group. * Interaction effect (group × day; p ≤ 0.05); # Day effect (Day 1 versus Day 8, the 
average of three groups; p ≤ 0.05). ¥ Day effect (Day 1 versus Day 8 within group; p ≤ 0.05). 
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 Adipose Tissue mRNA Expression 
As shown in Figure 6.6, adipose tissue SREBP-1c gene expression was up-regulated in all three 
groups and a difference was found among three groups following the intervention (p ≤ 0.05). 
Post hoc analysis revealed that the change in adipose SREBP-1c mRNA expression in OVER 
+ EN was higher than OVER and OVER + BREAKS groups (p ≤ 0.05), though no difference 
was found between OVER and OVER + BREAKS groups.  
 
Adipose tissue FAS mRNA expression was also up-regulated in all three groups after 
intervention and the difference approached statistical difference among three groups (p = 0.06). 
The expression of the remaining adipose genes were not different but there were systematic 
changes in all three groups. The expression of AMPK, adiponectin, PDK4, HSL and IRS2 were 
all down-regulated and GLUT4 was up-regulated after the one week energy surplus in all three 
groups, independent of the intervention applied.  
  





Figure 6.6 Fold changes in relative adipose tissue gene expression (mRNA levels) 
Fold changes (Day 8/Day1) in relative gene expression (mRNA levels) of metabolic, insulin signaling, glucose transport and inflammatory genes in adipose 
tissue in OVER and OVER + EN (both n = 5), and OVER + BREAKS (n = 8) groups, except for TNF-α (n = 4 in OVER, n = 1 in OVER + EN and n = 5 in 
OVER + BREAKS). The dashed line indicates baseline (Day 1). Data normalised to PPIA, internal calibrator and baseline. Samples that exceeded the detectable 
limit (Ct > 35) were excluded from the analysis. Values are means ± SEM. * p ≤ 0.05 OVER + EN greater than OVER and OVER + BREAKS.  
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6.4 Discussion  
This is the first study to investigate the effect of different forms of physical activities 
on the response to overfeeding. We demonstrated that short-term overfeeding combined 
with restricted physical activity resulted in the reduction of insulin sensitivity and 
altered the expression of genes related to carbohydrate and lipid metabolism, lipid 
synthesis and insulin regulation pathway expression in adipose tissue. In adipose lipid 
synthesis genes, the expression of SREBP-1c and FAS mRNA were up-regulated in all 
three groups after the intervention; however, the expression of these two genes was 
relatively lower in OVER + BREAKS when compared to OVER and OVER + EN 
groups. In addition, we also found that intermittent physical activity (constantly 
breaking prolonged sitting) is capable of alleviating the energy surplus-induced 
circulating inflammatory response (i.e., it reduced WBC counts). 
 
 Circulating blood measures responses after the intervention 
Only one other study has shown that a single, daily bout of vigorous intensity exercise 
(70% V̇O2max) was capable of reversing impairments to insulin sensitivity induced by 
overfeeding (Walhin et al., 2013). Our results demonstrated that insulin iAUCs were 
increased in all three groups after one week of overfeeding, irrespective of the type of 
physical activity assessed. One reason for this discrepancy could be due to the exercise 
intensity, as for exercise intensities above 70% V̇O2max, up to 70% of energy is derived 
from carbohydrate (Kang et al., 2007), which might translate to approximately 50 
g·day-1 of negative carbohydrate storage (Walhin et al., 2013). However, the exercise 
intensity in OVER + EN was 50% V̇O2max, reducing the capabilities of the body to utilize 
carbohydrate at this intensity (Venables et al., 2005; Kang et al., 2007). This might 
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explain why the insulin response to an OGTT might not have been affected in the 
current study.  
 
As was also observed in the only other study to investigate the effects of exercise and 
overfeeding (Walhin et al., 2013), in the present study, TAG and ALT were increased 
and NEFA was decreased after one week overfeeding.   
 
 Adipose tissue mRNA gene expression after the intervention 
AMPK regulates cellular energy homeostasis by becoming activated in the face of high 
AMP/ATP and ADP/ATP ratios, which stimulates energy synthesis and inhibits 
lipogenesis and gluconeogenesis (O'Neill, 2013). The expression of adipose AMPK 
mRNA was down-regulated after short-term overfeeding with a single daily bout of 
vigorous intensity exercise (Walhin et al., 2013). Similarly, we found that even though 
different forms of physical activity was undertaken, adipose AMPK mRNA expression 
was still down-regulated in all three groups. This implies that gluconeogenesis and 
lipogenesis might be elevated due to an extra 50% energy surplus. However, compared 
to the other two groups, the reduction of AMPK mRNA expression in OVER + 
BREAKS was relatively lower (albeit not significantly). Although far from certain at 
this stage, one explanation for this finding could be that regular body movements as a 
consequence of breaks to prolonged periods of sitting constantly stimulated AMPK 
activation.  
 
In addition to the reduced energy synthesis as a result of the down-regulation of AMPK 
mRNA expression, a reduction in glycolysis and lipolysis might also play a role in the 
regulation of energy metabolism. The expression of adipose PDK4 and HSL mRNA 
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were both down-regulated in all three groups in current study. The main role of PDK4 
is to regulate glucose metabolism by inhibiting the pyruvate dehydrogenase (PDH) 
complex and the activated PDK4, switching energy metabolism preference from 
glucose to lipid utilisation. Similar to other overfeeding studies (Shea et al., 2009; 
Walhin et al., 2013), we also found that the expression of PDK4 was down-regulated 
after one week’s overfeeding irrespective of the combination with different types of 
physical activity. The reduction of PDK4 would increase glucose utilisation which 
evidenced here by an increased RER in all three groups (0.80 ± 0.04 to 0.94 ± 0.09 in 
OVER; 0.82 ± 0.08 to 0.94 ± 0.12 in OVER + EN and 0.86 ± 0.05 to 0.95 ± 0.05 in 
OVER + BREAKS).  
 
ATGL and HSL are the two most important lipolytic enzymes which are activated 
during fasting and exercise and suppressed with feeding. Surprisingly, only HSL was 
down-regulated in OVER, OVER + EN and OVER + BREAKS. Adipose HSL gene 
expression was also found to decrease in response to overfeeding in combination with 
vigorous intensity exercise in a previous study (Walhin et al., 2013). Taken together, 
the down-regulation of adipose AMPK, PDK4 and HSL mRNA gene expression might 
potentially decrease glycolysis, lipolysis as well as energy synthesis.  
 
From an energy metabolism perspective, the proportion of substrate utilization in 
OVER + EN and OVER + BREAKS may differ. In OVER + EN group (continuous 
exercise), adipose and intramuscular triglycerides, and circulating NEFA are the main 
energy substrates (Horowitz, 2003). Therefore, the original stored lipid might provide 
most of the energy expenditure, so that most of the consumed energy needs to be 
processed and stored. On the contrary, the preference for energy substrate utilized in 
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OVER + BREAKS (intermittent exercise) might be have been towards carbohydrate 
(based on the result of the Chapter 5) and consumed carbohydrate might constantly be 
utilized during walking. Accordingly, even though physical activity induced energy 
expenditure was very similar (approximately 420 kcal per day) between OVER + EN 
and OVER + BREAKS groups; it could potentially result in very different types of 
substrate utilization throughout the intervention. As a result, this might influence energy 
storage and relevant gene regulation differently.  
 
SREBP-1c is a transcriptional factor, which is induced by feeding/insulin and plays a 
role to regulate the expression of several genes involved in lipid synthesis. FAS is one 
of the lipogenic enzymes regulated by SREBP-1c (Gosmain et al., 2005) and its main 
function is to catalyse malonyl-CoA into palmitoyl-CoA. The expression of adipose 
SREBP-1c and FAS mRNA has been shown to be up-regulated in response to 
overfeeding (Minehira et al., 2004; Walhin et al., 2013). However, Walhin et al. (2013) 
found that a daily 45 min bout of vigorous intensity exercise (70% V̇O2max) blunted both 
genes in response to overfeeding. Similarly, we found that the expression of SREBP-
1c and FAS was up-regulated in all three groups after overfeeding but surprisingly their 
expression was blunted in OVER + BREAKS rather than in OVER + EN group. There 
are several possible explanations for this occurrence: Insulin has been shown to affect 
SREBP-1c mRNA expression, demonstrating 3–4 fold changes in human adipose 
SREBP-1c mRNA expression after 4 h insulin infusion (Boden et al., 2013). In the 
current study, the OVER + EN group demonstrated the highest fasting insulin levels, 
possibly explaining why SREBP-1c mRNA expression was significantly higher than 
the other two groups. SREBP-1c has also been linked with de novo lipogenesis (DNL). 
The lipid stored in adipose tissue can be from dietary lipid, from carbohydrate via DNL, 
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or from a mixture of the two. Indeed, to lend support to this concept, DNL has been 
shown to significantly increase in response to high carbohydrate overfeeding 
interventions (Minehira et al., 2004; Acheson K, 1998). The short-term energy 
imbalance-induced weight gain might increase glycogen content alongside water 
storage via DNL (Walhin et al., 2013). As lean mass increased in the OVER (1.0 ± 0.8 
kg), OVER + EN (2.4 ± 1.7 kg) and OVER + BREAKS (1.0 ± 1.2 kg) groups, this could 
be demonstrative of increased glycogen and water storage as a result of DNL.  
 
The translocation of adipose GLUT4 from intracellular compartments to the cell surface 
is stimulated by insulin signalling pathways (e.g., in postprandial period) (Huang & 
Czech, 2007) and adipose tissue is one of the tissues which disposes of postprandial 
glucose. In agreement with other studies (Walhin et al., 2013; Gillberg et al., 2016), the 
expression of GLUT4 mRNA here was up-regulated in response to overfeeding. There 
are several possible explanations for this occurrence. First, the increase in fasting 
insulin levels in all three groups might result in the higher expression of adipose GLUT4 
at baseline level, and there was a correlation for these parameters (r2 = 0.55; p = 0.01). 
Adipose GLUT4 mRNA expression was found to be associated with insulin resistance 
(Kouidhi et al., 2013; Travers et al., 2015b). Another potential explanation could be 
that a short-term energy surplus resulted in GLUT4 insensitivity, resulting in high 
baseline GLUT4 expression to overcome this insensitivity.  
 
IRS2 is one of insulin receptors which mediates the initial stage of insulin signalling. 
In rodent studies, disruption of IRS2 (e.g., IRS2 deficient or knockout mice) impaired 
glucose homeostasis by a deterioration in peripheral insulin signalling and pancreatic 
β-cell function (Withers et al., 1998; Kubota et al., 2000; Kubota et al., 2004). 
Chapter 6                                                             Study 3  
147 
 
Moreover, chronic low levels of IRS2 mRNA have been found in insulin resistant 
humans (Travers et al., 2015b). It has been consistently shown that both short-term high 
carbohydrate and high-fat overfeeding reduces the expression of adipose IRS2 mRNA 
(Shea et al., 2009; Walhin et al., 2013; Gillberg et al., 2016). The reduction of adipose 
IRS2 mRNA expression in the present study might reflect the process of impaired 
insulin sensitivity in response to overfeeding. Interestingly, vigorous intensity exercise 
was found to prevent the overfeeding-induced down-regulation of IRS2 mRNA 
expression (Walhin et al., 2013), implying that exercise intensity has the capacity to 
regulate IRS2 mRNA expression even in the face of short-term energy surplus. 
Collectively, the expression of specific insulin signalling genes were systematically 
altered after overfeeding (i.e., increased GLUT4 and decreased IRS2 mRNA) which 
might be due to impaired insulin sensitivity, and this seems independent of the different 
types of physical activity involved. 
 
6.5 Conclusion  
This study demonstrated that short-term overfeeding combined with restricted physical 
activity resulted in the impairment of insulin sensitivity independent of the different 
type of physical activity involved and also altered the expression of genes related to 
carbohydrate and lipid metabolism, lipid synthesis and insulin regulation pathways in 
adipose tissue. However, constantly breaking prolonged sitting physical activity was 
able to reduce overfeeding induced circulating inflammatory response (i.e., reducing 
WBC counts) and reduced adipose lipid synthesis gene expression, suggesting that 
constant short bouts of walking might be considered useful for general populations and 
also applied for future exercise prescription.   
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7 Chapter 7: General discussion 
7.1 Overview  
Throughout the conducted three experimental projects, I have intended to explore the 
impact of different types of physical activity via structured prolonged exercise and 
NEAT-type physical activity on physiological responses – especially focusing on 
adipose tissue. Chapter 4 intended to understand how diet interacts with the responses 
to acute exercise. Chapter 5 investigated the effect of NEAT-type physical activity and 
Chapter 6 examined how different type of physical activity (a single bout of daily 
moderate intensity exercise versus NEAT-type physical activity) impacts upon the 
response to short-term energy surplus. The findings and conclusions in each chapter are 
summarised as follows:  
 
 Chapter 4: Feeding influences adipose tissue responses to exercise in 
overweight men 
1. Overnight fasting prior to exercise impacted upon metabolism during moderate 
intensity exercise (60% V̇O2max for 1 h), increasing fat oxidation and decreasing 
carbohydrate oxidation. 
2. Exercise in a fasted state influenced adipose tissue responses to exercise 
including an up-regulation of adipose lipolytic enzymes (ATGL and HSL), lipid 
transporter (FAT/CD36), glucose transporter (GLUT4), glycolytic inhibitor 
enzyme (PDK4) and insulin signalling receptor (IRS2) mRNA expression when 
compared to exercise in a fed state. 
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3. Circulating and adipose ex-vivo adipokine secretion (IL-6, adiponectin and 
leptin) responses were not affected with exercise either under a fasted or fed 
state. 
 
 Chapter 5: The effect of breaking prolonged sitting on metabolism and 
adipose tissue in middle-age overweight men and women 
1. Participating in regular short bouts of walking (merely 243 ± 66 kcal energy 
expenditure) reduces postprandial glucose and insulin concentrations in 
overweight and obese people, possibly via an increase in carbohydrate oxidation 
during walking.  
2. Even though there was a reduction of postprandial glucose and insulin 
concentrations with breaking sedentary behaviour, this did not influence 
adipose tissue metabolic, insulin signalling and inflammatory gene expression.  
3. Several adipose genes were systematically changed in both prolonged sitting 
and breaking sitting trials. This could reflect meal-induced adipose tissue 
responses and these might outweigh the small impact from regular walking. 
4. Accumulating short bouts of physical activity did not affect circulating and 
adipose ex-vivo adipokine secretion (IL-6, adiponectin and leptin). 
 
 Chapter 6: The effect of alternative physical activity strategies on short-
term overfeeding in young healthy men 
1. Short-term energy surplus (50% overfeeding of habitual diet) impaired insulin 
sensitivity irrespective of the type of physical activity. 
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2. NEAT-type physical activity (OVER + BREAKS) possibly alleviated 
overfeeding-induced inflammation, with no change in white blood cell (WBC) 
counts in comparison to both other groups.  
3. OVER + BREAKS blunted overfeeding induced lipogenic signals via a 
reduction in adipose SREPB-1c and FAS mRNA expression. 
  




The studies in this thesis used a variety of different physical activity interventions and 
meal/diet based challenges. A summary of energy intake and expenditure on trial days 
are shown as below (Table 7.1).  
 
Table 7.1 Energy intake and energy expenditure in each experimental trial 
 Chapter 4 Chapter 5 Chapter 6 












        










        
Energy expenditure 
during exercise  
(kcal· day-1·trial-1) 
 
746 ± 129 
 








427 ± 54 
 
416 ± 89 
        




56 ± 5  58 ± 8   58 ± 7  
Total energy intake 
(kcal·day-1·trial-1)  
- 648 ± 115 1,724 ± 369 1,730 ± 366 4,677 ± 1,001 5,567 ± 788 4,992 ± 978 
        
Overfeeding level (%) - - - - 50 ± 0 63 ± 3 64 ± 2 
        
Overfeeding-induced 
energy surplus (%·day-1) 
- - - - 46 ± 6 46 ± 7 41 ± 4 
Values are means ± SD.  
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7.2 The effect of the energy intake on adipose tissue  
Apart from providing energy during prolonged exercise, another main task of adipose 
tissue is to process and/or store consumed energy (Romanski et al., 2000; Summers et 
al., 2001). The results indicated that SREPB-1c, IRS2 and PDK4 were consistently 
altered throughout all three projects. Indeed, it seems that fasting and feeding 
effectively regulate these pathways. For instance, high levels of hepatic IRS2 mRNA 
expression was significantly reduced by feeding (Ide et al., 2004), and the expression 
of adipose and hepatic SREPB-1c mRNA was up-regulated after feeding (Palou et al., 
2008). Inverse correlations have been found between various nutritional conditions and 
SREPB-1c as well as IRS2 mRNA (Ide et al., 2004). In a rodent study, in liver, SREBP 
was found to directly repress transcription of IRS2 and this further inhibited hepatic 
insulin signaling with a switch from glycogen synthesis to lipogenesis (Ide et al., 2004).  
 
In this thesis, the expression of lipogenesis-related transcriptional molecules SREPB-
1c were all increased with energy intake in all trials (Figure 7.1). In Chapter 4 and 5, 
the expression of IRS2 mRNA was decreased after energy intake independent of the 
type of meal and total energy intake. In Chapter 6, overfeeding induced energy surplus 
down-regulated adipose IRS2 mRNA in OVER, OVER + EN and OVER + BREAKS 
(Figure 7.2). Taken together, over the three projects, and similar to rodents, the results 
demonstrate that human adipose SREPB-1c and IRS2 mRNA respond very clearly to 
feeding. Other studies also show similar findings, indicating that a short-term energy 
surplus resulted in increased adipose SREPB-1c and a decrease in IRS2 (Walhin et al., 
2013). Consistent with previous studies, the expression of adipose IRS2 mRNA is 
decreased whether after a single meal in lean, overweight and obese men (Travers et 
al., 2015b), or short-term energy surplus (Shea et al., 2009; Walhin et al., 2013). 





Figure 7.1 The expression of adipose SREBP-1c responses throughout this thesis 
Fasted-Ex and Fed-Ex (all n = 10), Prolonged sitting and Breaking sitting (all n = 9), OVER 
and OVER + EN (both n = 5) and OVER + BREAKS (n = 8). Values are means ± SEM. The 




Figure 7.2 The expression of adipose IRS2 responses throughout this thesis. 
Fasted-Ex and Fed-Ex (all n = 10), Prolonged sitting and Breaking sitting (all n = 9), OVER 
and OVER + EN (both n = 5) and OVER + BREAKS (n = 8). Values are means ± SEM. The 
dashed line indicates baseline. 
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PDK4 mainly regulates glucose metabolism and inhibits glycolysis when activated. 
Fasting elevated the expression of skeletal muscle and hepatic PDK4 mRNA (Spriet et 
al., 2004; Palou et al., 2008), and refeeding decreased hepatic PDK4 mRNA expression 
after 8 h of fasting (Palou et al., 2008). Consistent with previous findings, adipose 
PDK4 mRNA was up-regulated in Chapter 4 with exercise under a fasted state, and all 
other feeding trials consistently found that adipose PDK4 mRNA was down-regulated 
(Figure 7.3). A decrease in PDK4 elevates glycolysis and decreases lipolysis, which 




Figure 7.3 The expression of adipose PDK4 responses throughout this thesis. 
Fasted-Ex and Fed-Ex (all n = 10), Prolonged sitting and Breaking sitting (all n = 9), OVER 
and OVER + EN (both n = 5) and OVER + BREAKS (n = 8). Values are means ± SEM. The 
dashed line indicates baseline. 
 
The expression of IRS2 adipose mRNA is down-regulated in obese and overweigh 
populations compared to lean people (Travers et al., 2015b). In addition, IRS2 mRNA 
expression is down-regulated after one-week overfeeding plus sedentary life style 
(Walhin et al., 2013). Taken together, this demonstrates that the decrease in adipose 
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IRS2 mRNA could be a result of inflammatory processes. In addition, a previous study 
showed that feeding acutely down-regulated adipose IRS2 mRNA expression across 
obese, overweight and lean people (Travers et al., 2015b). Therefore, collectively, diet-
induced acute down-regulation of adipose IRS2 mRNA expression might potentially 
link inflammatory processes with a role of the insulin receptor. But, the expression of 
adipose IRS2 mRNA was increased only in the trial whilst exercising under fasted 
status in Chapter 4. The up-regulation in adipose mRNA might indicate that potential 
health benefits while exercise is undertaken under a fasted state. However, this 
hypothesis is not certain at this stage and would need results from long-term training 
studies.  
 
SREPB-1c is a transcription factor which regulates fatty acid synthesis when energy is 
consumed. It is reasonable to observe up-regulation of adipose SREPB-1c mRNA in 
Chapter 5 and 6 due to energy intake outweighing energy expenditure. Interestingly, in 
Chapter 4, while exercise under a fed condition, even though the overall exercise 
expenditure and energy intake was similar, the expression of adipose SREPB-1c mRNA 
was still increased 4 h after meal consumption. The increase of adipose SREPB-1c 
mRNA in this study might be due to an increased external energy intake, as a 
physiological response to store the consumed energy. On the contrary, whilst exercising 
under a fasted state in Chapter 4, even after a negative energy balance was induced by 
1 h of moderate intensity exercise, the expression of adipose SREPB-1c was not 
changed. Taken together, the result might demonstrate that whilst energy intake and 
expenditure were similar, dietary modifications could be the main factor influencing 
adipose SREPB-1c mRNA expression rather than exercise, per se.  
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Collectively, the changes in these two adipose molecules (IRS2 and SREPB-1c) 
emphasise how adipose tissue plays an active role in responding to feeding and physical 
activity.  
 
7.3 Physical activity in the regulation of insulin and glucose 
levels 
It is well established that a feeding-induced increase in insulin can be alleviated by 
acute structured exercise. Unsurprisingly, in Chapter 4, exercise at 60% V̇O2max for 60 
min reduced insulin concentrations in overweight people. In Chapter 5, participating in 
merely 2 min light intensity exercise every 20 min throughout two meals reduced 
circulating glucose and insulin levels in overweight middle-age men and women. This 
finding suggests that NEAT-type physical activity can be used as a strategy to regulate 
circulating glucose and insulin – and this could be useful because structured exercise is 
not feasible and practical for all populations. In addition, although this study is not fully 
complete, NEAT-type physical activity seemed to reduce overfeeding-induced 
inflammation (as indicated by white blood cell count). Therefore, for some outcomes, 
it appears that this could be an effective physical activity strategy for health and this 




There are some limitations in the experimental studies in this thesis. In Chapter 4, while 
exercising under different dietary status (fasted versus fed), due to the potential effect 
from repeated biopsies inducing adipose tissue inflammation (Dordevic et al., 2015), 
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an immediate pre-exercise adipose biopsy was not taken. Therefore, it is hard to 
elucidate whether the magnitude of adipose responses whilst exercising under a fasted 
state is caused by overnight fasting, exercise or interaction of both conditions. In 
Chapter 5, a resting trial was not included (i.e., without meal intake) and owing to the 
nature of adipose circadian rhythms (Johnston et al., 2009; Johnston, 2012), the 
regulation of gene expression in adipose tissue (i.e., meal or circadian rhythm effect) is 
still unclear. In Chapter 6, protein measures (i.e., Western Blotting) are missing and the 
study is also relatively short – thus it is difficult to extrapolate to longer term energy 
surpluses. 
 
Apart from the limitations in each experimental study, it is also important to highlight 
that any attempt to compare between the studies in this thesis is also limited. Firstly, 
the recruited participants’ characteristics were different, owing to the different research 
purpose of each project, which could induce a diverse adipose tissue and general 
physiological responsiveness to meals and exercise/physical activity. Secondly, the 
exercise/physical activity intensity, exercise/physical induced energy expenditure, the 
proportion of the macronutrients, absolute energy intake and the trial length are 
different among these three projects and this can also limit comparisons between studies. 
 
7.5 Future work 
Based on the results of Chapter 4, given that adipose tissue had a very different acute 
response while exercising under different dietary conditions, it is possible that adipose 
tissue adaptation might different when exercise training under diverse feeding states. 
This would need to be tested in an intervention study. In Chapter 5, in both prolonged 
sitting and breaking sitting trials, adipose tissue responded in a broadly-similar manner. 
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It is not clear whether this is a meal or circadian rhythm effect. Studies have reported 
circadian rhythms in adipose tissue (Johnston et al., 2009; Johnston, 2012). Therefore, 
studies could further examine this question to better understand the effect from feeding. 
The study described in Chapter 6 showed that at mRNA gene expression level, adipose 
tissue responsiveness to different physical activity interventions alongside overfeeding 
is different (especially in lipogenic signals). Western blotting analysis can be 
considered to further identify adipose tissue responsiveness at the protein level. 
 
7.6 Conclusion  
The results from this thesis emphasise the various ways in which physical activity can 
impact upon adipose tissue and metabolic health. This includes a clear effect on energy 
balance and changes in pathways in adipose tissue associated with a reduction in 
adipose tissue masses. However, this thesis also includes effects from physical activity 
that appear independent and not necessarily associated with a (profound) reduction in 
adipose tissue masses. This notwithstanding, the effects of feeding on adipose tissue 
are also profound and clearly more studies are required to understand the relationship 
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9.1 Appendix 1: Health Screen 
 
It is important that volunteers participating in research studies are currently in good health and 
have had no significant medical problems in the past.  This is to ensure (i) their own continued 
well-being and (ii) to avoid the possibility of introducing bias into the study outcomes. 
Please complete this brief questionnaire to confirm your eligibility to participate: 
1. Age……………………………………………………………………………………...... 
 
2. Do you smoke           Yes      No      
 
3.  At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .............................. Yes      No 
     
(b) attending your general practitioner ..................................... Yes      No 
     
(c) on a hospital waiting list ..................................................... Yes      No 
     
 
4.  In the past two years, have you had any illness which require you to: 
(a) consult your GP  ............................................................... Yes      No 
     
(b) attend a hospital outpatient department .............................. Yes      No 
     
(c) be admitted to hospital   .................................................... Yes      No 
     
 
5.  Have you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes      No 
     
(b) Asthma ................................................................................ Yes      No 
     
(c) Eczema ................................................................................ Yes      No 
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(d) Diabetes .............................................................................. Yes      No 
     
(e) A blood disorder ................................................................. Yes      No 
     
(f) Head injury.......................................................................... Yes      No 
     
(g) Digestive problems ............................................................. Yes      No 
     
(h) Heart problems .................................................................... Yes      No 
     
(i) Breathing problems ............................................................. Yes      No 
     
(j) Problems with bones or joints    ....................................... Yes      No 
     
(k) Disturbance of balance/coordination .................................. Yes      No 
     
(l) Numbness in hands or feet .................................................. Yes      No 
     
(m) Disturbance of vision .......................................................... Yes      No 
     
(n) Ear / hearing problems ........................................................ Yes      No 
     
(o) Thyroid problems ................................................................ Yes      No 
     
(p) Kidney or liver problems .................................................... Yes      No 
     
(q)   Problems with immune system ………………………….. Yes     
 ............................................................................................ No      
(r) Allergies to any anaesthetics  ............................................. Yes      No 
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(s) Porphyria  ........................................................................... Yes      No 
     
(t) Myasthenia gravis  ............................................................. Yes      No 
     
(u)  Adam’s-Stokes Syndrome  ................................................ Yes      No 
     
(v)  Wolff-Parkinson-White Syndrome ..................................... Yes      No 
     
 
The local anaesthetic we use is called lidocaine, this is the anaesthetic dentists typically use. Have 
you ever had this before to know if you have any allergies to this anaesthetic (or any other 
anaesthetics) or have you ever been told that you shouldn't have this?................................... Yes 
     No      
 
If YES to any question, or if there is any other information you think we should know, 




6.  Has anyone in your family been diagnosed with any of the above? If so, please specify  
............................................................................................................................................................. 
7.  During a typical 7-Day period (a week), how many times on the average do you do the 
following kinds of exercise for more than 15 minutes during your free time (write on each line 
the appropriate number –e.g. 2 hours total of moderate intensity exercise per week = 8 x 15 minutes, 
so write 8): 
a) STRENUOUS EXERCISE (HEART BEATS RAPIDLY) 
__________________________ 
(e.g., running, jogging, hockey, football, soccer, squash, basketball, judo, roller skating, 
vigorous swimming, vigorous long distance bicycling) 
b) MODERATE EXERCISE (NOT EXHAUSTING) 
________________________________ 
(e.g., fast walking, baseball, tennis, easy bicycling, volleyball, badminton, easy swimming, 
popular and folk dancing) 
c) MILD EXERCISE (MINIMAL EFFORT) 
_______________________________________ 
(e.g., yoga, archery, fishing from river bank, bowling, golf, easy walking) 
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9.3 Appendix 3: Instructions for the breaking sitting time 
 
Instructions for breaking sitting time  
Your target number of steps is __________ steps per day 
 
Overview 
You have been allocated to a group where the main aim is to engage in short bouts of activity 
throughout the day. This also means that there will only be a few periods of prolonged 
sedentary (e.g., sitting) time. So, from a conceptual perspective, we would like to ensure that 
you spread your target steps throughout the day – a bit like in the graph below: 
 
 
Although this means you will be able to move freely during this study, this might be challenging 
at times and so we have come up with a guide below to help you achieve your target steps spread 
throughout the day: 
1. You should try to take 15-25 walks throughout the day (i.e., approximately every 30-
40min), each lasting ~5 minutes to ensure you achieve your target steps (at your normal 
pace). This will make sure you reach your target number of steps easily. 
2. You should try to make sure that you never spend more than 1 h sat in one place.  
3. Plan your day to make sure you do not exceed your target number of steps. 
4. Aim to reach half your target number of steps ____________ before 2-3pm. 
5. Wear the pedometer on your waist every day but remember to re-set it to zero first thing 
in the morning. 
6. Please record the timing of the activity breaks and the number of steps in the booklet 
provided. 
7. Ideally, we would like to do activity ‘little and often’ and preferably you would not do any 
long walks Most of time, you should plan approximately 500-600 steps to meet your daily 
target number of steps little by little. Try to limit longer walks greater than 1,500 steps to 
only once per day, and try to keep this under 2000 steps as a maximum in one go.  
8. Try to do any weekly tasks on the days before the main trial starts (i.e. weekly shopping). 
Otherwise, you will exceed 1,500 steps in one go.  







8AM                                                                           10PM                                                                                            
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10. It does not matter if you have more activity breaks and these can be shorter than 5 
minutes if this is helpful or useful - as long as the target number of steps is reached each 
day. 
 
General strategies for reaching the step target 
 Find a place near where you spend most of your time which is roughly 500-600 steps 
walking distance. 
 You might want to set up an alarm to remind you to have a walk every 30-40min.  
 Plan short walks to increase your steps alongside other activities (e.g., when going to the 
toilet). 
 Plan 500-600 steps to grab your breakfast, lunch and dinner (you can accumulate 1,500-
1,800 steps by doing this). 
 Do 500-600 steps after finishing your breakfast, lunch and dinner (you can accumulate 
1,500-1,800 steps by doing this). 
 If possible, try to accumulate your steps on flat ground as much as possible (e.g. avoid 
increasing your steps by going upstairs and downstairs). 
 If you have a long meeting or lecture without a break, please plan a 1,000 steps walk (it 
takes approximately 10 min) before and afterwards. This can help you to accumulate your 
target number of steps easily.  
 
